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Escherichia coli (E. coli) are a diverse species of bacteria that reside, often 
harmoniously and beneficially, in the gastrointestinal tracts of humans and 
other mammals.  However, some strains are associated with serious intestinal 
and extra-intestinal disease and are considered pathogens.  The main differences 
between strains of these different E. coli pathotypes can be explained by the 
acquisition of genetic information introduced by mobile genetic elements, in 
particular bacteriophage.  In enterohaemorrhagic E. coli (EHEC) O157:H7 strain 
EDL933, a pathotype of E. coli containing prophage-encoded Shiga toxins 
associated with severe gastrointestinal and systemic disease in humans, these 
horizontally acquired elements have been termed O-islands (OIs) and include 
both fully functional and cryptic prophages.  The overall aim of this research 
was to try and determine what these OIs are actually doing for the bacteria.  
Systems pertinent in the life cycle and virulence of this pathogen were therefore 
investigated by phenotypically screening a large library of OI deletions in EHEC 
strain TUV93-0, a Shiga toxin-negative derivative strain of EDL933, and then 
comparing these with the parent strain.  These analyses highlighted a subset of 
OIs with the potential to regulate motility and type III secretion (T3S), the latter 
being an essential colonisation factor for EHEC that is encoded by the locus of 
xxi 
 
enterocyte effacement (LEE).  Deletion of OI-51, a 14.93 Kb cryptic prophage 
designated as CP-933C, significantly reduced persistence of faecal shedding in 
sheep and levels of T3S expression in vitro.  Cloning and complementation 
together with targeted allelic replacements in OI-51 identified a novel positive 
regulator of the LEE, encoded by ecs1581 in the sequenced E. coli O157:H7 strain 
Sakai that is present but not annotated in the EDL933 sequence.  Functionally 
important residues of ECs1581 were identified by site-directed mutagenesis 
based on phenotypic variants present in strains from different E. coli pathotypes, 
including strains not harbouring a LEE-encoded T3S system.  This regulator was 
subsequently termed RgdR based on a motif demonstrated to be important for 
stimulation of gene expression from LEE1.  Purified RgdR protein was able to 
form multiple complexes on a PCR generated LEE1 promoter fragment, and 
activation of this operon appeared to require this DNA binding capacity as a 
non-T3S inducing variant was unable to bind this same LEE1 promoter 
fragment.  RgdR did not directly activate LEE1 transcription in vitro, nor did it 
activate transcription by relieving H-NS repression as proposed for the global 
regulator Ler (LEE-encoded regulator).  However, RgdR activation did require a 
wild type LEE1 promoter and the Ler auto-induction cycle to induce LEE2-5 
expression and T3S.  RgdR was able to increase binding to Congo red and was 
xxii 
 
capable of repressing bacterial motility.  Further analyses demonstrated that 
RgdR did not regulate T3S and cell motility via GrlA (global regulator of LEE 
activator) and QseC (quorum sensing E. coli regulator C), two established 
regulators in E. coli that control LEE gene expression and motility in conjunction 
with their partners, GrlR (global regulator of LEE repressor) and QseB (quorum 
sensing E. coli regulator B) respectively.  RgdR is therefore identified as a novel 
regulator able to co-ordinate T3S and motility expression.  This research has 
identified OI-51 as being important for EHEC O157:H7 colonisation in sheep 
and has identified a completely new family of small bacterial regulators that 

























1.1 Introduction to Escherichia coli 
Escherichia coli (E. coli) is a highly diverse and adaptable species of Gram-
negative bacilli in the Enterobacteriaceae family.  As the predominant facultative 
anaerobe of the mammalian colonic flora, E. coli typically colonises the 
gastrointestinal (GI) tract within hours of life and with the commensal flora 
plays a crucial role in developing and maintaining intestinal physiology (Nataro 
and Kaper, 1998).  However, a subset of E. coli strains are associated with 
distinct syndromes of diarrhoeal disease, and different pathotype of this 
bacterium can also cause urinary tract infections, septicaemia and meningitis 
(Levine, 1987; Nataro and Kaper, 1998).  The main differences between strains of 
these different E. coli pathotypes can largely be explained by the acquisition of 
genetic information introduced by mobile genetic elements, in particular, 
bacteriophage. 
 
1.2 Pathotypes of E. coli 
As mentioned, several distinct pathogenic categories of diarrheagenic E. coli are 
now recognised.  Each pathotype is defined by a characteristic set of virulence-
associated factors that in turn determine the clinical, pathological and 
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epidemiological features of the disease they cause.  On the basis of these 
virulence associated determinants, diarrheagenic E. coli have been characterised 
into five principal pathotypes (Robins-Browne and Hartland, 2002).  
Serologically, each of these E. coli pathotypes can be distinguished by their 
distinctive O serogroups and O:H serotypes (Robins-Browne and Hartland, 
2002).  The current scheme for this classification of E. coli is a modified version 
of that originally proposed by the Danish bacteriologist Kauffman, in the 1940’s.  
In accordance with this scheme, E. coli are serotyped on the basis of their surface 
antigens, namely O (somatic), H (flagellar) and K (capsular) (Kauffman, 1947; 
Nataro and Kaper, 1998).  Although not without its limitations, this typing 
scheme has played an important role in the studies of the epidemiology and 
elucidating the pathogenesis of E. coli infection, and continues to do so though 
the scheme is now complemented by more modern typing techniques, such as 
multilocus sequence typing (MLST) that offer greater discrimination (Robins-
Browne and Hartland, 2002). 
 
1.2.1 Enterotoxigenic E. coli (ETEC) 
ETEC are one of the major etiological agents of infantile and traveller’s 
diarrhoea in less developed countries, and members of this group of 
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diarrheagenic E. coli are known to secrete at least one of two varieties of 
enterotoxin: (a) heat-stable enterotoxin (ST) and (b) heat-labile enterotoxin (LT) 
(Robins-Browne and Hartland, 2002).  It is the action of these enterotoxins, 
described below, that causes the diarrhoeal disease seen following infection by 
ETEC strains. ETEC infection is acquired mainly by the ingestion of 
contaminated food and water; with the bacteria colonising the proximal small 
intestine (Levine, 1987).  Clinical symptoms include loose stools, nausea, 
vomiting and abdominal cramps (Clarke, 2001). 
 
(a) Heat-stable enterotoxin (ST) 
ST is a low molecular weight peptide comprising 19 amino acids and shares 
significant homology with the intestinal paracrine hormone guanylin (Robins-
Browne and Hartland, 2002).  The heat stability of this monomeric enterotoxin is 
conferred by its multiple cysteine residues and their disulfide bonds (Nataro 
and Kaper, 1998).  Two unrelated classes of ST exist, namely STa (or ST-I) and 
STb, both of which are plasmid mediated (Clarke, 2001).  Genes for ST have also 
been found on transposons and in addition to ETEC, STa toxins are also 
produced by several other Gram negative bacteria, including Yersinia 
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enterocolitica (Y. enterocolitica) and Vibrio cholerae (V. cholerae) non-O1 (Nataro and 
Kaper, 1998).  The major receptor for STa is a membrane-spanning enzyme 
called guanylate cyclase C (GC-C), located in the apical membrane of intestinal 
epithelial cells (Nataro and Kaper, 1998).  Binding of STa to GC-C results in 
increased intracellular enzymatic activity and increased cyclic guanylate 
monophosphate (cGMP) levels (Nataro and Kaper, 1998), which in turn leads to 
the stimulation of chloride secretion and/or inhibition of sodium adsorption and 
subsequent intestinal fluid secretion (Nataro and Kaper, 1998).  Although STb is 
primarily associated with ETEC infections in pigs, some human ETEC isolates 
express this toxin (Nataro and Kaper, 1998). In contrast to STa however, the 
receptor for STb is still unknown. This is largely due to the tissue damage that is 
caused following binding of this toxin with the unknown ligand, resulting in the 
loss of villous epithelial cells, and partial villous atrophy (Clarke, 2001). 
 
(b) Heat-labile enterotoxin (LT) 
LT is an oligomeric toxin that shares significant homology (ca 80% identical 
protein sequence) with an enterotoxin expressed by V. cholerae, termed cholera 
enterotoxin (CT) (Nataro and Kaper, 1998).  In ETEC, two serotypes of LT can be 
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found, namely LT-I and LT-II.  Both these toxins are composed of a single A 
subunit (28 kDa), and five larger identical B subunits (11.5 kDa), the latter of 
which can bind ganglioside GM1, a receptor that is distributed widely in all 
tissues of the body (Nataro and Kaper, 1998).  It is the A subunit however that is 
solely responsible for the enzymatic activity of the toxin by activating adenylate 
cyclase (Clarke, 2001).  This results in increased intracellular levels of cyclic 
adenosine monophosphate (cAMP), which in turn leads to diarrhoea due to an 
alteration in electrolyte balance, a net result of decreased sodium absorbance by 
villous epithelial cells and stimulated chloride secretion by crypt cells (Clarke, 
2001).    
 
1.2.2 Enteroinvasive E. coli (EIEC) 
EIEC are an important cause of diarrhoea and are a significant cause of 
morbidity and mortality in young children in undeveloped countries, where 
sanitation and hygiene levels are of a poor standard (Robins-Browne and 
Hartland, 2002).  EIEC strains were first shown to be capable of causing 
diarrhoea in volunteer studies by DuPont et al (1971), and have since been 
shown to be biochemically, genetically, and pathogenically closely related to 
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Shigella spp (Nataro and Kaper, 1998).  Unlike ETEC, which remains within the 
intestinal lumen throughout the course of infection, EIEC are able to proliferate 
within the epithelial cells (Robins-Browne and Hartland, 2002).  This process 
results in the inflammation and ulceration of the mucosa and ultimately leads to 
cell death (Clarke, 2001).  This invasive phenotype, shared by both EIEC and 
Shigella spp, is dependant on the presence of a 120-140 MDa plasmid which 
encodes all the genes necessary for this virulence property (Clarke, 2001).  
Infection with EIEC is manifested clinically by fever; sever abdominal cramps, 
malaise, and watery diarrhoea followed by scanty dysenteric stools containing 
blood and mucus (Levine, 1987). 
 
1.2.3 Enteropathogenic E. coli (EPEC) 
As with ETEC and EIEC, EPEC are an important cause of infantile diarrhoea in 
the developing world (Nataro and Kaper, 1998).  A number of serotypes are 
responsible for disease and despite not producing any classical toxins, EPEC are 
armed with a variety of other virulence factors (Clarke, 2001).  In contrast to 
EIEC, EPEC do not penetrate the intestinal mucosa following infection and 
instead give rise to histopathological changes, termed attaching and effacing 
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lesions (A/E lesions) (Robins-Browne and Hartland, 2002).  This 
histopathological phenotype is the hallmark of EPEC and other diarrheagenic E. 
coli which share this phenotype.  The  pathological changes include bacterial 
attachment and effacement of the intestinal epithelial cell microvilli (Nataro and 
Kaper, 1998).  The intimate adherence of the bacteria to the epithelial cells causes 
marked changes in the host cell cytoskeleton and actin-rich pedestal formation 
at the site of bacterial contact (Nataro and Kaper, 1998).  The genes required for 
the formation of A/E lesions are contained within a pathogenicity island (PAI) 
on the bacterial chromosome termed the locus of enterocyte effacement (LEE) 
(Elliott et al., 1998; McDaniel et al., 1995; Schmidt, 2010).  Comprised of 
approximately 40 genes, the LEE encodes a type III secretion system (T3SS), 
multiple secreted proteins and a bacterial  adhesin called intimin, all of which 
are required by EPEC for the formation of A/E lesions on enterocytes (Elliott et 
al., 1998; Iguchi et al., 2009; Jarvis et al., 1995; Nataro and Kaper, 1998; Schmidt, 
2010).  The LEE and the TTSS it encodes are described in more detail in section 
1.3.2.2.  
 
In addition to the LEE, EPEC also possess a large virulence plasmid that 
includes genes encoding  bundle forming pili (bfp) (Clarke, 2001).  These Bfp are 
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considered to be responsible for the initial contact of EPEC with the intestine, 
and volunteer studies have shown that mutations in the genes required for bfp 
formation result in significantly milder illness, reinforcing their role in EPEC 
virulence (Robins-Browne and Hartland, 2002).  Clinically, EPEC illness is 
characterised by fever, malaise, vomiting, and diarrhoea with large amounts of 
mucus in the stool. In infants, EPEC infection tends to be clinically more severe 
than other diarrhoeal infections, and diarrhoeal episodes can persist for as long 
as two weeks (Levine, 1987).  The exact mechanism(s) of diarrhoea in EPEC 
infection however remain(s) to be fully elucidated, although several have been 
proposed.  These include malabsoption due to the dramatic loss of microvilli in 
the A/E lesion, alteration of ion transport in epithelial cells by EPEC, and 
diarrhoea due to inflammation and increased intestinal permeability (Nataro 
and Kaper, 1998).  
 
1.2.4 Enteroaggregative E. coli (EAEC) 
EAEC, like the other pathotypes of ETEC, EPEC and EIEC, are a significant 
cause of diarrhoea in developing countries and are associated with acute and 
persistent diarrhoea, particularly in children (Clarke, 2001).  EAEC derive their 
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name from their distinctive adherence patterns on cultured cells, but in contrast 
to EPEC, do not induce A/E lesions (Clarke, 2001).  Instead, EAEC form a 
characteristic bacterial layer, widely described as a stacked-brick configuration, 
and experimental studies have shown that infection by EAEC results in 
increased mucus secretion at the mucosal surface, and characteristic mucus 
biofilm formation (Nataro and Kaper, 1998).  Although the pathogenesis of 
EAEC infection is not as well understood as for some of the other diarrheagenic 
E. coli classes, several candidate virulence factors have been described.  One of 
these virulence factors is a 38 amino acid protein known as enteroaggregative 
heat-stable enterotoxin (EAST1) that is functionally similar to ST (Clarke, 2001; 
Nataro and Kaper, 1998).  More recently, a 108 kDa cytotoxin has been described 
although the role of this in EAEC pathogenesis remains to be fully established 
(Nataro and Kaper, 1998).  In addition to these toxins, two fimbriae have been 
characterised from EAEC, termed aggregative adherence fimbriae I and II (AAFI 
and AAFII) (Clarke, 2001).  These plasmid encoded fimbriae are believed to be 
responsible for the aggregative adherence (AA) phenotype of EAEC, although 
other as yet unknown adherence factors may play a role in the binding of the 
bacterium to the mucosa and in biofilm formation (Nataro and Kaper, 1998).  
Although the site of EAEC infection in the human intestine has yet to be 
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demonstrated and the clinical features of EAEC diarrhoea are not well defined, 
evidence suggests that either watery or mucoid diarrhoea, with little or no 
vomiting, largely represents the symptoms of EAEC infection (Nataro and 
Kaper, 1998). 
 
1.2.5 Enterohaemorrhagic E. coli (EHEC) 
1.2.5.1 Nomenclature – EHEC, STEC and VTEC 
EHEC constitute a subset of serotypes of Shiga toxin producing E. coli (STEC), 
formerly known as Shiga-like-toxin producing E. coli (SLTEC), that have been 
associated with haemorrhagic colitis (HC) and haemolytic uraemic syndrome 
(HUS) in industrialised countries (Caprioli et al., 2005; Chase-Topping et al., 
2008).  Regarded as an emerging pathogen, it was initial observations by both 
Riley et al (1983) and Karmali et al (1985) that were responsible for the 
association of HC and HUS with infection by EHEC.  
 
It was this discovery of EHEC by a number of different researchers that lead to 
the current nomenclature system for this diarrheagenic pathogen.  Confusingly, 
EHEC strains are also known as verotoxigenic E. coli or Verocytotoxin 
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producing E. coli (VTEC), a consequence of the observations made by 
Konowalchuck et al (1977); that these strains are cytotoxic for Vero cells (Nataro 
and Kaper, 1998).  STEC and VTEC both refer to E. coli strains that produce one 
or more toxins of the shiga toxin (Stx) family, and these terms are used 
interchangeably by the scientific community.  Not all strains of STEC/VTEC are 
able to cause HC and HUS however and so the term enterohaemorrhagic E. coli 
was chosen to denote those strains that cause HC and HUS, express Stx, and 
carry other virulence determinants such as the LEE pathogenicity island and a 
large virulence plasmid (Robins-Browne and Hartland, 2002).  In effect, all 
strains referred to as EHEC have clinical connotations, and are highly 
pathogenic, as opposed to many STEC/VTEC strains that are apparently of 
lesser virulence (Nataro and Kaper, 1998). 
 
1.2.5.2 Clinical importance of EHEC  
In humans, EHEC infection is associated with a spectrum of clinical symptoms 
that range from asymptomatic infection to mild-non bloody diarrhoea, HC 
(bloody diarrhoea), HUS, thrombocytopenic purpura and death (Boyce et al., 
1995).  HC is a distinct clinical syndrome that presents typically with severe 
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abdominal cramps, bloody stools, little or no fever, and evidence of colonic 
mucosal oedema, erosion or haemorrhage (Griffin and Tauxe, 1991).  The 
disease is distinguished from inflammatory colitis by the lack of significant fever 
and absence of an inflammatory exudate in stools (Griffin and Tauxe, 1991).  For 
patients suffering from HC, the quantity of blood presented in faeces can vary 
enormously from a few streaks, to a stool comprised almost entirely of blood.  In 
severe cases of HC this can be life threatening, particularly in the young and 
elderly (Coia, 1998).  
 
Haemolytic uraemic syndrome is the most important complication of EHEC 
infection and this clinical syndrome is characterised by microangiopathic 
haemolytic anaemia, thrombocytopaenia and acute renal failure.  It occurs in 
approximately 7% of cases 5-10 days after the initial presentation of symptoms 
(Coia, 1998).  On the basis of epidemiological, clinical and laboratory data, two 
major subgroups of HUS syndrome have been identified: typical (or epidemic) 
and atypical (or sporadic) (Su and Brandt, 1995).  As is the case with HC, infants 
and elderly are more likely to develop HUS and mortality rates range from 5% 
to 10%, with a proportion of patients developing long-term sequelae (Su and 
Brandt, 1995).   
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1.2.5.3 Epidemiology of EHEC O157:H7 
EHEC may belong to a number of O serogroups, but those of serogroup O157 
are the most important in human disease (Clarke, 2001).  E. coli O157:H7 was 
first recognised as a cause of human illness in 1982, where outbreaks of HC were 
associated with the consumption of undercooked hamburgers, at a chain of fast 
food restaurants in Michigan and Oregon, USA (Robins-Browne and Hartland, 
2002).  The causative organisms were found to be E. coli O157:H7 that were 
isolated from the stools of those persons affected, and from a sample of the 
implicated burgers (Su and Brandt, 1995).  Increasing numbers of diseases 
relating to O157:H7 have been reported since these two outbreaks, most of 
which have been sporadic, although a number of community wide outbreaks in 
nursing homes, schools, day care centers and restaurants have also occurred (Su 
and Brandt, 1995). 
 
1.2.5.4 Reservoirs of EHEC 
1.2.5.4.1 Cattle 
Ruminants, in particular cattle, are considered to be the most important source 
of human infection with E. coli O157:H7, being asymptomatic excretors of the 
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organism, which is as a transient member of their normal gut flora (Caprioli et 
al., 2005).  Prevalence studies in Scotland have shown that 23% of herds and 
7.9% of cattle shed E. coli O157:H7 in their faeces, presenting a considerable 
environmental risk to humans, particularly by those animals regarded as high 
shedders (>105/g) (Strachan et al., 2006).  Studies have shown that E. coli O157:H7 
may remain viable in animal faeces for in excess of 20 months, and 
contamination of soil with effluents from agriculture, sewage and abattoirs all 
potentiate the risk of human infection (Beutin, 2006).  Differences in prevalence 
and shedding of O157:H7 have also been found between countries, regions, 
farms and herds.  In Scotland, it has been calculated that 80% of transmission 
arises from 20% of the most infective individual animals, termed ‘super 
shedders (Matthews et al., 2006).  Studies conducted in the United States, 
England and Wales all suggest that faecal shedding is more prevalent in young 
calves immediately after weaning, and these results have also been reproduced 
in experimental infection studies, where it was shown that EHEC O157:H7 
shedding is longer and more intense in calves than in adult cattle (Caprioli et al., 
2005).  Interestingly, excretion of EHEC O157:H7 by cattle has been shown to be 
higher during summer and early autumn, which also coincides with the 
seasonal peak of human infections (Karch et al., 2005).   
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1.2.5.4.2 Non ruminants 
E. coli O157:H7 has also been sporadically isolated from non-ruminant animals 
including: pigs, cats, dogs, chickens, horses and gulls (Nataro and Kaper, 1998). 
The roles that these animals play in terms of the harbouring and transmission of 
E. coli O157:H7 remains to be fully established (Caprioli et al., 2005). 
 
1.2.5.5 Transmission of EHEC 
1.2.5.5.1 Food-borne transmission 
EHEC can be transmitted by a number of different routes but perhaps the most 
important is food-borne-transmission.  Indeed, many of the largest outbreaks of 
E. coli O157:H7 have been linked to the consumption of under cooked meat, in 
particular, hamburgers (Karmali, 1989).  E. coli O157:H7 can enter the food chain 
in a variety of ways but contamination of meat from bovine faeces during 
slaughter and meat processing is one of the major routes by which this happens 
(Karch et al., 2005). Sources other than undercooked meat have also been 
implicated in the transmission of E. coli O157:H7, with unpasturised milk being 
one of the most commonest means of transmission (Karch et al., 2005).  The 
spectrum of vehicles implicated in the transmission of E. coli O157:H7 now 
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includes many sources far beyond the original hamburger associated outbreaks 
(Nataro and Kaper, 1998), with infection by E. coli O157:H7 even being linked to 
properly treated meat and dairy products, such as yoghurt and pasteurised milk 
(Karch et al., 2005).  Additionally, E. coli O157:H7 has also been linked to 
unpasturised apple juice and fermented salami.  These two vehicles 
demonstrate the potential acid tolerance of E. coli O157:H7, which is able to 
grow and survive in extremely acidic conditions that would normally destroy 
other pathogens (Nataro and Kaper, 1998).   
 
More recently, raw vegetables and fruits have also become major vehicles for 
the transmission of E. coli O157:H7, probably through contamination with cattle 
faeces during harvesting and processing (Karch et al., 2005).  Lettuce in 
particular has been implicated as a vehicle in several outbreaks (Nataro and 
Kaper, 1998) and uncooked radish sprouts were responsible for an outbreak of 
E. coli O157:H7 infection in Sakai City, Japan, where more than 6000 school 





1.2.5.5.2 Water-borne and environmental transmission 
Non food-borne vehicles have also been implicated in the transmission of E. coli 
O157:H7.  Drinking of contaminated water from sources such as recreational 
water, wells and municipal systems, have all been associated with outbreaks 
(Nataro and Kaper, 1998).  Research has shown that E. coli O157:H7 is able to 
survive in both drinking water and recreational water for many weeks, and 
evidence suggests that E. coli O157:H7 can enter a viable but non-cultural state 
after persisting in water for 12 weeks (Henderson et al., 1999). Along with the 
contamination of preserved foods and vegetables, water contamination is of 
particular concern in terms of the scale of risk that it poses to public health 
(Nataro and Kaper, 1998).    
 
An increasing number of outbreaks of E. coli O157:H7 infection have also 
occurred amongst people visiting music festivals, fairs, parties and petting zoos, 
particularly in the summer months (Caprioli et al., 2005).  The sources of 
infection are believed to be wells, exposure to mud contaminated with cattle 
faeces, and direct contact with animals (Caprioli et al., 2005).  Transmission 
through direct animal contact has been reported in outbreaks and sporadic 
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infections by E. coli O157:H7, and visiting farms or petting zoo and direct 
contact with animal faeces is now considered a significant hazard (Karch et al., 
2005). 
 
1.2.5.5.3 Person-to-person transmission       
The infective dose for E. coli O157:H7 is very low and has been estimated to be 
in the order of 100 to 200 organisms (Nataro and Kaper, 1998).  Because of this 
low infectious dose, person-to-person faecal-oral transmission of E. coli O157:H7 
has become one of the major routes of infection in daycare settings and in any 
institution where poor hygiene and close contacts may exist (Karch et al., 2005).  
In an outbreak of E. coli O157:H7 among kindergarten children, who probably 
acquired their infection through drinking raw milk at a farm, the occurrence of 
secondary cases among family members suggested that person-person 
transmission was responsible for the spread of infection (Karmali, 1989).  This 
case reinforces the importance of person-to-person transmission as a vehicle for 
E. coli O157:H7 infection, and highlights the importance of good hygiene and 




1.2.5.5.4 Incidence of EHEC  
To date, the largest outbreaks of EHEC infection have affected thousands of 
individuals.  However, sporadic EHEC infections make up the vast majority of 
the disease burden for this organism, and evidence suggests that the frequency 
of sporadic cases of EHEC infection is on the increase (Nataro and Kaper, 1998).  
Like outbreaks, sporadic infections due to E. coli O157:H7 have become a major 
problem in both the United States and Canada, where geographical differences 
in the incidence of this pathogen can be seen (Nataro and Kaper, 1998).  In the 
USA, sporadic cases of E. coli O157:H7 and HUC are more common in the 
northwestern states than the southern states; and in Canada, infection by E. coli 
O157:H7 has been reported more frequently from western provinces than 
eastern provinces (Griffin and Tauxe, 1991).  In the USA, this higher incidence of 
E. coli O157:H7 infection in the north may be explained by larger rural 
populations and increased contact with farm animals (Beutin, 2006).  The annual 
incidence of reported E. coli O157:H7 infections in Canada and the United States 
ranges from 1.7 to 5.3 per 100,000 persons, and within the United States alone, it 
has been estimated that approximately 73,000 cases of E. coli O157:H7 infection 




E. coli O157:H7 is also an important pathogen in Europe and Japan, and has 
been isolated in many other parts of the world including Asia, Africa and South 
America (Boyce et al., 1995).  In the developed countries of the northern 
hemisphere, E. coli O157:H7 follows a distinct seasonality of infection with most 
sporadic cases being reported in the warm summer months (Nataro and Kaper, 
1998).  This seasonal variation may reflect the ecology of E. coli O157:H7 or may 
be due to some unknown factor (s) (Boyce et al., 1995).  The reasons for the 
increase in sporadic E. coli O157:H7 infections can be explained in part by the 
establishment of more sophisticated EHEC detection and isolation methods, and 
to increased surveillance, resulting in more identified clinical cases (Beutin, 
2006).  Other factors which may explain the increase in frequency of sporadic E. 
coli O157:H7 infections include the industrialisation of agriculture coupled with 
mass production of livestock and animals; and behavioral changes in consumer 
habits including the increased consumption of raw vegetables, dairy products, 






1.3 Pathogenesis and virulence of EHEC O157:H7 
1.3.1 Shiga toxin 
One of the most important and defining virulence characteristics of E. coli 
O157:H7 is its ability to produce one or more Shiga toxins.  Shiga toxins, namely 
Stx1 and Stx2, occur in two major antigenic groups and have an A-B structure 
(Robins-Browne and Hartland, 2002).  Stx1 has been shown to be 
indistinguishable from the toxin produced by Shigella dysenteriae type 1, whilst 
Stx2 exhibits far more diversity, sharing only 56% amino acid homology with 
Stx1 (Mead and Griffin, 1998).  Variants of Stx2 have been identified, including 
Stx2c, d, e, f and g.  Human disease however is most significantly correlated 
with Stx2 and Stx2c (Spears et al., 2006).  The structural genes encoding Stx1 and 
Stx2 are carried on a bacteriophage and are considered to be transferred to the 
chromosome of E. coli O157:H7 and other host EHEC following phage lysogeny 
(Osawa et al., 2000). 
 
1.3.1.1 Mode of action of Shiga toxin 
Across all members of the Shiga toxin family, the basic A-B subunit structure is 
conserved.  A single 32 kDa A subunit is proteolitically cleaved to yield a ca. 28 
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kDa peptide (A1) and a 4 kDa peptide (A2) linked by a disulphide bond (Nataro 
and Kaper, 1998).  The A1 peptide is solely responsible for the enzymatic activity 
of the toxin and is bound to a pentamer of five identical 7.7 kDa B subunits via 
the A2 peptide of the A subunit (Nataro and Kaper, 1998).  The eukaryotic cell 
surface receptor for members of the shiga toxin family is globotriaosylceramide 
(Gb3), and it is this glycolipid receptor that is bound by the B subunit of Shiga 
toxin (Paton and Paton, 1998).  Following initial binding by the B subunit to a 
target cell membrane, internalisation of  toxin is thought to occur through a 
process of receptor-mediated endocytosis (Paton and Paton, 1998).  The toxin is 
endocytosed in clathrin-coated pits and processed by retrograde transport 
through the Golgi apparatus and endoplasmic reticulum, where the A1 subunit 
exerts its N-glycosidase activity following translocation to the cytoplasm 
(Nataro and Kaper, 1998).  This leads to the cleavage of  28S ribosomal RNA 
which disrupts the integrity of the ribosome and inhibits protein synthesis, 
ultimately leading to cell death (Robins-Browne and Hartland, 2002; Spears et 





1.3.1.2 Role of Shiga toxin in intestinal disease 
The involvement of Stx in intestinal disease has been supported by a large 
number of studies involving animal models, cell lines and genetically mutated 
strains of pathogenic bacteria (Nataro and Kaper, 1998).  Studies in rabbits for 
example have shown that Stx has direct enterotoxic properties on the rabbit 
ileum, where Gb3 containing absorptive villus epithelial cells are targeted (Paton 
and Paton, 1998).  Work by Fontaine et al (1988) demonstrated that in monkeys, 
S. dysenteriae type I causes less severe disease when it has a specific mutation for 
Stx, as compared to Stx positive S. dysenteriae type I in feed challenge studies 
(Nataro and Kaper, 1998).  Although these studies strongly support an 
association between Stx and intestinal disease in animals, the mechanisms 
involved in Stx pathogenesis in humans are not well understood. Direct 
exposure of enterocytes to Stx may explain diarrhoeal disease in humans 
although the presence of Gb3 on human enterocytes has yet to be demonstrated 
(Paton and Paton, 1998).  Gastrointestinal pathology as a result of systemic Stx 
exposure has also been suggested, although the exact mechanisms of toxin 
translocation from the site of colonisation in the gut lumen, to the underlying 
tissues and blood stream remains to be fully elucidated (Paton and Paton, 1998).  
Studies using cell lines have shown however that Stx can translocate across 
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epithelial cells without obvious cellular disruption, presumably through a 
transcellular pathway; and this may in part explain the systemic sequelae 
observed following infection with Stx producing E. coli O157:H7 (Nataro and 
Kaper, 1998). 
 
1.3.1.3 Role of shiga toxin in HUS 
HUS is thought to develop when Stx produced in the intestine enters the blood 
and binds to Gb3 rich endothelial cells in the kidneys, although toxin has never 
been detected in the blood of HUS patients (Mead and Griffin, 1998; Nataro and 
Kaper, 1998).  In addition to the direct action of Stx on renal endothelial cells, 
clinical studies have strongly associated both the severity and outcome of HUS 
with the production of pro-inflammatory cytokines (Nataro and Kaper, 1998).  
For example, interleukin 6 (IL-6) has been shown to be elevated in both the 
serum and urine of patients suffering from HUS, suggesting that renal 
pathology in HUS is a consequence of both the host immunological response to 
Stx; and the direct cytotoxic action of Stx (Nataro and Kaper, 1998).  The typical 
features of renal pathology in HUS includes swollen and detached glomerular 
endothelial cells; deposition of fibrin and platelets within glomeruli and other 
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parts of the renal microvasculature; and capillary occlusion resulting in reduced 
blood flow to the kidneys (Paton and Paton, 1998).  Other pathological 
abnormalities found in HUS include decreased platelet counts; increased plasma 
platelet aggregation activity; the occurrence of abnormal factor VIII; and 
microangiopathic haemolytic anaemia (Karmali, 1989). 
 
1.3.2 Attaching and effacing (A/E) lesions  
E. coli O157:H7 along with other EHEC, EPEC and the mouse pathogen 
Citrobacter rodentium (CR), all belong to a family of enteric bacteria that form A/E 
lesions and cause diarrhoea (Deng et al., 2004).  As described earlier in relation 
to EPEC pathogenesis, A/E lesions are characterised by the effacement of 
microvilli on the surface of intestinal epithelial cells, an intimate adherence of 
bacteria to the host cell membrane and the formation of organised cytoskeletol 
structures called actin-pedestals underneath the host cell membrane at the site 
of bacterial attachment (Campellone and Leong, 2003; Kaper et al., 1998).  
Studies have shown that both EHEC and EPEC have the ability to form actin 
pedestals on cultured cells and this feature correlates with the ability to colonise 
the intestine and cause disease in human and animal hosts (Campellone and 
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Leong, 2003).  Intriguingly, LEE-negative EHEC isolates are regularly isolated 
from patients with severe disease.  Although unable to form A/E lesions, these 
strains are invasive on cells in vitro where they are internalized within a 
membrane-bound vacuole; suggesting that aside from the LEE PAI that confers 
the A/E lesions, other unidentified factors can enhance the virulence potential of 
these strains (Girardeau et al., 2009; Luck et al., 2005). 
 
1.3.2.1 Role of LEE in A/E lesion formation 
For EHEC O157:H7, A/E lesion formation and pathology is determined by the 
LEE which contains most of the genes critical for lesion formation (Deng et al., 
2001; Perna et al., 1998).   It has been demonstrated that when cloned onto a 
plasmid, the LEE from EPEC strain E2348/69 can confer an A/E phenotype in the 
non pathogenic E. coli strain K12 (McDaniel and Kaper, 1997).  In contrast, when 
the LEE of EHEC was cloned into the same K12 strain, it was unable to form A/E 
lesions (Elliott et al., 2000).  Publication of the complete LEE sequence from three 
A/E pathogens; EPEC O127:H6 strain E2348/69; EHEC O157:H7 strain EDL933 
and rabbit O15:H- strain RDEC-1 have shown that the LEE is highly conserved, 
suggesting a common origin for all three pathogens (Deng et al., 2001).  It has 
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also been shown that the LEE has a considerably lower G+C content (38%) as 
compared to the average E. coli genome (51%), indicating that the LEE was 
probably acquired by these pathogens following horizontal gene transfer from 
another species (Wieler et al., 1997).  Exactly where the LEE originated and when 
it was transferred however still remains to be fully established (Deng et al., 
2001). 
 
1.3.2.2 LEE and type III secretion (T3S) 
The discovery of T3S was first made in the 1980’s and 1990’s, when researchers 
studying Yersinia found that the bacteria produced proteins called Yops (Yersinia 
outer proteins).  Thought to be associated with the outer membrane, it was soon 
realised that these proteins lacked classical signal sequences and were not 
secreted via the general secretion-dependent pathway (type II secretion) 
(Gauthier et al., 2003; Michiels et al., 1990).  A new secretion system was 
therefore proposed and this later became known as a Type III secretion system 




EHEC and EPEC along with many other pathogenic Gram negative bacteria, 
including those that infect plants, utilise a T3SS to secrete and inject bacterial 
effector proteins into the cytosol of host cells (Hueck, 1998).  These bacterial 
effector proteins, which often resemble eukaryotic factors, are able to subvert 
host cell signaling pathways, and are also responsible for the cytoskeletol 
rearrangements that occur during A/E lesion formation following infection by 
EHEC and other A/E pathogens (Hueck, 1998).  In general, the T3SS comprises a 
basal apparatus, with proteins present in the inner and outer bacterial 
membranes, and a needle complex known as a translocon which allows the 
injection of effector proteins through the host cell membrane (Figure 1.1B) 
(Germendia et al 2005).  In EHEC O157:H7 strain EDL933, the LEE is 43.359 kb in 
size and is composed of 54 ORF’s, of which 13 fall within a putative prophage 
region known as 933L (Figure 1.1A) (Perna et al., 1998).    The LEE encoded 
genes are organised into five major operons (LEE1 through LEE5) and it is LEE1, 
LEE2 and LEE3 operons that contain the type III basal apparatus genes (Figure 
1.1A-B).  The LEE4 operon encodes EscF and the E. coli-secreted proteins A, B 
and D (EspA,-B,-D) which are involved in E. coli O157:H7 needle and translocon 
complex formation, as well as factors whose function remains unclear (Figure 


















Figure 1.1 Locus of enterocyte effacement (LEE) encoding a type III secretion 
system (T3SS) (A) Genetic organisation of the LEE PAI in EHEC O157:H7. (B) 
Translocon apparatus of the LEE encoded T3SS.  The basal body of the TTSS is 
composed of the secretin EscC, the outer membrane proteins EscR-EscV and the 
lipoprotein EscJ which connects the inner and outer membrane ring structures.  EscF 
forms the needle structure where EspA polymerises to form the EspA filament.  EspB 
and EspD form the translocation pore in the host cell membrane, providing a continuous 
but gated channel from the bacteria to the eukaryotic cell.  EscN provides energy to the 




translocated receptor Tir, and a Tir chaperone known as CesT (Figure 1.1A-B) 
(Garmendia et al., 2005; Gauthier et al., 2003).  Following the assembly of the 
type III basal apparatus and EspA needle complex, EspB and Tir are 
translocated to the host epithelial cell where Tir is integrated into the plasma 
membrane.  It is the binding of  the translocated Tir with intimin on the bacterial 
surface that is responsible for the formation of intimate attachment during 
infection with E. coli O157:H7 (Campellone and Leong, 2003; Gauthier et al., 
2003).  Other LEE encoded effectors (Map, EspF, EspG, and EspH) have been 
identified which are involved in the modulation of the host cytoskeleton, 
although these effectors are dispensable for A/E lesion formation (Deng et al., 
2004; Spears et al., 2006).  In addition to binding Tir, intimin has also been shown 
to bind to host derived receptors (Spears et al., 2006).  It has been suggested that 
the interaction of different antigenic subtypes of intimin with these endogenous 
host receptors may responsible for the differences in tissue tropism observed for 
both EHEC and EPEC (Spears et al., 2006).  Sequence comparison analyses has 
shown that while most of the genes coding for the T3SS show greater than 95% 
identity among the two sequenced strains from EPEC and EHEC, strains 
E2348/69 and EDL933 respectively (Deng et al., 2001), those coding the secreted 
proteins EspA, EspB, EspD and EspE are far more diverse (84.63, 74.01, 80.36, 
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and 66.48% homology respectively) (Kresse et al., 1999).  Somewhat surprisingly 
given its role in A/E lesion formation, Tir is the most divergent of all the Esps, 
sharing only 58% homology between EPEC and EHEC (Campellone et al., 2004).  
This divergence of Tir is illustrated by the fact that unlike EPEC, EHEC does not 
accumulate tyrosine phosphorylated proteins beneath adherent bacteria, and 
requires other bacterial factors in addition to Tir for the formation of actin 
pedestals (Campellone and Leong, 2003; DeVinney et al., 1999).  Although the 
LEE PAI of EHEC and EPEC is highly conserved, differences in pedestal 
generation highlight just one of the many important variations that exist 
between these two A/E pathogens.  
 
1.3.2.3 Regulation of the LEE and T3S 
Genetic determinants governing bacterial virulence are tightly regulated so as to 
ensure their appropriate expression when environmental conditions are at their 
optimum; avoiding unnecessary wastage of energy and risking premature 
stimulation of host immune responses that may otherwise compromise the 
infectious process.  In E. coli O157:H7, LEE gene expression is regulated in an 
extremely complex manner governed by environmental signals; by regulatory 
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proteins encoded within the LEE PAI itself; by a system of global regulators 
found in E. coli; and a variety of regulators that have been acquired via 
horizontal gene transfer.  A summary diagram depicting some of the better 
characterised transcriptional regulators of the LEE PAI and where they feed in 
to the LEE operon are shown in Figure 1.2. 
 
1.3.2.4 Intrinsic regulation of the LEE 
LEE gene expression is under the direct control of the LEE-encoded regulator 
(Ler), which is the first gene in the LEE1 operon (Hacker and Kaper, 2000; 
Sperandio et al., 2002).  Ler proteins (predicted to be 15.1 kDa) of A/E pathogens 
are highly homologous in structure and function (Mellies et al., 2007) and share 
sequence similarity to H-NS, a global regulator in E. coli that can silence the 
expression of foreign DNA; including the LEE PAI.  These two regulators share 
most sequence similarity at the C-terminus of H-NS (predicted to be a DNA 
binding domain) (Bustamante et al., 2001; Mellies et al., 2008).  Ler is essential for 
A/E lesion formation as it activates the transcription of those operons 
downstream of LEE1, LEE2-5, as well as other operons (e.g. grlRA, espG and 










Figure 1.2 Schematic summary of the complex regulation of the LEE PAI in EHEC 
O157:H7.  The diagram shows T3S is regulated at multiple levels and by many factors 
encoded both within and out with the LEE. Transcriptional regulators are annotated as 
shown along with their input site into the LEE operon.  The mechanisms of action of 
individual regulators are discussed in more detail in the main text.  This image was 






regulate the expression of genes and genetic elements (prophage and plasmid 
encoded) encoded outside of the LEE, for example stcE (plasmid O157 (pO157) 
encoded zinc metalloprotease that is secreted by the etp type II secretion system) 
and lpf (long polar fimbriae) (Mellies et al., 2007).  Ler is therefore regarded as a 
global regulator able to coordinate LEE and virulence gene expression in EHEC.  
 
In EPEC, it has been shown that Ler and H-NS can occupy the same binding 
sites upstream of the LEE2 and LEE5 promoters (Mellies et al., 2007).  As Ler is 
considered to have a lower dissociation constant (Kd) than H-NS, these findings 
have led to the suggestion that Ler disrupts H-NS from binding to the upstream 
and downstream regions of target genes and operons (Berdichevsky et al., 2005; 
Dame et al., 2005; Mellies et al., 2008); where biochemical analyses have shown 
that H-NS silences transcription by binding over extended regions of DNA, with 
the capacity to bridge and loop DNA (Dame et al., 2005; Dorman 2004; Dorman 
and Kane, 2009).  Ler does not activate the transcription of all H-NS repressed 
genes (e.g proU) and as such, it is not considered as a general H-NS antagonist, 
but rather as a specific global activator of virulence gene expression (Mellies et 
al., 2007).  It has also been reported that Ler has the capacity to auto-regulate its 
own expression under certain environmental conditions; indicating that local 
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Ler concentrations at the LEE1 promoter may be important for the proper 
regulation of LEE gene expression in both EPEC and EHEC (Berdichevsky et al., 
2005; Mellies et al., 2008; Mellies et al., 2011).   
 
The LEE1 regulatory region located immediately upstream of ler is crucial in 
controlling expression of the LEE.  In EHEC, this region has been reported to 
contain two promoters, P1 and P2 that are respectively distal and proximal to 
the ler translation start site (Sperandio et al., 2002). The global regulator LEE 
activator and repressor proteins, GrlA and GrlR respectively, are located 
between LEE1 and LEE2; and these proteins have the ability to control LEE1 
transcription in a positive feedback loop with Ler (Barba et al., 2005; Iyoda et al., 
2006).  Studies by Barba et al (2005) have shown                                                                  
the expression of LEE-encoded proteins to be significantly reduced following 
mutation of grlA; and increased following mutation of grlR.  It is suggested that 
since grlA lies immediately downstream of grlR, these two genes form a 
bicistronic operon; where GrlR may directly repress GrlA by protein-protein 
interactions that result in the down regulation of ler expression (Iyoda et al., 




Recent works by Islam et al and Bustamante et al (2011) have also indicated that 
GrlA may have dual functions at the LEE1 regulatory region (promoter region 
upstream of LEE1); by counteracting the global repressor H-NS, and by 
activating the P1 promoter.  These authors argue that GrlA may function as a 
true transcription activator by directly accelerating one of the transactions 
between RNA polymerase holoenzyme and the LEE1 promoter.  In addition to 
regulating T3S, GrlRA have also been shown to coordinate LEE expression with 
enterohaemolysin gene expression; and can reciprocally regulate T3S and 
motility gene expression in EHEC O157:H7 (Iyoda et al., 2006 and Saitoh et al., 
2008).   
 
1.3.2.5 Horizontally acquired regulators of the LEE 
The EAF plasmid of EPEC harbours the operon perA-C (plasmid encoded 
regulator C), termed pchA-C in EHEC (plasmid encoded regulator C 
homologue), which activates LEE1 and then via Ler, the rest of the LEE (Porter et 
al., 2004; Porter et al., 2005; Iyoda and Watanabe, 2004).  In EPEC, PerA directly 
activates perABC and bpf transcription, conferring a localised adherence (LA) 
phenotype to EPEC on host cells (Lida et al., 2010; Mellies et al., 2007).  PerA, 
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which shares sequence similarity to the AraC family of transcriptional 
regulators, directly activates bfp by binding to the promoter region upstream of 
bfp.  The promoter regions upstream of perA and bfp share a significant amount 
of homology, and as such, perA is also subject to auto-regulation by PerA (Ibarra 
et al., 2003; Mellies et al., 2007).  The perB gene product has not been well 
characterised, however, PerC is a known transcriptional activator of Ler 
(Bustamante et al., 2001; Porter et al., 2004). 
 
EHEC do not harbour an EAF plasmid, however seven PerC like homologues 
(pchA-E, pchX and pchY) can be found in the EHEC chromosome; nearly all of 
which are prophage (OI) associated (Iyoda and Watanabe 2004; Porter et al., 
2005).  Of these, PchA, PchB and PchC have been demonstrated to activate LEE 
expression through Ler; where mutation in these genes reduces T3SS translocon 
secretion and adherence of EHEC to tissue culture cells (Iyoda and Watanabe, 
2004).  These proteins also regulate genes encoded outside of the LEE on OIs 
(Iyoda and Watanabe 2004; Porter et al., 2005), and PerC like proteins (YfdN) 
have also been identified on prophage elements in UPEC, Salmonella enterica 
serovar Typhimurium (ST64 phage), Shigella flexneri (SfV phage) and E. coli K12 
(Mellies et al., 2007).   
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The exact mechanism of action of these regulators is unknown although it is 
hypothesised that in EHEC and EPEC, PerC and PerC like proteins activate LEE 
transcription in the presence of other regulatory proteins, such as IHF (DNA 
bending protein which positively regulates LEE expression); and perhaps other 
factors that have yet to be identified (purified PerC has not been shown to bind 
to the LEE regulatory region in vitro (Porter et al., 2005).  The function (s), if any, 
of PchD and PchE in EHEC remain to be determined, although these proteins, 
which are much smaller than the PchA-C proteins, are known not to affect LEE 
gene expression in a K12 background (Porter et al., 2005).   
 
1.3.2.6 E. coli regulators of LEE 
Given Ler’s pivotal role in A/E lesion formation (an EHEC ler mutant does not 
form A/E lesions on tissue culture cells (Elliot et al., 2000) and its role as a master 
regulator of the LEE, its perhaps unsurprising that several transcription factors 
exert their control over LEE1 expression via Ler; either directly or indirectly.  Fis 
and IHF for example positively regulate LEE1 by switching on ler expression; 
subsequently Ler then activates LEE2-5 transcription in a regulatory cascade 
(Bhatt et al., 2011; Umansci et al., 2002; Yona-Nadler et al., 2003).  BipA, a protein 
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sharing amino acid homology with the eukaryotic ribosome-binding elongation 
factor G, also increases LEE transcription by promoting steady state transcript 
levels of ler (Grant et al., 2003; Bhatt et al., 2011).  Moreover, BipA is reported to 
be required for intimin proteolysis in EPEC (Grant et al., 2003; Bhatt et al., 2011).  
Examples of LEE repressors include the H-NS homologue, Hha, which represses 
ler transcription (Sharma and Zeurner 2004); and the acid response regulator 
GadX, which represses ler transcription indirectly via the repression of the LEE 
activator PerC (Mellies et al., 2007).  Hha has also been shown to form a complex 
with H-NS which has the capacity to regulate α haemolysin gene expression in 
response to temperature and osmolarity (Mellies et al., 2007; Nieto et al., 2000).   
 
Additional repressors of the LEE can also be found in a second cryptic T3SS, 
termed ETT2 (E. coli type III secretion system 2), that is reported to be present in 
the majority of E. coli strains on prophage region OI-115 (Mellies et al., 2007; 
Zhang et al., 2004).  Mutations in two ETT2 encoded genes, eivF and etrA, 
increase EspA and EspB translocon secretion; and over-expression of these 
proteins represses T3S in a high secreting O26:H- EHEC strain (Zhang et al., 
2004).  In addition, the two component system regulators YhiEF control effector 
protein secretion; where they repress LEE gene expression not via ler, but at 
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LEE2 and LEE4 (Mellies et al., 2007; Tatsuno et al., 2004).  In EHEC, LEE gene 
expression is also regulated by the RcsC-B-D phosphorelay system through 
RcsB and the previously mentioned PchA; where RcsB represses PchA to down-
regulate ler expression; effectively repressing the entire LEE (Tobe et al., 2005).  
This system is positively regulated via the EHEC specific protein, GrvA, which 
activates LEE gene expression via LEE1 (Tobe et al., 2005). 
 
1.3.2.7 Environmental regulation of LEE 
Quorum sensing (QS) is a cell to cell signaling system in bacteria mediated 
through the secretion and sensing of host and bacterial hormones known as 
autoinducers (epinephrine, norepinephrine and autoinducer-3) (Sperandio et al., 
2003).  These signalling molecules allow bacteria to sense their environment and 
gauge population density levels both within and between bacterial species 
which share the same environment (Sperandio et al., 2003).  When these 
compounds reach a certain threshold, they are able to interact with transcription 
factors to regulate gene expression; enabling the bacteria to rapidly respond to 
the prevailing environmental conditions (Spernadio et al., 1999; Sperandio et al., 
2001; Sperandio et al., 2003). 
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In EHEC, quorum sensing E. coli regulator A (QseA) is a member of the LysR 
family of transcriptional regulators that is able to directly bind to the LEE1 
regulatory region and control LEE gene expression via Ler (Sperandio et al., 
2002).  QseA also has the capacity to bind other promoter regions and genes 
carried on OIs, as well as to its own promoter (Kendall et al., 2011; Russell et al., 
2007; Sharp and Sperandio, 2007).  Via a hierarchical regulatory cascade, QseA is 
induced through the major two-component system QseBC (Hughes et al., 2009; 
Kendall et al., 2011; Sperandio et al., 2002).  QseBC is know to control a number 
of genes involved in virulence and motility; where QseBC exerts is control over 
flagella expression via the master flagella regulators FlhDC (Kostakioti et al., 
2009; Sperandio et al., 2002).  QseC has been shown to harbour phosphatase 
activity and it is proposed that QseC can exert control over QseB by interfering 
with its dephosphorylation mechanism; allowing flhDC expression and the 
positive regulation of motility (Kostakioti et al., 2009).  QseB binds to high and 
low affinity sites upstream of qseBC implying it is subject to auto-regulation by 
QseB (Clark and Sperandio, 2005).  In UPEC, in the absence of QseC (∆qseC), 
QseB is able to increase its own transcription, where it then goes on to repress 
the expression of multiple genes involved in type I pili, curli and flagella 
formation (Kostakioti et al., 2009).  This same qseC deletion strain was also 
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shown to be adversely affected for intracellular bacterial community formation.  
These studies support a role for QseC as a key regulator required for UPEC and 
EHEC virulence gene expression.  Another two-component system in EHEC 
which has the capacity to influence virulence gene expression is QseEF.  QseF 
activates the transcription of the EHEC effector protein EspFu which is required 
for actin pedestal formation; where a qseF deletion strain is unable to form A/E 
lesions (Reading et al., 2007).  The qseEF operon also encodes an OMP protein, 
QseG, which is believed to be necessary for Tir translocation (Reading et al., 
2009).  As for QseA, QseEF is induced via the major QS regulator QseC.   
 
In bacteria, the stringent response is a global regulatory system that is triggered 
by various nutritional and metabolic stresses; for example starvation.  In E. coli, 
this system is mediated via the signalling molecule ppGpp, whose concentration 
increases in starved cells to control gene transcription in both a positive and 
negative manner (Chatterji and Ojha 2001; Nakanishi et al., 2006).  As ppGpp 
synthesis and degradation is rapid, this allows bacteria to adapt quickly to 
changes in their environment.  In E. coli, ppGpp turnover is catalysed by two 
enzymes, relA (synthase) and SpoT (hydrolase synthase) which respond 
differently to environmental conditions and bacterial growth phase (Mellies et 
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al., 2007; Nakanishi et al., 2006).  Another protein, DksA, has also been identified 
as a critical component of this system and affects ppGpp mediated activation 
and repression of gene transcription at target promoters (Nakanishi et al., 2006).  
Specifically in EHEC, the stringent response has been shown to enhance LEE 
gene expression directly through the global LEE activators Ler and Pch; where 
ppGpp directly activates ler and pch promoters in an in vitro transcription 
system (Nakanishi et al., 2006). 
 
The ubiquitous SOS response system in bacteria is regulated through proteins 
involved in DNA replication, repair and metabolism.  The system is activated in 
response to DNA damaging agents (e.g. antibiotics, UV radiation and 
mitomycin C) (Janion, 2008).  In EHEC, Stx toxin production is co-regulated 
with the induction of the lysogenic Stx-encoding bacteriophage which is also 
linked with the induction of the bacterial SOS system (Matsushiro et al., 1999; 
Muhldorfer et al., 1996; Plunkett et al., 1999).  stx genes are encoded in the late 
lytic region of bacteriophages, interestingly with a number of EHEC effector 
proteins.  As such, the SOS response has been postulated to coordinate DNA 
damage with phage lysis, Stx production and effector protein secretion (Croxen 
and Finlay, 2010; Fuchs et al., 1999; Tree et al., 2009).  In EPEC, mitomycin C 
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increases the expression of the LEE2 and LEE3 operons, as well as the non-LEE 
encoded effector A (nleA) that is encoded on OI-71 but secreted via the T3SS 
(Mellies at al., 2007).  This regulation is mediated by LexA and RecA, two major 
players in the bacterial SOS response.  LexA is a transcriptional regulator which 
binds to an SOS box present in some operon promoter regions, such as found 
upstream of the LEE2 and LEE3 promoters on the LEE PAI, repressing 
transcription (Mellies at al., 2007).  RecA counteracts LexA mediated repression 
by catalytically cleaving and inactivating LexA; so promoting transcription 
(Mellies et al., 2007).   
 
1.3.2.8 Post-transcriptional and post-translational control of LEE 
Recent studies have shed light on the increasing importance of post-
transcriptional and post-translational control of LEE gene expression.  CsrA 
(carbon storage regulator A) for example is a small RNA binding protein that 
regulates flagella and T3S in EHEC (Bhatt et al., 2011; Wei et al., 2001); and 
represses glycogen biosynthesis and biofilm formation in non-pathogenic E. coli 
(Wang et al., 2005).  CsrA is highly conserved among different species of 
bacteria, where it governs pleitrophic phenotypes associated with cellular 
46 
 
metabolism and virulence (Romeo, 1998; Timmerman and Melderen, 2010).  In 
EPEC, CsrA is known to bind to, and is believed to stabilise, the LEE4 transcript 
(Bhatt et al., 2011).  CsrA is also known to promote A/E lesion formation by 
activation the T3SS inner membrane protein EscD; through an intermediate 
regulator (Bhatt et al., 2011; Timmerman and Melderen, 2010).  At increased 
concentrations, CsrA has a dual function, when it is believed to repress LEE 
expression by reducing the transcript stability of the global LEE regulators, 
grlRA (Bhatt et al., 2011).   
 
Another important post-transcriptional regulator of the LEE in EHEC and EPEC 
is the small RNA chaperone, hfq (Bhatt et al., 2011).  As with CsrA, Hfq has the 
capacity to influence a large number of cellular processes (inactivation of hfq in 
E. coli causes cells to become extremely sensitive to environmental stresses 
(Bhatt et al., 2011; Tsui et al., 1994) as well as being a virulence regulator.  In 
EHEC, Hfq is believed to repress LEE transcription via two mechanisms that 
depend on the growth phase of the cell.  During exponential growth, Hfq has 
the capacity to reduce GrlA expression by de-stabilising grlRA transcripts.  This 
in turn reduces levels of Ler, and as such, Hfq is able to silence the whole of the 
LEE PAI (Bhatt et al., 2011; Hansen and Kaper, 2009).  During stationary phase 
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growth, Hfq mediated repression of the LEE is independent of grlRA, where this 
time ler translation is adversely affected (Bhatt et al., 2011; Hansen and Kaper, 
2009; Shakhnovich et al., 2009).   In addition to the non-catalytic RNA-binding 
protein Hfq, RNase E (single strand specific endoribonuclease E) exerts post-
transcriptional control over LEE expression (Lodato and Kaper, 2009).  RNase E 
is a component of the bacterial degradosome that is involved in the maturation 
and degradation of RNA species, and is believed to antagonistically co-regulate 
several transcripts with Hfq; where it is responsible for the post-transcriptional 
processing of the LEE4-encoded sepLespADB transcript in EHEC (Bhatt et al., 
2011; Lodato and Kaper, 2009).  
 
ClpXP is a post-translational regulator of the LEE that has been extensively 
characterised (Bhatt et al., 2011; Iyoda et al., 2005; Tomoyasu et al., 2005).  In 
EHEC, ClpX and ClpP degrade damaged and incomplete proteins and proteins 
involved in various stress responses.  These proteins are also believed to 
influence LEE gene expression by degrading GrlR; so allowing GrlA to activate 
ler and the LEE regulatory cascade (Iyoda et al., 2005).  In EHEC, ClpXP is 
believed to activate ler in an RpoS and GrlR dependant manner, where ClpXP is 
believed to degrade RpoS.  In addition, deletion of grlR circumvents the need for 
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functional grlR; and in a grlR mutant, ClpXP levels and stability are elevated; 
suggesting that grlR may be a direct substrate for this protease (Bhatt et al., 2011; 
Iyoda et al., 2005).  Interestingly, it has recently been shown that ClpXP has the 
ability to regulate flagella gene expression through flhDC transcriptional and 
post-translational control mechanisms.  This repression is also believed to be 
mediated via grlRA (Kitagawa et al., 2011).  Small RNA mediated control of LEE 
gene expression has also been observed in E. coli.  For example, DsrA is as an 87 
nucleotide un-translated transcript that modulates gene expression by antisense 
pairing with its target mRNAs in the presence of Hfq (Bhatt et al., 2011; Lease et 
al., 2000).  When over-expressed, DsrA activates ler in an H-NS and RpoS 
dependant manner, and it is postulated that DsrA may activate LEE gene 
expression through H-NS de-repression at LEE1 (Bhatt et al., 2011). 
 
1.3.2.9 Non LEE-encoded effector proteins 
As previously mentioned, many Gram-negative pathogens utilise a T3SS to 
inject LEE encoded bacterial effector proteins directly into the cytosol of host 
cells, to subvert signalling pathways, and promote bacterial colonisation.  
However, in addition to these LEE encoded effectors, an ever increasing number 
of non LEE-encoded effector proteins (Nle) have been identified that utilise the 
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LEE encoded T3SS for translocation (Deng et al., 2004; Gruenheid et al., 2004).  In 
EHEC, Tobe and colleagues (2006) identified 49 putative effectors; including 
NleA through NleH (including 12 homologues of NleG), EspJ-O, EspR and 
EspV-Y; many of which are homologues (Dean and Kenny 2009).  As most Nles 
are found on lambda phage and/or transposase like genes, these effectors have 
likely been acquired by horizontal gene transfer (Iguchi et al., 2009; Tobe et al., 
2006).  Although these effectors are highly conserved, effector repertoires appear 
to be flexible between different strains and pathotypes; where EPEC have been 
shown to harbour a much smaller effector repertoire than EHEC (Iguchi et al., 
2009; Tobe et al., 2006).   
 
Many functions have been attributed to these effector proteins.  In EHEC and 
EPEC for example, the effector proteins NleH1 and NleH2 are believed to confer 
a survival phenotype, where NleHs inhibit apoptosis via various stimuli in 
epithelial cells, dependant on their binding to the anti-apoptopic Bax inhibitor-1 
(Hemrajani et al., 2010; Vossenkamper et al., 2011).  Another effector protein 
attributed with apoptopic activity is the metalloprotease, NleD, which prevents 
JNK-mediated pro-apoptopic signalling by cleaving and inactivating JNK 
(Baruch et al., 2010; Vossenkamper et al., 2011).  More recently, the effectors 
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proteins, NleB, NleH, NleC, NleD and NleE, have been demonstrated to 
harbour anti-inflammatory activity (Nadler et al., 2010; Newton et al., 2010; 
Royan et al., 2010; Vossenkamper et al., 2010; Vossenkamper et al., 2011; Yen et 
al., 2010).  EspF from EHEC and EPEC prevent phagocytic uptake by 
macrophages and M cells in vitro (Martinez-Argudo et al., 2007; Vossenkamper 
et al., 2011).  Interestingly, this effector is also believed to mediate EPEC invasion 
into intestinal cells (Weflen et al., 2010; Vossenkamper et al., 2011).  Effectors 
EspH and EspJ have been reported to inhibit phagocytic uptake (Dong et al., 
2010; Vossenkamper et al., 2011) and opsonophagocytic uptake respectively 
(Marches et al., 2008; Vossenkamper et al., 2011).   
 
In Citrobacter rodentium, NleA is associated with increased severity of disease 
(Gruienheid et al., 2004; Schwidder et al., 2011) and NleA has the capacity to 
compromise protein synthesis after translocation into host cells (Kim et al., 2007; 
Schwidder et al., 2011).  More recently, NleA has been found to play a role in the 
destruction of tight junctions in EPEC (Thanabalasuriar et al., 2010; Schwidder et 
al., 2010).  As mentioned, the up-regulation of NleA is believed to be mediated 
via Ler in response to a number of environmental stimuli, such as the SOS 




Lastly, in vivo analyses have also demonstrated an important role for EspZ in  
the colonisation of mice by Citrobacter rodentium (Deng et al., 2004). 
 
1.3.3 Plasmid encoded factors  
All strains of EHEC O157:H7 contain a highly conserved virulence plasmid of 
approximately 90 kb, termed pO157 (Caprioli et al., 2005).  As well as being 
present in O26:H11 strains, pO157 can also be found in most STEC strains 
isolated from humans (Nataro and Kaper, 1998).  In vitro and in vivo studies 
have reported conflicting results on the role of the plasmid in adherence to 
epithelial cells, where loss of the plasmid has shown both increased adhesion, 
decreased adhesion, or has had no effect on adhesion (Nataro and Kaper, 1998).  
However, several reports do correlate pO157 with virulence and it carries a 
number of putative virulence genes; including four genes encoded on the Ehx 
operon that are necessary for the synthesis and transport of enterohaemolysin 
(Ehx); a serine protease (EspP); a cluster of 13 genes encoding a type II secretion 
system; a catalase peroxidase (KatP); a zinc metalloprotease (EscE); and a 9.5 kb 
putative virulence gene, the product of which has been designated ToxB 




Plasmid encoded enterohaemolysin was the first pO157 sequence to be 
determined and hybridisation studies have shown that it is closely related but 
not identical to α-haemolysin, which is produced by a number of pathogenic E. 
coli strains (Schmidt et al., 1995).  Enterohaemolysin belongs to the RTX (repeat 
in toxin) family of exoproteins, and exerts its toxicity by forming pores in the 
cytoplasmic membrane of eukaryotic cells and ultimately disrupts the 
permeability control of the cell (Burland et al., 1998).Belonging to the RTX 
(repeat in toxin) family of exoproteins, enterohaemolysin exerts its toxicity by 
forming pores in the cytoplasmic membrane of eukaryotic cells and ultimately 
disrupts the permeability control of the cell (Burland et al., 1998).  Boerlin et al 
(1998) have shown that through restriction fragment length polymorphism 
(RFLP) of the highly conserved enterohaemolysin (ehxA) operon, several active 
sites for the toxin in an apparently more variable region of the plasmid are also 
highly conserved.  This has led to the suggestion that the toxin is under strong 
selective constraints and so may play an important role in the survival of EHEC 
and STEC (Boerlin et al., 1998).   Although not proven, enterohaemolysin may 
aid in the infection process as the iron which is released from lysed erythrocytes 
(RBC) in the form of haem and haemoglobin may be used by the bacteria to 
53 
 
stimulate growth (Nataro and Kaper, 1998).  As the incidence of EHEC 
enterohaemolysin in STEC strains is high, it has also been implicated as a 
virulence determinant in HC and HUS.  In support of this, serological responses 
to enterohaemolysin have been frequently observed in humans with O157:H7 
associated HUS, but seldom observed amongst controls (Schmidt et al., 1995). 
 
1.3.3.2 EspP 
EspP is an extracellular secreted protease which is a member of the serine 
protease autotransporter of Enterobacteriaceae (SPATE) family of exported 
proteins (Leyton et al., 2003).  Although little is known about the source of the 
espP gene, it is widely observed among O157:H7 strains and several homologues 
have been observed in other pathogenic E. coli and enteric bacteria.  Examples 
include the espC gene of EPEC, the pet gene of EAEC and the sepA gene of 
Shigella flexneri (Brunder et al., 1999).  Functional analysis of EspP has shown 
that it is able to cleave pepsin A and human coagulation factor V, and can also 
induce a cytopathic effect on Vero cells (Leyton et al., 2003). This has led to the 
suggestion that like enterohaemolysin, EspP may significantly contribute to 
EHEC pathogenesis in that it probably exacerbates epithelial cell degradation 
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and haemorrhage following infection, and antibodies to EspP have been found 
in convalescent-phase sera from children who suffered EHEC infection (Burland 
et al., 1998; Caprioli et al., 2005). 
 
1.3.3.3 EHEC type II secretion system (T2SS) 
The pO157 plasmid contains a cluster of 13 genes (etpC through etpO) that are 
closely related to those genes found in the T2SS of Gram-negative bacteria.  In 
Klebsiella pneumoniae for example, these genes encode a pulluanase secretion 
pathway that provides a mechanism for exoprotein secretion (Burland et al., 
1998; Caprioli et al., 2005).  Although the pO157 plasmid has all the genes 
necessary for protein secretion, functional export of proteins has yet to be 
demonstrated (Burland et al., 1998).   
 
1.3.3.4 KatP  
KatP is a catalase peroxidase that is encoded on the pO157 plasmid by katP. This 
enzyme may protect EHEC from the reactive oxygen species found in host cells 
that it will encounter during the infection process (Burland et al., 1998).  
Interestingly, the occurrence of the katP gene in EHEC strains has been shown to 
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be closely associated with the enterohaemolysin operon found in pO157 
(Burland et al., 1998). 
 
1.3.3.5 StcE 
StcE is a zinc metalloprotease, the expression of which is regulated by the 
previously mentioned LEE regulator ler (Grys et al., 2005).  Encoded by the stcE 
gene on pO157, StcE is able to cleave C1-esterase inhibitor (C1-INH), a serine 
protease inhibitor that is able to regulate complement and other mechanisms of 
inflammation (Grys et al., 2005).  Interestingly it has been show that despite 
being cleaved by StcE, C1-INH can remain functional and as such can continue 
to inhibit components of the classical complement cascade.  Moreover, StcE has 
been shown to bind and localise functional C1-INH to cell membranes, 
effectively promoting complement regulation by C1-INH at sites of potential 
lytic complex formation.  Taken together, it has been proposed that StcE 
potentiates C1-INH activity, thereby reducing inflammation and complement 
mediated lysis at sites of EHEC infection (Grys et al., 2005).  In addition to C1-
INH, two other substrates for StcE have been identified, namely glycoprotein 
340 (gp340) and mucin 7 (MUC7); both of which have been implicated as 
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defensive glycosylated proteins in saliva and other tissues (Grys et al., 2005).  As 
StcE exhibits mucinase activity and is also positively regulated by ler, the 
expression of which also regulates many of the effector proteins involved in A/E 
lesion formation, it has been hypothesised that StcE contributes to the intimate 
adherence of EHEC to host cells by degrading the protective layers of mucus 
and glycoproteins (Grys et al., 2005). 
 
1.3.3.6 ToxB  
Sequencing of the pO157 plasmid has shown that it contains a large putative 
virulence gene, termed L7095 in EHEC O157 EDL933 strain and toxB in RIMD 
0509952 Sakai strain (Tozzoli et. al., 2005).  L7095/toxB is 9.5 kb in size and its 
product ToxB shares approximately 20% homology in deduced amino acid 
sequence with the toxin B of Clostridium difficile, and 28% (identical amino acids) 
and 47% (similar amino acids) homology with the products of the efa-1/lifA 
virulence genes found in non-O157:H7 isolates and EPEC strain 2348/69 (Tozzoli 
et al., 2005).  efa-1/lifA has been detected in EHEC strains although these strains 
contain only a fragment of this gene (Tozzoli et. al., 2005). Tatsuno et al., (2001) 
have shown that ToxB contributes to the adherence of E. coli O157:H7 in vitro to 
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Caco-2 cells through the modulation of proteins secreted by the T3SS.  In EPEC 
strain 2348/69, lifA confers the ability to inhibit human peripheral blood 
lymphocyte proliferation and the mitogen-stimulated synthesis of the cytokines 
interleukin-2 (IL-2); IL-4; IL-5 and interferon gamma (IFN-γ) (Spears et al., 2006).  
Although studies have indicated that pO157 encoded toxB is consistently 
present in E. coli O157:H7 strains, little is known about its presence in non-O157 
and EPEC strains (Tozzoli et al., 2005).  
 
1.3.4 Fimbrial adhesins 
E. coli express a variety of different surface factors, including fimbrial and non-
fimbrial adhesins, which have been demonstrated to be important for 
pathogenesis. 
 
1.3.4.1 Type 1 fimbriae 
In EHEC O157:H7, at least 16 loci have been identified encoding genes 
putatively involved in fimbriae or pili biosynthesis (Hayashi et al., 1991; Perna et 
al, 2001).  One of these clusters contain the genes encoding type 1 fimbriae, the 
most common adhesin produced by E. coli which mediates adherence to 
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mannose-containing glycoproteins found on the surface of eukaryotic cells 
(Leathart and Gally, 1998).  In uropathogenic E. coli (UPEC), this adhesin plays a 
crucial role in the colonisation of the human urinary tract (Holden et al., 2006).  
Although most EHEC O157:H7 isolates harbour the type 1 fimbrial operon, they 
are unable to express it due to a conserved 16 bp deletion in the type 1 fimbrial 
operon promoter region, known as the fim switch (Li et al., 1997; Roe et al., 2001).  
This promoter region is a phase variable invertible DNA element lying 
upstream of fimA encoding the main fimbrial subunit protein, FimA (Abraham 
et al., 1985).  When the fim switch is in the off orientation, type 1 fimbriae cannot 
be produced.  This inversion is dependent on the recombinase proteins FimB 
and FimE, as well as a number of other co-factors (Gally et al., 1996).  In EHEC, 
the 16 bp deletion in the fimA promoter region prevents inversion of the fim 
switch to the on orientation, thus type 1 fimbriae cannot be produced (Li et al., 
1997; Roe et al., 2001). 
 
1.3.4.2 Long polar fimbriae 
Long polar fimbriae (LPF), related in their genetic organisation to type 1 
fimbriae, are surface expressed structures that extend from the poles of the 
bacterial cell (Baumler et al., 1995).  First identified in Salmonella enteric serovar 
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Typhimurium, LPF are considered to mediate the attachment of Salmonella 
enterica to Peyer's patch epithelium in mice (Baumler et al., 2006).  In the 
chromosome of EHEC O157:H7 strain EDL933, two non-identical loci encoding 
LPF (lpf1 and lpf2) have been identified (Perna et al., 2001); and studies indicate 
that LPF play an important role in the pathogenesis of EHEC and other E. coli 
pathotypes (Jordan et al., 2004; Torres et al., 2002; Newton et al., 2004).  In EHEC 
O157:H7 strain 86-24 for example, isogenic lpf mutants have been shown to form 
fewer A/E lesions in vivo and are recovered in significantly lower numbers 
compared to their parent strain (Jordan et al., 2004).  Torres et al (2007) have 
shown that mutation in both the lpf1 and lpf2 loci reduces the ability of EHEC 
O157:H7 to persist in the intestine of lambs.  Interestingly, it has also been 
demonstrated that the same mutant is able to better colonise intestinal mucosal 
explants in vitro compared with the wild-type strain; suggesting that the role of 
LPF in persistence may not involve initial adherence.   
 
1.3.4.3 Curli  
Many E. coli strains express a type of fimbriae at their surface known as curli 
(Barnhart and Chapma, 2006).  These thin aggregative fimbriae, or curli fibres, 
are typically expressed in response to low temperatures (below 30°C), low 
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oxygen, low nutrients or low osmolarity; as well as during stationary phase 
growth (Barnhart and Chapma, 2006).  For many enterobacteria, curli have been 
recognised as a major virulence factor due to there role in mediating bacterial 
cell aggregation, adhesion to surfaces, and biofilm formation (Olsen et al., 1993; 
Prigent-Combaret et al., 2001); and bind fibronectin, laminin, serum proteins and 
Congo red dye (Hammar et al., 1995; Ben Nasr et al., 1996; Olsen et al., 1989; 
Sjobring et al., 1994).   
 
The genes responsible for curli biogenesis are organised into two divergently 
transcribed operons, csgBAC and csgDEFG, which are under complex regulation 
by numerous regulators, including by CsgD itself (Barnhart and Chapma, 2006).  
CsgD is the major transcriptional activator of the csgBAC operon that encodes 
the curli subunit protein CsgA and the nucleator protein CsgB, which are 
required for the production of mature curli along with the outer membrane 
lipoprotein CsgG and two curli assembly factors; CsgE and CsgF (Barnhart and 
Chapma, 2006).  Although encoded by the csgBAC operon, CsgC has no known 
role in curli formation (Barnhart and Chapma, 2006).  Lee et al (2011) have 
shown that curli production in EHEC strain EDL933 is an important factor in 
biofilm formation, along with its ability to produce cellulose.  Also, mutations 
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within the csgD promoter have been documented in a few outbreak strains of 
EHEC O157:H7 and it has been suggested that in these strains, curli expression 
levels can vary in a temperature-independent phase-variant manner (Uhlich et 
al., 2001).  These examples highlight the importance of curli for biofilm 
formation in EHEC and the complexity of their regulation, as shown by the 
markedly different levels of expression that can be observed between different 
EHEC strains.  
 
1.3.4.4 Type IV pili 
EHEC produce a type IV pilus, termed haemorrhagic E. coli pilus (HCP) that is 
composed of a 19 kDa pilin subunit encoded by hcpA (Xicohtencatl-Cortes et al., 
2007).  HCP are important for EHEC adhesion to cultured cells in vitro; where 
inactivation of hcpA results in significantly reduced adherence of EHEC to 
human and bovine intestinal cells (Xicohtencatl-Cortes et al., 2007).  More 
recently, studies have demonstrated that purified HCP has the capacity to 
significantly increase levels of the pro-inflammatory cytokines IL-8 and TNF-
alpha from cultured polarised tissue culture cells; and it is hypothesised that 
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HCP may play an important role in the pathogenesis of HC following infection 
by EHEC (Ledesma et al., 2010). 
 
1.3.5 Non-fimbrial adhesins 
Iha (iron regulated gene A homologue adhesin) is a 67 kDa outer membrane 
protein that is capable of conferring an adherence phenotype to non-adherent 
laboratory E. coli strains (Tarr et al., 2000).  Sharing a high degree of homology to 
the IrgA protein of Vibrio cholerae (Goldberg et al., 1992), iha forms part of a 
conserved tellurite resistance (TeR) and adherence-conferring island (TAI) which 
can be found in distantly related pathogenic E. coli (Tarr et al., 2000; Taylor et al., 
2002).  In EHEC strain EDL933, two copies of iha are present in the chromosome 
on duplicated prophage elements, OI-43 and OI-48 (Perna et al., 2001).  In closely 
related O157:H7 strain Sakai, only one copy of iha exists (OI-48 (Hyashi et al., 
2001).  The TAI itself can be characterised into three functionally distinct gene 
clusters that encode TER, a urease, and the putative adhesins Iha and AIDA-1 
(adhesin involved in diffuse adherence).  AIDA-I is an auto-transporter 
membrane protein that confers on EPEC a diffusely adherent phenotype on 
epithelial cells (Benz and Schmidt, 1989; Benz and Schmidt, 2002).  Work by Yin 
et al (2009) has suggested that this cluster of genes may contribute to EHEC 
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O157:H7 pathogenesis; where deletions in these regions affect bacterial 
adherence to tissue culture cells and enterocytes in pig ileal loops.  The precise 
roles of Iha and AIDA-1 in EHEC virulence however remain to be clearly 
demonstrated. 
 
Another protein implicated to have a role in EHEC adherence is the outer 
membrane protein A (OmpA). Initially identified from a transposon mutant 
library screened for hyper-adherent phenotypes, an ompA mutant was found to 
adhere poorly to HeLa cells compared with its parent strain.  In this same study, 
antibodies directed against OmpA inhibited adhesion, suggesting OmpA may 
play an important role during EHEC colonisation.  Moreover, recent studies in 
Shigella have provided some evidence that OmpA is an important colonisation 
factor in this pathogen; where immunisation of mice with recombinant OmpA 
was enough to protect these animals from experimental challenge with a 
virulent strain of Shigella flexneri 2a (Pore et al., 2011).   
 
1.3.6 Flagella 
The genes regulating flagella gene expression and biogenesis are divided among 
17 operons which constitute a large and co-coordinately regulated flagellar 
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regulon.  Within this regulon, operons are divided into three temporally-
regulated, hierarchical transcriptional classes: early genes (class 1), middle genes 
(class 2) and late genes (class 3) (Chilcott and hughes, 2000).  The early genes 
encode the master flagella regulator, flhDC, which activates transcription of 
middle genes, including genes encoding the hook-basal body and the 
transcriptional regulators flgM and fliA (σ28) (Chilcott and hughes, 2000).  fliA 
regulates the transcription of the late genes which include fliC and the mot 
operon (Chilcott and hughes, 2000).  The flagellar filaments themselves are 
made up of 11 proto-filaments which polymerise to form monomers of the 
flagellin protein FliC that are attached to a hook complex which is anchored to a 
basal body and forming the flagellar motor (MacNab, 2003).  The flagellum 
components are functionally related to the LEE-encoded T3SS and it is 
hypothesised that flagellin polymerisation occurs via a similar mechanism to the 
translocation of T3SS effector proteins (Aldridge and Hughes, 2002).   
 
The precise role(s) of flagella (H7) in EHEC pathogenesis are to be properly 
elucidated although several studies have suggested that flagella are important 
for EPEC during the early stages of colonisation; where Giron et al (2002) 
demonstrated that a fliC mutant is attenuated for adherence in vitro.  In this 
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same study however, antibodies directed against EHEC H7 antigen did not 
inhibit adherence; and purified H7 was shown not to directly adhere to cells 
(Giron et al., 2002).  More recently, studies by Mahajan et al. (2009) have 
provided strong evidence that flagella in EHEC mediates adherence where 
binding of a fliCH7 mutant O157 strain to rectal epithelium in vitro was 
significantly reduced; as was binding of the flagellated wild-type strain 
following incubation with H7-specific antibodies. Moreover, complementation 
of the fliCH7 mutant with fliCH7 was then enough to restore adherence to wild-
type levels, suggesting that H7 flagellum acts as an adhesin to bovine intestinal 
epithelium (Mahajan et al., 2009).  Luck et al (2006) have also reported an 
important role for FliC in EHEC O113:H21; where deletion of fliC significantly 
decreased bacterial invasion on tissue culture cells; a phenotype that was 
complementable when fliCH21 was provided back in trans on a plasmid.  
Together, these studies strongly implicate flagella as having an important 
contribution in the multi-step colonisation process of different E. coli strains. 
 
In EHEC, T3S and motility are reciprocally regulated, where T3S is up-regulated 
and motility is down-regulated in response to different environmental ques; and 
vice versa.  Indeed, EHEC have been shown to shut down flagella gene 
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expression in micro- colonies whilst up-regulating genes associated with T3S; a 
switching mechanism that is reported to be mediated via the DNA-bending 
protein IHF (IHF activates ler and represses flhDC gene transcription) (Yona-
Nadler et al., 2003).  Reciprocal regulation of T3S and motility has also been 
demonstrated for the intrinsic LEE regulators GrlRA; and for a number of QS 
regulators that are present in the chromosome of E. coli (Sperandio et al., 2002; 
Iyoda et al., 2006). 
 
1.4 Evolution of EHEC 
EHEC strains fall into at least four divergent clonal groups.  One group includes 
EHEC strains of serotype O157:H7; a second clonal group includes EHEC strains 
of serotype O111:H8 and O26:H11; a third group includes EHEC strains of 
serotype O103:H2 and O45:H2; and a fourth group that includes many different 
O types that are usually associated with H21 flagellar antigen, such as O113:H21 
and OX3:H21 (Caprioli et al., 2005).  Evolutionary analysis has shown that E. coli 
O157:H7 is only distantly related to other EHEC clonal groups and is most 
closely related to an EPEC clone of serotype O55:H7, a non-Stx producing strain 
of E. coli associated with infantile diarrhoea (Whittam et al., 1993).  Phylogenetic 
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studies by Feng et al (1998) have inferred that E. coli O157:H7 strains evolved in 
a step wise fashion from an O55:H7 like ancestor by acquisition of bacteriophage 
derived Stx (Stx1 and Stx2), a large virulence plasmid (pO157), and the 
transition of somatic antigen O55 to O157.  The most common E. coli O157:H7 
isolates are motile, non-sorbitol fermenting (SOR-), and β-glucuronidase 
negative (GUD-), although nonmotile SOR+ GUD+ O157:H- isolates has been 
identified in Germany, Hungary, Finland and Swede; and a nonmotile SOR- 
GUD- O157:H-  isolate has been commonly observed in Australia (Steele et al., 
2007).  Loss of ability to ferment sorbitol and β-glucuronidase activity are 
believed to be two key landmarks in the proposed stepwise evolution of E. coli 
O157 that has led to the emergence of the most commonly isolated GUD- and 
SOR- phenotype that accounts for most disease caused by EHEC (Feng et al., 
1998; Zhang et al., 2006).   
 
1.5 Comparative genomics: EHEC O157:H7 versus K-12 
The complete genome sequence of non-pathogenic laboratory E. coli K-12 strain 
MG1655 was published in 1997 (Blattner et al., 1997).  Four years later in 2001, 
the complete genome sequences of two pathogenic strains of E. coli O157:H7 
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were published; strains EDL933 and Sakai (RIMD0509952)  (Hayashi et al., 2001; 
Perna et al., 2001).  On comparison, it was shown that the genome of EDL933 
and MG1655 share a large amount of ‘backbone’ DNA (~ 4.1 million base pairs 
each) that is arranged similarly in the two strains, with the exception of a 422 kb 
inversion located at the replication terminus (Blattner et al., 1997; Perna et al., 
2001).  However, lineage-specific DNA segments were also found to be scattered 
throughout the genomes in both strains (Perna et al., 2001).  In EDL933, these 
DNA segments (1.34 Mb in total) were numbered and designated ‘O-islands’ 
(OIs), and in MG1655, numbered and designated ‘K-islands’ (KIs) (0.53 Mb in 
total).  In total, 177 OIs and 234 KIs (>50 kb) were identified (Perna et al., 2001).  
In EDL933, approximately 26% of all the genes in the genome lie within these 
OIs, and of these OIs, 40% may be assigned a function (Perna et al., 2001).  
Additionally, ~33% of OIs in the EDL933 genome contain only genes with no 
known function, 6.2% of which lie within phage-related clusters (Perna et al., 
2001).  It has been suggested by Perna et al (2001) that a large proportion of the 
DNA found in OIs and KIs was acquired through horizontal gene transfer.  
Indeed, several of the OIs described by Perna et al (2001) include many known 
and predicted virulence determinants that have been previously well studied, 
such as the stx (stx1 is located within a cryptic prophage designated CP-933V 
69 
 
and stx2 is located within a lambdoid phage designated BP-933W) and LEE 
genes, which are known to be subject to lateral transfer (Whittam and 
Bumbaugh, 2002).   
 
1.6 Research aims and rationale 
The horizontal acquisition of foreign DNA is not only associated with the 
emergence of pathogenic bacteria and their adaptation to unique niches, but is a 
major driving force in their diversification and evolution.  In the sequenced 
EHEC O157:H7 strain EDL933, these horizontally acquired elements have been 
termed O-islands (OIs) and include both fully functional and cryptic prophages.  
Crucially, comparative genomic analyses of EDL933 with non-pathogenic E. coli 
strain MG1655 have demonstrated that these OIs are specific to the pathogenic 
E. coli strain.  Leading on from this, the overall aim of this research was to 
characterise these prophage-associated regions in EHEC strain TUV93-0, a Shiga 
toxin-negative derivative strain of EDL933, by phenotypically screening a large 
collection of OI deletions and comparing these with the parent strain.  The 
rationale was that such phenotypic screening would provide an insight into the 
function of these islands and the evolution of this specific pathogen, in 
particular its capacity to colonise the gastrointestinal tract of ruminants and 
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transmit to humans.  Given the focus on screening for effects on T3S, it was 
envisaged that novel regulators of the LEE PAI  may be identified, along with 
novel OI-derived factors that potentially cross-talk with this essential 
colonisation system.  An aim was to contribute to the understanding of the 
complex regulatory biology of this pathogen.  To achieve this, a variety of 
molecular genetic and proteomic approaches were adopted that permitted the 
defined research objectives detailed below: 
 
Objectives 
1. Phenotypically screen a large collection EHEC derived OI deletions for 
important phenotypes such as T3S, motility, growth rate and acid 
resistance; and then compare these with the parent strain to identify 
potentially significant OI regions (Chapter 3). 
 
2. Phenotypic and genotypic characterisation of OI regions (identified 
through the initial phenotypic screening process) using cloning and 
complementation and allelic exchange mutagenesis in the relevant 




3. Assess the in vivo significance of OI targets identified as significant 
through objectives 1 and 2, by comparing the equivalent deletion strain 
and wild type parent in a ruminant competition infection model  
(Chapter 4).  
 
4. Functionally characterise OI encoded proteins of interest to determine 
their mechanism of action and their interplay with other proteins and 
























2.1 Bacterial strains and plasmids  
All of the bacterial strains and plasmids used in this research are detailed in 
Tables 2.1 and 2.2. 
 
2.2 Bacterial culture conditions and media 
Bacterial strains were routinely cultured at 37oC with shaking (200 rpm) in 
Luria-Bertani (LB) broth or agar (Oxoid) prepared in accordance with the 
manufacturer’s instructions.  For the analysis of T3S proteins, minimal essential 
media with 25 mM HEPES (MEM-HEPES) (Sigma-Aldrich) supplemented with 
250 nM Fe(NO3)2 and 0.2% glucose was used for culturing strains.  For bacterial 
growth rate assays, M9 medium was used containing 1 × M9 salts supplemented 
with 2 mM magnesium sulphate (MgSO4.7H2O), 0.1 mM calcium chloride 
(CaCl2.H2O) and 0.2% glucose.  CFA agar (LabM), prepared according to the 
manufacturer’s instructions, and CFA broth (0.15% yeast extract (Becton 
Dickinson), 1% casamino acids (Oxoid), 0.01% Congo red (Sigma-Aldrich), 400 
µM magnesium sulphate and 40 µM manganese chloride (MnCl2.4H2O)) was 
used for selecting and culturing colonies respectively in Congo-red binding 
assays. When required, Isopropyl β-D-1-thiogalactopyranoside (IPTG), 5-




added to media at the follow final concentrations: 1 mM IPTG; 20 ng/ml -1 X-gal; 
50 µg/ml -1 ampicillin; 50 µg/ml -1 chloramphenicol; 100 µg/ml -1 kanamycin and 
15 µg/ml -1 nalidixic acid. 
 
2.3 DNA analysis and genetic manipulation methods 
Unless otherwise stated, all methods were performed as for Sambrook et al 
(1989). 
 
2.3.1 Genomic DNA extraction from E. coli strains 
Genomic DNA was extracted from E. coli isolates using a ChargeSwitch genomic 
DNA (gDNA) Mini Bacterial Kit (Invitrogen) in accordance with the 
manufacturer’s instructions.  Aliquots of purified DNA were stored at -20 oC 
and genomic DNA was diluted 1:100 in Milli-Q water (MQ) (Sigma-Aldrich) 
before being used as DNA template in Polymerase Chain Reaction (PCR). 
 
2.3.2 Preparation of crude DNA extracts from E. coli strains 
Crude DNA preparations were used as templates for diagnostic and screening 
PCRs mainly in cloning experiments. A single bacterial colony from overnight 




block to 100oC for 10 min.  Aliquots were stored at -20oC and 1 µl of lysate was 
used as DNA template in all PCR reactions. 
 
2.3.3 Plasmid DNA extraction from E. coli strains 
Plasmids were extracted from bacteria cultured overnight in 5 ml LB broth 
supplemented with appropriate antibiotic using the GeneJET Plasmid Miniprep 
Kit (Fermentas) in accordance with the manufacturer’s recommendations.  
 
2.3.4 DNA amplification by PCR 
All of the PCR primers used in this research are detailed in Table 2.3.  PCR was 
carried out in sterile thin-wall tubes in 50 µl reaction volumes, containing 1 µl 
template DNA (1:100 dilution for gDNA), 200 µM dNTP mixture (Roche), 0.5 
µM primer, 1 × ThermoPol Taq PCR reaction buffer (20 mM Tris-HCl, 10 mM 
(NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% Triton X-100 pH 8.8 at 25 oC), 1.25 U 
Taq DNA polymerase (NEB) and MQ water to the final volume.  For high-
throughput PCRs (e.g. screening bacterial colonies for positive clones), Quick-
Load Taq 2× Master Mix (NEB) was used according to the manufacture’s 





For cloning and sequencing purposes, high fidelity Expand Long Template PCR 
(Roche) was used to amplify large DNA fragments (>4 Kb) and Phusion high-
fidelity DNA polymerase (Finnzyme) was used to amplify DNA fragments <4 
Kb; both according to the manufacturer’s guidelines and contained 1 µl 
template DNA, 200 µM dNTP, 0.5 µM each primer, 1 × kit specific reaction 
buffer, 1.5 U Taq/Tgo polymerase mix and 0.5 U Phusion DNA polymerase 
respectively.  High Fidelity Expand Long Template PCR contains an enzyme 
mix of Taq DNA polymerase and Tgo DNA polymerase with inherent 
proofreading activity, ensuring a lower error rate than PCR using Taq DNA 
polymerase alone. Phusion High-Fidelity DNA Polymerase contains a 
Pyrococcus-like enzyme and has an error rate 50-fold lower than Taq DNA 
polymerase.  All PCRs were performed in a Thermo-Hybaid PCR Express cycler 
using cycling conditions in line with each supplier’s specific recommendations.  
Amplification products were subsequently resolved by agarose gel 
electrophoresis as described in section 2.11.2 
 
2.3.5 DNA electrophoresis 
DNA fragments were resolved by electrophoresis in gels containing between 




mM ethylenediamine tetraacetic acid (EDTA) (Sigma-Aldrich), pH 8.3, 
containing ethidium bromide or SafeView (NBS Biologicals) for DNA staining. 
Electrophoresis was performed in 1 × TBE buffer at constant voltage (100 V) 
using Bio-Rad systems. DNA samples were mixed with DNA loading buffer 
(Invitrogen) prior to loading and fragment sizes were determined by 
comparison to molecular markers (NEB; 1 Kb or 100 bp). PCR amplicons were 
visualised under UV illumination in a Flowgen MultiImage light cabinet 
(Shenstone, England) and images were captured and analysed using 
ChemiImager 4000i v.4.04 software. 
 
2.3.6 DNA fragment purification 
2.3.6.1 Column and gel purification 
DNA fragments from PCR and restriction digests were purified using the 
GeneJET PCR Purification Kit (Fermentas) and DNA fragments from agarose 
gels were purified using the GeneJET Gel Extraction Kit (Fermentas); according 







2.3.7 Transformation of competent E. coli  
E. coli strains were made competent for transformation with plasmid DNA 
using the protocols described in Sambrook et al., 1989. 
 
2.3.8 DNA digestion  
Enzymatic digestion of DNA was carried out in a 50 µl reaction volume in a 1.5 
ml eppendorf tube (Greiner) and typically contained 30 µl genomic or plasmid 
DNA, 2 µl restriction endonuclease (NEB), 5 µl 10 × appropriate NEB buffer, 5 
µl 10 × bovine serum albumin (BSA) (NEB) and MQ water to the final volume.  
Incubation was carried out for at least 2 hours in a water bath set at the 
appropriate temperature for each restriction enzyme. 
 
2.3.9 Klenow fill-in 
When necessary, digested DNA products were blunt-ended using Klenow 
(Large fragment of DNA polymerase I) (NEB) in a 60 µl reaction volume in a 1.5 
ml eppendorf tube (Greiner) and typically contained 30 µl plasmid DNA, 2 µl 
Klenow fragment (NEB), 6 µl 10 × Klenow reaction buffer, 6 µl 10 × bovine 
serum albumin (BSA) (NEB) and MQ water to the final volume.  Incubations 




column clean up as described in section 2.3.6.1.  Subsequent ligation reactions 
were carried out exactly as described in section 2.3.10. 
 
2.3.10 DNA ligation 
In the construction of recombinant DNA plasmids, vector and insert DNA was 
digested with the appropriate restriction endonucleases and purified as 
described in section 2.3.6.1.  Linearised vector was treated with shrimp alkaline 
phosphatase (SAP) (NEB) to dephosphorylate 5’ restricted termini to help 
prevent vector re-ligation. Ligation reactions were carried out in a thin-walled 
tube and typically contained 6 µl insert, 2 µl vector, 1 µl 10 × ligase reaction 
buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM ATP, 10 mM dithiothreitol (DTT), 
25 µg/ml BSA, pH 7.5 at 25°C) (NEB) and 1 µl T4 DNA ligase (NEB) to a final 
volume of 10 µl.  Ligation reactions were mixed thoroughly and incubated in a 
Thermo-Hybaid thermocycler machine at 16oC overnight. 
 
2.3.11 Preparation and transformation of chemically-competent E. coli cells 
E. coli strain DH5α (Invitrogen) was cultured in 5 ml LB broth shaking at 200 
rpm at 37oC overnight. The following day the culture was diluted 1:100 in LB 




optical density at 600 nm (OD600) of between 0.5-0.7. Cultures were incubated on 
ice for 20 min prior to centrifugation at 4000 × g for 8 min at 4oC. Cell pellets 
were gently suspended in 0.4 volumes (of the original culture volume) of ice-
cold transformation buffer I (TFBI: 30 mM potassium acetate (KC2H3O2), 10 mM 
CaCl2.2H2O, 100 mM KCl, 15% (v/v) glycerol and 45 mM MnCl2) and incubated 
on ice for 15 min. Cells were harvested as above and gently suspended in 0.04 
volumes of ice-cold transformation buffer II (TFBII: 75 mM CaCl2, 10 mM KCl, 
15% (v/v) glycerol and 10 mM Na-MOPS pH 7.0). Aliquots (200 µl) of cells were 
stored at -70oC. 
 
Chemically-competent E. coli DH5α cells were defrosted on ice and mixed with 
10 µl of ligation reaction (sections 2.3.10 and 2.3.11).  The cell-ligation mixture 
was transferred into a glass tube and incubated on ice for 30 min before heat 
shocking in a water bath at 42oC for 45 sec. Reactions were incubated on ice for a 
further 2 min and then 800 µl of SOC media (Invitrogen) was added. 
Transformants containing pIB307-based temperature-sensitive vectors were 
recovered at 28oC for 3 h with shaking at 100 rpm. All other plasmid 
transformants were recovered by incubation at 37oC for 90 min with shaking 




with the appropriate antibiotics and incubated overnight at the appropriate 
temperature. 
 
2.3.12 Preparation and transformation of electro-competent cells 
All plasmid transformations in wild-type E. coli and strains and their derivatives 
were performed by electroporation.  Preparation of cultures to make electro-
competent cells was in a similar manner as for chemically-competent cells 
(section 2.3.11).  Culture pellets were washed twice by suspending in 0.5 
volumes of ice-cold 10% glycerol (v/v) (Fisher Scientific) and then centrifuging 
at 4000 × g for 8 min at 4oC.  The final cell pellet was resuspended in 0.005 
volumes of ice-cold 10% glycerol (v/v) and stored in aliquots (50 µl) at -70 oC.   
 
Electro-competent cells were defrosted on ice and mixed with 1 µl purified 
plasmid DNA. The cell-plasmid mixture was transferred into a pre-chilled 1.5 
ml electroporation cuvette (Flowgen, UK) and electroporated at 2.5 KV in a 
(machine name).  SOC medium (1 ml) was added immediately and the 
suspension was transferred into a 1.5 ml eppendorf tube and transformants 
were recovered as described for the transformation of chemically competent 




supplemented with appropriate antibiotic and incubated overnight at the 
appropriate temperature. 
 
2.3.13 TOPO TA cloning 
The TOPO TA cloning kit (Invitrogen) provides an efficient strategy for the 
direct insertion of Taq DNA polymerase amplified PCR products into 
commercial cloning vector pCR4-TOPO.  Taq amplified PCR products contain 
poly-A 3’ overhangs that are created by the addition of single deoxyadenosine 
(A) to the 3’ end of PCR products during amplification as a result of Taq’s non-
template dependant terminal transferase activity.  pCR4-TOPO vectors contain 
poly-T 3’ overhangs that increase the efficiency of vector ligation with Taq DNA 
polymerase amplified PCR products carrying complementary poly-A 3’ 
overhangs.  Ligation reactions were carried out according to the manufacturer’s 
instructions (Invitrogen TOPO TA user manual version U) and chemically 
transformed into One shot TOP10 chemically-competent E. coli cells 







2.3.14 Construction of OI deletions in EHEC strain TUV93-0 
All pre-study OI deletion mutants were constructed in the laboratory of 
Professor John Leong, University of Massachusetts, using the method described 
by Campellone et al (2004).   
 
2.3.15 Construction of defined mutations in EHEC and UPEC 
Deletions were constructed for genes ecs1581 (EHEC), qseC (EHEC) and c1493 
(UPEC) using allelic exchange as described by Blomfield et al (1991) and 
Emmerson et al (2006).  Briefly, chromosomal regions (~600-1000bp) flanking the 
gene of interest were PCR amplified with a high fidelity Phusion polymerase 
(Fiinzyme) (Section 2.3.4) and cloned into a chloramphenicol resistant 
temperature sensitive exchange plasmid (pIB307).  A kanamycin cassette was 
then cloned in between the homologous flanking regions on the exchange 
plasmid and subjected to several rounds of temperature and antibiotic selection.  
Integration of the exchange plasmid was achieved at 42°C in the presence of 
chloramphenicol, whilst plasmid excision was achieved at 28°C in the presence 
of kanamycin.  All mutants were verified by PCR and successful 
complementation was achieved by providing the related genes in trans on low 




2.3.16 Construction of plasmids for complementation 
All complementation plasmids were constructed using PCR products amplified 
with high fidelity Phusion polymerase cloned into pWSK29.  E. coli strain DH5α 
was used as the intermediate host strain for cloning constructs and all constructs 
were verified by sequencing (GenePool). 
 
2.3.16.1 Construction of engineered ECs1581 and ECED1_1787 protein variants  
Site directed mutagenesis was carried out using an overlap PCR approach.  
Briefly, the 5’ and 3’ regions of each gene were PCR amplified with engineered 
mutations in the relevant primers.  The two PCR products were then used as a 
template for the overlap PCR using the outside primers.  The PCR products 
were cloned into vector pWSK29, verified by sequencing, and then tested for 
their effects on motility and T3S in an ecs1581 deletion strain background. 
 
2.3.17 Measurement of LEE1 promoter activity 
In order to assess LEE1 gene expression in both wild type and mutant E. coli 
O157:H7 backgrounds, a 428 bp PCR generated DNA promoter fragment (-444 
to -16 bp upstream from the ler ATG start codon) was amplified from strain 




less green fluorescence protein (gfp) plasmid pKC26 to create transcriptional 
fusion plasmid pLEE1::gfp.  Test strains harbouring this reporter were cultured 
in DMEM supplemented with chloramphenicol and the GFP produced by each 
bacterial population was measured every 60 min by transferring 200 µl aliquots 
of culture into triplicate wells in a black 96-well plate (FluoroNunc) and reading 
the plate in a fluorimeter (FLUOstar Optima) using 485 nm absorbance and 520 
nm emissions at a gain of 1250.  Promoter-less plasmid pKC26 in each strain 
background acted as a control for auto-fluorescence.  When LEE1 promoter 
activity was measured in response to induced expression of ecs1581 from low 
copy number plasmid pWSK29 (pECs1581), strains were cultured in DMEM 
supplemented with chloramphenicol, ampicillin and IPTG and both pKC26 and 
pWControl in each strain acted as a control for auto fluorescence.  All were 
tested in triplicate and on at least three separate occasions. 
 
2.3.18 RT-qPCR 
Total RNA was purified from bacteria using an RNeasy kit (Qiagen) and 
random primers were used to reverse transcribe the RNA using Affinityscript 
(Stratagene); both in accordance with the manufacturer’s guidelines.  qPCR was 




a MxPro 3000 qPCR machine (Stratagene). Transcript abundance was 
normalized to 16SrRNA and relative transcription calculated using MxPro 
software (Stratagene).  
 
2.4 Bioinformatic analyses 
Variants of ECs1581 were identified using blastp (www.ncbi.nlm.nih.gov) and 
sequences were obtained from Genebank (www.ncbi.nlm.nih.gov/genbank).  
Putative hypothetical domains in ECs1581 were identified using MyHits 
(www.myhits-isb-sib.ch) and KEGG (http://www.genome.jp/kegg).  OI-51 
prophage alignments were adapted from Magnifying Genomes (MaGe), a 
relational based prokaryotic genome database (www.genoscope.cns.fr).  
Sequence alignments were performed using ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2), EMBOSS Align 
(http://www.ebi.ac.uk/Tools/emboss/align) and LALIGN 
(http://www.ch.embnet.org/software/LALIGN_form.html).  CLC Sequence 
Viewer (http://www.clcbio.com) was used to construct and visualize alignments 
among the protein coding regions of ECs1581; the ECs1581 region was identified 






All DNA sequencing was carried out by GenePool, School of Biological Sciences, 
University of Edinburgh, and was performed using an ABI Prism BigDye 
terminator cycle sequencing kit version 3.1 (Applied Biosystems).  Reactions 
were analysed on an ABI 3730 DNA sequencer. 
 
2.6 Bacterial growth analysis  
A single bacterial colony for each test strain was cultured overnight in 5 ml M9 
media at 37oC with shaking (200 rpm).  Cultures were diluted in the same media 
to a starting OD600 of 0.05, incubated as before and OD600 measurements taken 
every 60 min (Cecil spectrophotometer).  The mean generation time (g) for each 
strain was then calculated (using the equation log10 Nt = log10 N0 + g log102) and 
plotted as a bar chart. 
 
2.7 Acid survival 
Ability to survive in acid was assessed using the method described by Small et al 
(1994).  In brief, strains were grown overnight in LB broth at 37ºC with shaking 




Strains were incubated as before for 2 h and serial dilutions were made in sterile 
phosphate buffered saline (PBS) and plated in triplicate onto LB agar 
(100µl/plate) and incubated overnight at 37ºC.  Colony counts (cfu/ml) were 
compared with those from plated dilutions of the original culture to determine 
the percentage survival of each strain following acid challenge. 
 
2.8 Congo red binding assay 
Strains were initially streaked onto CFA agar plates (LabM) before individual 
colonies were taken and inoculated into CFA broth and grown overnight at 
37°C with shaking.  Cultures were diluted in PBS to an OD600 of 1.0, centrifuged 
at 4, 000 × g for 5 min and re-suspended in 1 ml of sterile PBS.  Washing was 
repeated a further two times to remove all traces of culture broth before finally 
re-suspending the culture pellets in 2.5 ml of PBS containing a final 
concentration of 0.01% Congo red.  Samples were incubated at 37°C for 30 min 
before a 1 ml aliquot was taken and centrifuged at 10, 000 × g for 10 min.  
Supernatants were discarded and pellets were air dried and photographed 






2.9 Motility assays 
Bacterial motility was assessed using a soft agar method.   Motility plates were 
prepared by adding 0.3% agar (Sigma-Aldrich) to 1% Bacto-Tryptone (Becton 
Dickinson) broth containing 0.5% NaCl (Sigma-Aldrich); or by adding 
autoclaved agar to pre-warmed DMEM to give a final agar concentration of 
0.3%.  For plasmid based complementation experiments, IPTG and ampicillin 
was added to plates when appropriate and all plates were poured the night 
before use and allowed to air dry on the bench.  Sterile inoculation needles were 
used to touch the tops of isolated colonies and stabbed vertically into the agar 
making sure not to touch the bottom of the plates to avoid twitching activity.  
Plates were incubated either at 28°C or 37°C for 16 h and motility was assessed 
by observing the circular halo that forms as a result of the bacteria swimming 
through the agar.  All strains were tested in quadruplicate and each experiment 
was carried out in triplicate.   
 
2.10 In vivo colonisation model 
Crossbred lambs (six weeks old) were housed in bio-secure containment level 2 
accommodation and supplied with food and water ad libitum.  All lambs were 




separation prior to commencing the studies.  Lambs were dosed orally with 1 × 
1010 CFU of WT E. coli O157:H7 and mutant bacteria (5 × 109 CFU of each).  
Inocula (10 ml resuspended in 10 ml of PBS pH 7.4) were delivered using a 
worming gun (Novartis Animal Health) ensuring that the whole inoculum was 
delivered directly to the pharynx.  Rectal faecal samples from each lamb were 
collected daily for direct plating onto sorbitol-MacConkey (Oxoid) plates 
supplemented with appropriate antibiotics.  Enrichment was carried out on 
samples in buffered peptone water for 6 h at 37°C and then plated onto sorbitol-
MacConkey plates supplemented with the appropriate antibiotic.  
Representative colonies were confirmed to be E. coli O157 by latex agglutination 
(Oxoid).  Animal experiments were performed in line with the Animals 
Scientific Procedures Act (1986) and were approved by the local ethical review 
committee. 
 
2.11 Methods for protein analysis 
2.11.1 Preparation and analysis of T3S culture supernatant proteins  
Strains were cultured overnight in either 5 ml LB broth or MEM-HEPES with 
added glucose and iron at 37ºC with shaking (200 rpm) before being diluted to 




as previously described and grown to a final OD600 of 1.  Cultures were 
centrifuged at 4,000 × g for 30 min at 4ºC and supernatants were filtered through 
0.45µm low protein-binding filters (Millipore).  A 10% (v/v) final concentration 
of trichloroacetic acid (TCA; Sigma-Aldrich) was used to precipitate the proteins 
and bovine serum albumin (BSA; NEB) (4µg/ml) was added to act as a co-
precipitant and to rule out the precipitation procedure as a source of variation in 
protein levels between culture supernatants.  Supernatants were incubated 
overnight at 4ºC and centrifuged at 4,000 g for 30 min at 4ºC.  Protein pellets 
were air-dried and re-suspended in an appropriate volume of re-suspension 
buffer (1.5 M Tris-HCL) to standardise samples and take into account the slight 
variation in OD600 at which cultures were harvested.  Culture supernatant 
proteins were subsequently analysed by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) on a 12% polyacrylamide gel 
with Colloidal blue staining (Severn Biotech).  In order to verify the presence of 
type three associated proteins in culture supernatants, antibody detection of 
EspD (T3 secreted translocon protein) was carried out as described in section 






2.11.2 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis  
Secreted or whole cell protein samples were separated by SDS-PAGE using 
either BIO-RAD Mini-protean II gel apparatus (Bio-Rad) or a Hoefer SE600 Midi 
gel electrophoresis unit.  Protein samples were mixed 1:1 with 2 × SDS loading 
buffer (Sigma-Aldrich) and incubated at 100oC for 5 min to denature the 
proteins.  Protein samples were loaded in a 5% stacking gel (5% acrylamide-
bisacrylamide, 0.125 M Tris-HCl, pH 6.8, 0.1% SDS, 0.1% ammonium persulfate 
(APS) and 0.001% N,N,N',N'-Tetramethylethylene diamine (TEMED)) and 
resolved in a 12% resolving gel (12% acrylamide-bisacrylamide, 0.375 M Tris-
HCl, pH 8.8, 0.1% SDS, 0.1% APS, 0.001% TEMED)  by electrophoresis.  
Electrophoresis was carried out in Tris-glycine running buffer (25 mM Tris-HCl, 
pH 8.3, 250 mM glycine and 0.1% SDS) at a constant voltage of either 100 V or 
150 V for mini and midi gels respectively.  Protein sizes were determined using 
a broad range pre-stained protein marker (NEB colorplus; 7-174 kDa). 
 
2.11.3 Colloidal blue staining of SDS-PAGE gels 
Proteins separated by polyacrylamide gel electrophoresis were stained 
overnight with Colloidal blue (Severn Biotech) according to manufacturer’s 




using a Flowgen MultiImage light cabinet and ChemiImager 4000i v.4.04 
software. 
 
2.11.4 Protein detection 
SDS-PAGE separated proteins (section 2.11.2) were transferred onto Hybond 
ECL nitrocellulose membrane (Amersham Biosciences) using a Trans-Blot 
electrophoretic transfer cell (Bio-Rad).  Briefly, the gel and nitrocellulose 
membrane were placed between two pieces of filter paper (3MM Whatman 
paper), which were in turn placed between two sponge pads, pre-soaked in 
transfer buffer (20 mM Tris, 154 mM glycine  and 20% (v/v) methanol) and held 
together in a plastic cassette.  Transfer was carried out in cold transfer buffer at a 
constant voltage of 60 V for 90 min.  Nitrocellulose membranes were blocked 
with 8% (w/v) dried milk powder (Marvel) in PBS at 4oC overnight and 
incubated with the relevant antibody diluted in wash buffer (1% dried milk 
(Marvel) and 0.05% (v/v) polyoxyethylenesorbitan monolaurate (Tween 20, 
Sigma-Aldrich) in PBS): mouse monoclonal anti-EspD and rabbit polyclonal 
anti-mouse IgG HRP conjugated antibodies (Dako) were both diluted 1:4000  
and mouse monoclonal anti-His (Qiagen) antibody was diluted 1:500.  All 




shaker and were washed for 3 × 10 min in wash buffer before and after each 
antibody step.  Detection of His-tagged proteins was carried out according to 
Protocol 7 in the QIAexpress detection and assay handbook and proteins were 
sized using a His-tagged protein ladder (6×HPL; Qiagen) which also acted as a 
control for the successful transfer of His-tagged proteins onto the nitrocellulose 
membranes.  For ECL detection, membranes were incubated in 2.5 ml of ECL 
Solution 1 (100 mM Tris-HCl, pH 8.5, 2.5 mM Luminol (C8H7N3O2) and 0.4 mM 
p-Coumaric acid (C9H8O3)) mixed with 2.5 ml of ECL Solution 2 (100 mM Tris-
HCl, pH 8.5 and 0.02% hydrogen peroxide (H2O2)) for 5 minutes at room 
temperature on the bench.  Chemiluminescence was detected on Hyperfilm ECL 
chemiluminescence film (Amersham Bioscience) developed in a Protec 
automatic film processor (Optimax).  Images were taken using a Flowgen 
MultiImage light cabinet and ChemiImager 4000i v.4.04 software.   
 
2.11.5 Native protein purification 
E. coli BL21 (DE3) (Invitrogen) cells harbouring plasmid pET28a-ECs1581, 
pET28a-ECED1_1787 or pET28a-ECED1_1787C20R were grown in LB broth in 
the presence of kanamycin at 37°C with shaking to an OD600 of 0.5.  Cultures 




before harvesting by centrifugation at 4000 x g for 30 min.  Cell pellets were 
suspended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole 
and 1 mg/ml lysozyme, pH 8.0) and lysed by sonication (6 × 10 second pulses 
with a 10 second cooling period on ice in between each pulse).  Lysates were 
centrifuged at 10,000 x g at 4°C for 30 min, incubated with Ni2+ NT resin 
(Qiagen) for 1 h at RT on a platform shaker and loaded onto a purification 
column (BioRad).  The column was washed twice with wash buffer (50 mM 
NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0) and the protein was eluted 
from the column in elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM 
imidazole, pH 8.0).  Crude preparations were transferred into dialysis tubing 
(8,000 kDa molecular weight cut-off, Medicell international Ltd) and dialysed in 
2 L of sterile PBS which was replenished every 24 hours for a total of three 
changes.  Total protein concentration was determined by BCA according to the 
manufacturer’s instructions (Novagen) and purity was verified by SDS-PAGE 
and antibody detection of recombinant His-tagged proteins.  Purified proteins 
were subsequently used in electrophoretic mobility shift and in vitro 
transcription assays along with PCR generated DNA promoter fragments as 





2.12 Electrophoretic mobility shift assay (EMSA) 
To determine if ECs1581 activation of LEE1 is direct or indirect, a 291 bp LEE1 
promoter (-288 to +3, with respect to the ler ATG start codon) and a control gapA 
fragment (also 291 bp) were PCR amplified from EHEC strain TUV93-0 and 
subjected to EMSA with either purified ECs1581, ECED1_1787 or ECED1_1787 
C20R proteins. EMSA was carried out as described previously (Tree et al., 2011). 
Briefly, the purified proteins were co-incubated with concentrations of ddUTP-
11-DIG (Roche) end-labeled DNA in binding buffer (10mM Tris (pH 8.0), 50mM 
KCl, 5 mM EDTA, 200µg/ml BSA, 100ng/ml poly d(I-C), 50mM glutamate and 
5% glycerol) for 30 min at 25oC and loaded onto 5% non-denaturing 
polyacrylamide gels in 0.5X TBE.  50 ng of unlabelled DNA was used for 
competition experiments and added to the binding reaction. The DNA and 
DNA-protein complexes were electro-transferred onto nylon membranes and 
developed with AP conjugated anti-DIG antibody (Roche) as per manufacturer’s 
instructions. 
 
2.13 In vitro transcription assay (IVT) 
In vitro transcription experiments were performed as described previously 




control promoters (LEE1 and gapA), RNA polymerase (Epicenter, Madison,WI), 
RNAsin and test proteins, ECs1581 and/or H-NS (gift of Prof. C. Dorman; 
Tupper et al., 1994), were incubated for 15 min at 37°C prior to the addition of 
the transcription mix containing x5 IVT buffer, heparin (1.2 µg/ml), NTPS,  and 
α32P-UTP (Perkin Elmer, UK).  The reaction was stopped 5 min later followed by 
the addition of Gel loading buffer II (Ambion) and denaturation at 95°C for 5 
min.  The resulting products were electrophoresed on a 7% polyacrylamide/8M 
urea gel.  Images were acquired following exposure of the dried gels to a 
phosphorscreen.  
 
2.14 Data analyses 
Data was analysed and graphs were drawn using Microsoft ® office Excel 2003.  
Significant differences were assessed by the Student’s t-test using Minitab 
software.  All error bars that are shown are a result of the standard deviation of the 
mean.  Statistical advice was provided by Dr Darren Shaw, Veterinary Clinical 
Sciences, R(D)SV, University of Edinburgh, Easter Bush Veterinary, Roslin, 
Midlothian who plotted and analysed the ruminant colonisation data shown in 
Fig. 4.1. 
 
Table 2.1 List of strains used in this research 
Strain Description Source/Reference 
TUV93-0 Shiga toxin negative derivative of EHEC O157:H7 strain 
EDL933 
Campellone et al., 2004 
TUV93-0 NalR Naladixic acid resistant strain of TUV93-0 This study 
TUV93-0 ∆OI-1CamR Lambda red generated OI-1 chloramphenicol cassette 
replacement mutant in strain TUV93-0 
John Leong, University 
of Massachusetts, USA  
Campellone et al, 2004 
TUV93-0 ∆OI-7 CamR Lambda red generated OI-7 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-8 CamR Lambda red generated OI-8 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-10-13 CamR Lambda red generated OI-10-13 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-14-15 CamR Lambda red generated OI-14-15 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-28-29 CamR Lambda red generated OI-28-29 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-30 CamR Lambda red generated OI-30 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-35 CamR Lambda red generated OI-35 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-36 CamR Lambda red generated OI-36 mutant in strain TUV93-0 John Leong 




Table 2.1 strains cont 
TUV93-0 ∆OI-47 CamR 
 
Lambda red generated OI-47 mutant in strain TUV93-0 
 
John Leong 
TUV93-0 ∆OI-50 CamR Lambda red generated OI-50 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-51 CamR Lambda red generated OI-51 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-52 CamR Lambda red generated OI-52 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-61 CamR Lambda red generated OI-61 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-62-63 CamR Lambda red generated OI-62-63 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-66 CamR Lambda red generated OI-66 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-67 CamR Lambda red generated OI-67 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-70 CamR Lambda red generated OI-70 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-76 CamR Lambda red generated OI-76 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-79 CamR Lambda red generated OI-79 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-80 CamR Lambda red generated OI-80 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-102 CamR Lambda red generated OI-102 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-112-113 CamR Lambda red generated OI-112-113 mutant in strain 
TUV93-0 
John Leong 




Table 2.1 strains cont 
TUV93-0 ∆OI-122 CamR 
 
Lambda red generated OI-122 mutant in strain TUV93-0 
 
John Leong 
TUV93-0 ∆OI-133 CamR Lambda red generated OI-133 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-138 CamR Lambda red generated OI-138 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-139 CamR Lambda red generated OI-139 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-141 CamR Lambda red generated OI-141 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-144 CamR Lambda red generated OI-144 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-148A CamR Lambda red generated OI-148A mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-148C CamR Lambda red generated OI-148C mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-149-150 CamR Lambda red generated OI-149-150 mutant in strain 
TUV93-0 
John Leong 
TUV93-0 ∆OI-153 CamR Lambda red generated OI-153 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-154 CamR Lambda red generated OI-154 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-156 CamR Lambda red generated OI-156 mutant in strain TUV93-0 John Leong 
TUV93-0 ∆OI-172 CamR Lambda red generated OI-172 mutant in strain TUV93-0 John Leong 







Table 2.1 strains cont 
TUV93-0 ∆ecs1581 (KanR) 
 
Allelic exchange strain with a kanamycin resistance 




TUV93-0 ∆qseC (KanR) Allelic exchange strain with a kanamycin resistance 
cassette inserted into the open reading frame of qseC in 
strain TUV93-0 
This study 
CFT073 UPEC pyelonephritis strain CFT073 (serotype O6:K2:H1) Mobley et al.,1990 
CFT073 ∆c1493 (KanR) Allelic exchange strain with a kanamycin resistance 




ZAP198 ∆grlA::Tn5 (KanR) 
Wild type EHEC O157:H7 strain 
GrlA transposon mutant in EHEC strain ZAP198  
Low et al., 2006 
This study 
ZAP1327 (KanR) Constitutive LEE1 expression strain with a kanamycin 
resistance cassette inserted into the LEE1 promoter region 
in strain ZAP198 
This study 





Table 2.1 strains cont 
ED1a 
 
Commensal E. coli strain (serotype O81) isolated from the 
faeces of a healthy individual 
 
Clermont et al., 2008 
DH5α Host strain used for cloning with pWSK29 Invitrogen 
BL21 (DE3) Bacteriophage T7 expression E. coli strain used with 













Table 2.2 Plasmids used in this research 
Plasmid purpose/name Description Source/Reference 
Cloning plasmids   
pET28a (+)  (KanR) His-tagged expression vector Novagen 
pKC26 (CamR)       Promoter-less GFP+ reporter fusion construct Holden et al., 2007 
pWSK29/pWControl (AmpR) IPTG inducible low copy number cloning vector Wang and Kushner, 
1991 
pIB073 (CamR) Chloramphenicol resistant temperature sensitive plasmid 
used for allelic exchange 
Blomfield et al, 2001 
pDG28 (CamR KanR)       Host vector harbouring the kanamycin resistance cassette 
used for all pIB073 based allelic exchanges 
Gally et al., 1994 
 
Plasmid complementation 
pZ1835-Z1843           
 
 





pZ1841 z1841 cloned into pWSK29 
 
This study 







Table 2.2 plasmids cont 





ecs1581 amplified from strain TUV93-0 and cloned into 
pWSK29 (representative of Lineage I EHEC O157:H7 
strain variants) 
EHEC ecs1581 orthologue (ecsp_1496) amplified from 
strain TW14539 and cloned into pWSK29 (representative 






p96788 (LII) EHEC ecs1581 orthologue amplified from strain 96788          
(un-sequenced) and cloned into pWSK29 (representative 
of Lineage II and LI/II O157:H7 strain variants) 
This study 
pC1493               c1493 cloned into pWSK29 This study 
pECED1_1787      eced1_1787 cloned into pWSK29 This study 
pQseC qseC cloned into pWSK29 This study 
pECED1_1787C20R        
 
eced1_1787 cloned into pWSK29 with a Cys to Arg  
substitution at position 20 
This study 
pECED1_1787C20R+N35K   
 
eced1_1787 cloned into pWSK29 with a Cys to Arg and Asn 








Table 2.2 plasmids cont 
pECs1581R20C 
 
pECs1581R20C20N      
 
ecs1581 cloned into pWSK29 with an Arg to Cys 
substitution at position 20 
ecs1581R20C cloned into pWSK29 with an Arg to Asn 





pECs1581K35N     
 
ecs1581 cloned into pWSK29 with a Lys to Asn substitution 
at position 35 
This study 
pECs1581R20C+D10A    
 
ecs1581 cloned into pWSK29 with an Arg to Cys and Asp 
to Ala substitution at positions 20 and 10 respectively 
This study 
pECs1581R20C+K35N ecs1581 cloned into pWSK29 with an Arg to Cys and Lys to 
Asn substitution at positions 20 and 35 respectively 
This study 
pECs1581R20C+Q27K    
 
ecs1581 cloned into pWSK29 with an Arg to Cys and Gln to 
Lys substitution at positions 20 and 27 respectively 
This study 
pECs1581R20C+H45R    
 
ecs1581 cloned into pWSK29 with an Arg to Cys and His to 
Arg substitution at positions 20 and 45 respectively 
This study 







Table 2.2 plasmids cont 
pECs1581R20C+R61D     
 
Recombinant  protein 
expression 
 
ecs1581 cloned into pWSK29 with an Arg to Cys and Arg 
to Asp substitution at positions 20 and 61 respectively 
 
This study 
pET28a-ECs1581 ecs1581 cloned into expression vector pET28a (+) This study 
pET28a-ECED1_1787 eced1_1787 cloned into pET28a (+) This study 
pET28a-ECED1_1787C20R 
H-NS 
eced1_1787C20R cloned into pET28a (+) 
Purified recombinant H-NS protein gifted from Prof. 
Charles Dorman and Prof. Jay Hinton 
This study 
(Tupper et al., 1994) 
Transcriptional fusion    
pLEE1-gfp Upstream region of LEE1 cloned into GFP+ reporter 
pKC26 to create transcriptional fusion construct pLEE1::gfp 
This study 
Allelic exchange   
pIBECs1581-US                                 
pIBECs1581-DS     
 
Upstream flanking region of ecs1581 cloned into pIB073 











Table 2.2 plasmids cont 
pIBECs1581- KanR                            
 
pIBC1493-US                                 
pIBC1493-DS     
pIBC1493-KanR                            
 
Kanamycin resistance cassette cloned in between ecs1581 
US and DS flanking regions on pIB073 
Upstream flanking region of c1493 cloned into pIB073 
Downstream flanking region of c1493 cloned into pIB073 
Kanamycin resistance cassette cloned in between c1493 US 







pIBQseC-US                                 
pIBQseC-DS     
pIBQseC-KanR                            
Upstream flanking region of qseC cloned into pIB073 
Downstream flanking region of qseC cloned into pIB073 
Kanamycin resistance cassette cloned in between qseC US 



















z1835-z1843.R           
z1841.F 
z1841.R 
ecs1581.F                                 











c1493.F                                      




eced1_1787.F                            









ler.F                                                








Table 2.3 primers cont                           
qseC.F                                                CG TCTAGACATGTGCATCATCTGCGACG 
 
This study 
qseC.R                            
 

























eced1_1787C20R+N35K.F          
eced1_1787C20R+N35K.nestR              
eced1_1787C20R+N35K.nestF              































ecs1581R20C20N.F                         
ecs1581R20C20N.nestR                                          










ecs1581K35N.F      
ecs1581K35N.nestR                                                      
ecs1581K35N.nestF 

















Table 2.3 primers cont 
ecs1581R20C+D10A.F 
 











ecs1581R20C+K35N.F                 
ecs1581R20C+K35N.nestR                               
ecs1581R20C+K35N.nestF                                









ecs1581R20C+H45R.F            
ecs1581R20C+H45R.nestR               
ecs1581R20C+H45R.nestF                     


















Table 2.3 primers cont 
ecs1581R20C+R61D.F       
ecs1581R20C+R61D.nestR                
ecs1581R20C+R61D.nestF                







 This study 
 
ecs1581R20C+Q27K.F       
ecs1581R20C+Q27K.nestR          
ecs1581R20C+Q27K.nestF           

















eced1_1787-pET28a.F   













               




EMSA-LEE1.F                                
EMSA-LEE1.R          
EMSA-gapA.F  
EMSA-gapA.R        
EMSA-hns.F 











































Table 2.3 primers cont 
Screening and sequencing 
pWSK29-screen.F                                                           
pWSK29-screen.R                                                           
pIB073-screen.F                                                                  
pIB073-screen.R                                                                  
pET28a-screen.F                                                                   
pET28a-screen.R                                                                                                    
pKC26-screen.F 











































 The genome of EHEC O157:H7 strain EDL933 contains 177 regions of DNA, 
termed OIs, which are absent from non-pathogenic E. coli strain K-12.  Many of 
these islands contain sequences related to bacterial viruses and are believed to be 
horizontally acquired (Perna et al., 2001).  Many OIs have been suggested to be 
associated with virulence determinants but there is considerable uncertainty of 
gene function and their importance to the organism. This chapter describes the 
phenotypic characterisation of a large collection of OI deletions in EHEC O157:H7 
strain TUV93-0 to gain a broad overview of what these horizontally acquired 
elements may actually be doing for this important pathogen. The hypothesis was 
that some of the OI deletion strains would differ when compared phenotypically 
to the parent strain.  
 
3.1 Growth analysis 
Bacterial generation time (g) was used as a marker to gauge the metabolic 
activity of EHEC strain TUV93-0 and a selection of sixteen isogenic OI mutants 
cultured in M9 minimal media at 37ºC with agitation (200 rpm).  Strains ∆OI-14-
15, ∆OI-36, ∆OI-80 and ∆OI-148C all had doubling times (g = 89.0, 87.5, 87.3 and 
88.9 minutes respectively) equivalent to the parent strain (g = 87.7 minutes) 





























Figure 3.1.  Growth phenotypes for EHEC O157:H7 strain TUV93-0 and a selection of sixteen isogenic OI deletion 
cultured in M9 minimal media at 37°C with shaking (200 rpm).  Strain names are annotated as shown.  The mean generation 
time for each OI-deletion was calculated as described in Chapter 2.  Values represent the mean of two batches (n=2) for each 







parent with mean generation times ranging from between 81.0 to 83.0 minutes 
(Figure 3.1).  Strains ∆OI-7, ∆OI-148A, ∆OI-8, ∆OI-10-13, ∆OI-115 and ∆OI-122 
grew with shorter mean generation times ranging from between 73.6 minutes 
for ∆OI-122, the fastest replication rate of all the mutants tested, up to 78.4 
minutes for ∆OI-148A (Figure 3.1).  Strain ∆OI-44 had the slowest growth rate of 
all the mutants tested, with a difference in mean generation time of 16.9 minutes 
in comparison with the parent strain (Figure 3.1).  These initial observations 
suggest that OI-122 somehow reduces the stains growth rate while OI-44 
increases the replication rate of EHEC O157:H7 under the nutrient restricted 
growth conditions used in this study.    
 
3.2 Acid survival 
Acid resistance is perceived to be an important property for EHEC O157:H7 
which enables survival under extremely acidic conditions such as those 
encountered in the mammalian GI tract.  The possibility that OIs may in some 
way contribute to this important survival phenotype and potentially to other 
stress responses was therefore investigated.  Twelve OI deletions and the parent 
strain were screened for their ability to survive acid challenge in LB broth pH 






































































TUV93-0 ∆OI-79 ∆OI-80 ∆OI-115 ∆OI-122 ∆OI-144 ∆OI-148C ∆OI-172
A
B
Figure 3.2.  Acid survival phenotypes for EHEC O157:H7 strain TUV93-0 and 
a selection of twelve isogenic OI deletions growth in LB broth pH 2.0 for 2 h.  
(A-B) Challenge strains are annotated as shown and were assayed as described 
in Chapter 2.  The number of colony forming units per millilitre (cfu/ml) for each 
strain was calculated post acid-challenge, and then compared with those from 
plated dilutions of the original culture to determine the % survival of each strain. 
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challenge (t=2) to allow the percentage survival of each strain to be calculated 
(cfu/ml) following plating out of the cultures onto LB agar plates and incubation 
at 37ºC for 16 h.  With the exception of ∆OI-44, all of the deletions demonstrated 
survival rates on a par with the parent strain post acid challenge (Figure 3.2A-
B).  ∆OI-44 displayed a fivefold reduction in survival compared to TUV93-0 
(Figure 3.2A), and somewhat interestingly, this mutant also had a reduced 
growth rate in minimal M9 medium (Figure 3.1).  Taking these two phenotypes 
together for this one mutant, these data indicate that OI-44 may be an important 
‘fitness’ island for E. coli O157:H7.  
 
3.3 Motility 
A total of forty OI deletions were screened for motility by colony inoculation 
into soft agar and incubation at 37°C for 16 h.  Although the majority of the OI 
deletions tested were as motile as the parent strain, deletion strains ∆OI-14-15 
and ∆OI-52 were significantly less motile (Figure 3.3); suggesting that these 
islands may positively regulate cell motility.  Likewise, several OI deletions had 
enhanced motility in comparison with the parent strain, for example ∆OI-44 and 
∆OI-51; indicating that these islands may have a repressive effect on motility 





















Figure 3.3.  Analysis of motility in EHEC O157:H7 strain TUV93-0 and a selection 
of thirty nine isogenic OI deletions.  (A-C) Test strains are annotated as shown. 
Strains were screened for motility as described in Chapter 2 and each experiment was 
carried out on at least three separate occasions. 
 
C
A TUV93-0 ∆OI-148A ∆OI-10-13 ∆OI-14-15 ∆OI-7 ∆OI-8 ∆OI-36 ∆OI-44 ∆OI-50
∆OI-52 ∆OI-79 ∆OI-80 ∆OI-115 ∆OI-122 ∆OI-144 ∆OI-148C ∆OI-172 ∆OI-28-29
TUV93-0 ∆OI-1 ∆OI-67 ∆OI-138 ∆OI-139 ∆OI-141
∆OI-153 ∆OI-154 ∆OI-156 ∆OI-173-175∆OI-149-150
B TUV93-0 ∆OI-30 ∆OI-35 ∆OI-47 ∆OI-51 ∆OI-61
∆OI-62-63 ∆OI-67 ∆OI-70 ∆OI-76 ∆OI-102 ∆OI-112-113 ∆OI-133
122 
 
suggesting this island has the potential to affect major phenotypes for O157:H7; 
although these remain to be thoroughly investigated.  In relation to OI-14-15, 
this deletion had by far the clearest difference in motility compared with the 
parent strain (Figure 3.3), indicating that this island may have the capacity to 
either directly or indirectly affect bacterial motility in EHEC O157:H7. 
 
3.4 Analysis of T3S culture supernatant proteins 
Type III secretion (T3S) is an essential virulence determinant for EHEC that is 
required for successful colonisation of the bovine host (Naylor et al., 2004). To 
investigate the impact of OIs on T3S levels, twenty four OI deletions were 
cultured in MEM--HEPES at 37°C with shaking (200 rpm).  Supernatants were 
filtered, TCA precipitated and analysed by SDS-PAGE and colloidal blue 
staining.  Initial screening identified a subset of OIs with the capacity to either 
repress or activate T3S.  For example, ∆OI-47, ∆OI-76 (Figure 3.4A) and ∆OI-141 
(Figure 3.4B) deletions all had levels of T3S above that of the wild type parent, 
suggesting repression by these islands; whilst ∆OI-51, ∆OI-70 (Figure 4.3A) and 
∆OI-133 (Figure 4.3B) deletions had reduced levels of T3S, suggesting activation 














Figure 3.4 Screening of EHEC O157:H7 OI deletions for altered levels of T3S      
(A-B) SDS-PAGE gels showing culture supernatant secretion profiles for EHEC strain 
TUV93-0 and a selection of twenty four isogenic deletion strains.  Strain names are 
annotated as shown.  Parent strain TUV93-0 acted a positive control for T3S and a T3S 
system mutant (∆LEE1-3) provided a negative control for secretion.  The translocon 
protein bands are indicated, EspB/D and EspA as well as Bovine serum albumin (BSA) 
which was added as a loading control to help rule out the precipitation process as a 
source of variation and to act as a co-precipitant.  The wild type parent and OI-51 
deletion strain that was taken forward for further analysis are marked with an asterix for 




and also displayed enhanced motility compared with the parent strain.  
Although speculative at this stage, OI-51 may have the capacity to reciprocally 
control motility and T3S; regulatory cross-talk that has already been observed in 
EHEC.  OI-51 is therefore identified as a potentially important OI controlling 
T3S and motility and was taken forward for further investigation.   
 
3.5 Discussion 
EHEC O157:H7 is a serious human pathogen that can cause bloody diarrhoea, 
haemorrhagic colitis and haemolytic uremic syndrome.  EHEC pathogenesis is a 
diverse and often complex process involving the co-ordinated expression of 
virulence factors and transcriptional regulators that enable the bacteria to 
survive and cause disease, such as can be found on horizontally acquired 
genomic elements, for example on plasmids and in the genome of 
bacteriophage, that are transferred between bacteria. 
 
In the chromosome of EHEC O157:H7 strain EDL933 a large number of 
multigenic regions, or OIs, have been identified that include both fully 
functional and cryptic prophages (Perna et al., 2001); and studies on EHEC have 
demonstrated that the genotypic diversity observed amongst different strains of 
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EHEC O157:H7 is largely attributable to these bacteriophage-associated 
fragments (Ohnishi et al., 2002; Zhang et al., 2007).  Given that these regions can 
to some extent be considered accessory to the core genome, their presence in 
EHEC O157:H7 indicates selection in relation to the specific ‘lifestyle’ of the 
organism; for example, EHEC colonisation of the bovine gastrointestinal tract at 
the terminal rectum (Naylor et al., 2003).  It is now evident that a number of the 
larger OIs are cryptic lambdoid phage encoding effector proteins that are 
secreted through the T3S and which  contribute to EHEC O157 colonisation 
through effects on adherence and immune modulation.  Indeed, A number of 
OIs have already been partially characterised,  for example, OI-7 (putative 
macrophage toxin), OI-10-13 (EaeH putative adhesin), OI-28 (RTX-toxin-like 
exoprotein), OI-50 (SopA like protein; Psr regulators), OI-71 (NleF, NleH1-2, and 
NleA), OI-79 (EspFu effector protein), OI-80 (putative invasion), OI-115 
(ETTA2), OI-122 (cytotoxin), OI-144 (putative adhesin) and OI-148 (LEE PAI) 
(Campellone et al., 2003; Perna et al., 2001). 
 
Although not all of the OIs identified in the genome of EDL933 will have a role 
in virulence, those that do not may still have important biochemical and 
physiological functions.  Further characterisation of these OIs is therefore crucial 
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to enable a clearer understanding of the mechanisms utilised by this important 
zoonotic pathogen that help it colonise at the bovine terminal rectum; and that 
help the bacterium survive in vivo on passage to this colonisation site; including 
its persistence and survival in the environment and transmission to other 
animals and humans.  Therefore, an initial aim of this research was to 
phenotypically screen a large selection of OI deletions in EHEC strain TUV93-0; 
to try and identify novel prophage regions that confer important phenotypes on 
the bacterium which may help it to survive and colonise in its mammalian host.  
It was envisaged that at least a few OI deletions would be sufficiently different 
from their parent strain so as to provide a subset of targets regions that could be 
systematically analysed through cloning and complementation and targeted 
mutagenesis. 
 
Of interest, an OI-44 deletion strain was shown to have a growth rate 
considerably slower (~17 min) than its wild type parent following culture in 
minimal M9 medium (Figure 3.1).  Furthermore, this mutant was phenotypically 
more motile and less resistant to acid stress.  OI-44 is a 9.3 kb partial cryptic 
prophage, originally designated as CP-933M (Campellone et al., 2004; Perna et 
al., 2001) that is composed of 15 open reading frames.  Many of these are of 
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unknown function although this deletion has been reported to form A/E lesions 
on HeLa cells at wild type levels (Campellon et al., 2004).  Preliminary evidence 
here may support this prophage as being important for EHEC O157:H7 survival, 
although this would clearly require further investigation.  Also of interest was 
an OI-122 deletion which had a growth rate considerably quicker (~ 14 min) 
than its parent.  OI-122 is a 21.2 kb genomic island composed of 25 open reading 
frames, some of which share significant homology to virulence genes found in  
S. enterica (pagC) and S. flexneri (enterotoxin 2 or sen) (Karmali et al., 2003; Perna 
et al., 2001); and recently a number of T3S effector proteins have been identified 
on OI-122 (ent/EspL2, NleB, and NleE), although this island was not screened 
for T3S in this study; however, Campellone et al (2004) have previously 
demonstrated that an OI-122 deletion strain can form wild type levels of A/E 
lesion on cells.  The pattern of Nle genes encoded in OI-71 and OI-122 have also 
recently been closely associated with certain serotypes of EHEC and EPEC that 
are associated with severe illness and outbreaks in children (Bugarel et al., 2010; 
Bugarel et al., 2011).  As the loss of OI-122 from the genome of TUV93-0 
appeared to increase growth rate, this may suggest that OI-122 has the potential 
to suppress bacterial metabolism and/or cell division.  Again however, the full 
significance of these findings remains to be fully established. 
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Acid resistance enables organism such as E. coli O157:H7 to survive gastric 
acidity (pH <3.0) and volatile fatty acids produced as a result of fermentation in 
the intestine (Castanie-Cornet et al., 1999).  The ability to resist these acid 
stresses is believed to be necessary for E. coli to colonise its mammalian host and 
the low infectious dose associated with pathogenic E. coli O157:H7 is attributed 
to its acid resistant nature (Castanie-Cornet et al., 1999).  With this in mind, an 
acid shock assay was carried out to assess the acid resistance phenotype for a 
number of OI deletions following acid challenge at pH 2.0 for 2 hours.  Initial 
findings were somewhat disappointing in that most of the deletions assayed 
displayed no significant reduction in survival compared with the wild type 
parent; although one deletion (∆OI-44) did show a small reduction (5 fold) in 
survival.  The significance of this result however was uncertain due to a number 
of issues relating to this assay; such as harsh pH followed by mechanical stress 
on plating out.  Moreover, this assay was also extremely labour intensive, and so 
on this basis, it was decided not to pursue this island. 
 
For many bacteria, flagella play an important role in bacterial adaptation to 
environmental conditions and have also been associated with virulence (Yona-
Nadler et al., 2003).  A selection of sixteen TUV93-0 derived OI deletions were 
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therefore examined for differences in this phenotype.  Of particular interest was 
an OI-14-15 deletion as this strain was significantly less motile than its parent 
strain.  OI-14-15 is a 16.5 kb genomic island composed of 9 genes and 11 open 
reading frames, and is believed to contain a putative adhesion (Campellone et 
al., 2004; Wells et al., 2008).  The flagellar system of E. coli is known to be 
encoded by over 40 genes organised into several co-regulated operons (Yona-
Nadler et al., 2003).  Over a dozen of these operons have been discovered and 
are classified into three hierarchical classes (classes 1, 2 and 3), which together 
form the flagellar regulon (Iyoda et al., 2006).  It may be that there is cross-talk 
between OI-14-15 and the flagellar regulon in TUV93-0, although this island was 
over-looked for further investigation in place of another OI target, OI-51, which 
was shown to affect motility and T3S; the latter being an extremely important 
virulence mechanism required for EHEC colonisation in ruminants (Naylor et 
al., 2004). 
 
The delivery of virulence factors directly into host cells to interfere with and 
alter host processes is a crucial step in bacterial virulence.  In E. coli O157:H7, 
this is achieved through the LEE encoded T3SS which the bacteria utilises to 
inject a number of T3SS effector proteins into the cytosol of host cells, resulting 
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in cytoskeleton actin rearrangement and pedestal formation (A/E lesion).  The 
expression of LEE and T3SS proteins however is a complex and coordinated 
process responding to many environmental signals, such as temperature, pH, 
osmolarity, growth phase and quorum sensing (Laaberki et al., 2006).  In this 
study, secreted protein profiles for a number of OI mutants were examined and 
compared with their parent strain.  MEM-HEPES and DMEM were used as the 
growth medium of choice as studies have shown that levels of type III secretion 
are strain and medium dependant, with MEM-HEPES and DMEM being known 
promote the secretion of T3SS proteins such as EspA, EspB  and EspD (Roe et al., 
2003).  Major differences in secretion levels allowed a number of mutants to be 
classified as either high secretors or low secretors in comparison with the 
parent.  It would have been exciting to pursue a number of these OIs, but due to 
time restrictions, it was decided to take forward only one of these mutants for 
further investigation.  Given that an OI-51 mutant was attenuated for T3S and 
appeared more motile than its parent strain, the prospect that this prophage 
region may encode a potentially new regulator able to coordinate T3S and 
motility in EHEC swayed the decision to study this island.  The genotypic and 




















T3S is essential for EHEC O157:H7 colonisation in ruminants (Naylor et al., 2005) 
and previous analyses here identified an OI-51 deletion as having markedly 
reduced levels of T3S compared with its wild type parent.  This chapter goes on 
to describe the genotypic and phenotypic characterisation of this potentially 
significant region in EHEC O157:H7. 
 
4.1 In vivo analysis of OI-51  
To assess the potential importance of OI-51 for colonisation, an OI-51 deletion 
and parent strain were competed in an established ovine colonisation model 
(Wales et al., 2001).  The OI-51 deletion was marked with a chloramphenicol 
resistance cassette and the parent strain by selection for resistance to Naladixic 
acid to allow direct plating and enumeration of the two strains from faeces 
(Figure 4.1).  The strains were competed in 6 animals, only one of which failed to 
be properly colonised (< 20 CFU/gram faeces from the daily counts).  For the 
remaining five animals the estimated relative total levels of the mutant excreted 
from day 5 onwards, to remove inoculum effects, were estimated (Figure 4.1).  A 
significant reduction was demonstrated for the mutant (p=0.004) indicating that 
OI-51 is indeed important for colonisation and persistence in the ruminant GI 
tract.       
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Figure 4.1.  Contribution of OI-51 to EHEC colonisation in sheep.  Six animals were orally 
dosed with both wild type (TUV93-0) and OI-51 deletion strains as described in Chapter 2.  (A) 
Levels of both strains were determined daily from faecal samples.  ‘PosE’ are samples that 
were positive e for the strain following broth enrichment; ‘NegE’ samples were negative 
following broth enrichment.  (B) The cumulative shedding levels for each animal and strain 
were estimated for colonised animals from day 5 onwards to avoid inoculum effects. One 
animal was excluded from the analysis that was not properly colonised by either strain (<20 
CFU per gram of faeces).  The different symbols represent individual animals and allow direct 
comparison of the two strains in each animal.  The right hand panel of the graph shows the 
percentage mean decrease of the mutant strain by comparison with the WT.  The difference in 
median cumulative shedding levels is statistically significant (p=0.004).  All animal work was 
carried out by the VLA Weybride and the associated statistical analyses were carried out with 
help from Dr Darren Shaw. 
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4.2 OI-51 sequence analysis 
OI-51 is a 14.93 Kb cryptic prophage designated as CP-933C in sequenced EHEC 
O157:H7 strain EDL933, and Sp7 in closely related EHEC O157:H7 strain Sakai 
(Figure 4.2).  Bioinformatic analyses of this genomic region show it to be an 
unusual and highly degraded prophage comprised mainly of P4 phage 
remnants.  The majority of open reading frames annotated in OI-51 are 
hypothetical although several share features with known proteins; including a 
P4 integrase (similar to CP4-like integrase and integrase used for 933L and LEE 
PAI); a P4-like excisionase (Xis); a replication gene similar to the P4 α gene; a 
putative DNA binding protein similar to P4 ORF88; a putative single stranded 
DNA binding protein; a putative transcriptional activator, PchE, that shares 
homology to the plasmid encoded regulator C (PerC) locus in enteropathogenic 
E. coli (EPEC); and phage structural genes.  Although many morphogenesis 
genes are absent in OI-51, evidence suggests this prophage can still be packaged 
and replicated, and it is hypothesised that OI-51 may be complemented for these 
defects by procuring the relevant proteins from other prophages in the O157:H7 
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Figure 4.2.  Schematic representation of the genomic organisation of OI-51 and similar prophages in a subset of E. 
coli and Shigella reference strains (EHEC O157:H7 strains EDL933 and Sakai, UPEC strain CFT073, Shigella flexneri 
(2a) strain 301 and commensal strain ED1a).  Putative characterised genes are annotated as shown.  Sequence related 








4.3 OI-51 cloning and complementation 
In order to genotypically investigate ∆OI-51s reduced T3S phenotype further, 
OI-51 genomic fragments were PCR amplified (Figure 4.3A) from strain   
TUV93-0 and cloned into the commercial cloning vector TOPO (Invitrogen), to 
create expression plasmids pTZ1835-Z1843 and pTZ1850-Z1857; and then these 
were assessed for their effects on T3S levels following transformation into the 
OI-51 deletion strain (Figure 4.3B).  Unfortunately, attempts to clone the middle 
portion of OI-51 (harbouring genes z1844-z1849) were unsuccessful at this point.  
The potential significance of this prophage region will be discussed later as this 
harbours the previously mentioned pchE allele, a PerC like  that is can be found 
in certain EPEC strains(perA-C); termed pchA-E in EHEC, that can regulate LEE 
gene expression (Abe et al., 2008; Bustamante et al., 2011; Iyoda and Watanabe, 
2004; Porter et al., 2005).  Following culture, expression construct pTZ1835-43 
was able to rescue T3S in the OI-51 mutant by restoring T3S to the levels 
demonstrated in the parent strain, indicating that a positive regulator of the LEE 
was encoded somewhere on this fragment (Figure 4.3B).  By comparison, 
expression construct pTZ1850-57 had no discernable effect on T3S levels and 
was therefore regarded as a good internal cloning control (Figure 4.3B).  
Subsequent cloning of fragment z1835-z1843 into the low copy number vector 
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pWSK29 (pWZ1835-43) also rescued T3S when expressed in the OI-51 deletion 
strain (Figure 4.3C); reducing the likelihood that the regulation was due to 
issues associated with the use of a high copy number vector. 
 
4.4 Analysis of cloned OI-51 fragment z1835-z1843  
Previous analyses identified pTZ1835-43/pWZ1835-43 (harbouring OI-51 genes 
z1835-z1843 on high and low copy number vectors respectively) as a 5.8 Kb 
cloned fragment that is able to stimulate T3S in EHEC O157:H7 (Figure 4.3B).  
This finding was informative as it enabled an original ~15 Kb (OI-51) DNA 
region of interest to be narrowed down to 5.8 Kb.  To now narrow this region 
down even further, a series of restriction endonuclease cut-backs were made in 
pWZ1835-43, creating expression plasmids pXbaI+SphI, pSphI+HpaI, 
pHpaI+BstZ171, pHpaI+Bsu361 and pBsu361+HindII (Figure 4.4A-E); and then 
these were screened for their effects on T3S following Klenow-fill in, re-ligation 
and then transformation back into the OI-51 mutant.  The rationale for this being 
that any loss in activity (i.e. the construct is no longer able to rescue T3S) is 
indicative of the regulator having been removed; thus localising the regulator to 
that fragment.  T3S levels were significantly reduced in only one of the 
constructs; the OI-51 deletion harbouring pHpaI+Bsu361 (missing orfs z1840, 
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z1841 and z1842) (Figure 4.4F).  As expression plasmids pHpaI+BstZ17I (missing 
orf z1840) and pBsu361+HindIII (missing half of orf z1842 and all of z1843) were 
still able to stimulate T3S in the OI-51 deletion (Figure 4.4F), this ruled out all of 
the genes harboured on these fragments as being the regulator (s); leaving only 
orf z1841 and an intergenic region between z1841 and z1842 (Figure 4.4D).  
When z1841 was provided in trans on low copy number vector pWSK29 
(pZ1841), this construct was unable to rescue T3S levels in the OI-51 mutant 
(Figure 4.4H).  This unexpected result prompted closer inspection of the 
intergenic region between z1841 and z1842 (Figure 4.4I).  In closely related 
EHEC O157:H7 strain Sakai, an open reading frame is annotated between these 
two open reading frames, designated as ecs1581 (Figure 4.4I).  Successful PCR 
amplification of ecs1581 using EDL933 derived strain TUV93-0 as a genomic 
template confirmed the presence of ecs1581 in this strain (data not shown).  
Consequently, ecs1581 was cloned into pWSK29 (pECs1581) and analysed for 




























































Figure 4.3. Analysis of T3S levels in an OI-51 deletion in trans expressing cloned 
OI-51 fragments.  (A) OI-51 genomic fragments (z1835-z1843 and z1850-z1857) were 
PCR amplified from parent strain TUV93-0 and cloned into TOPO to create expression 
constructs pTZ1835-Z1843 and pZ1850-Z1857. (B) Analysis of T3S levels in an OI-51 
deletion expressing pTZ1835-Z1843 or pTZ1850-Z1857. Empty vector alone 
(pTControl) acted as a control (C) Analysis of T3S levels in an OI-51 deletion 
expressing pWZ1835-43 (T3S rescue fragment z1835-z1843 re-cloned into low copy 
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Figure 4.4. Construction of pWZ1835-43 cut-back derivatives and the analysis of their 
effects on T3S levels.  (A) Schematic representation of the cut-backs made in pWZ1835-43. 
Allelic fragments were cleaved from T3S rescue construct pWZ1835-43 using the restriction 
enzymes detailed in panel 4.4G.  Resulting constructs (pXbaI+SphI, pSphI+HpaI, 
pHpaI+BstZ171, pHpaI+Bsu361 or pBsu361+HindIII) were Klenow filled, re-ligated and then 

























Figure 4.4 cont. An 1191 bp cloned fragment from OI-51 can stimulate T3S in EHEC 
O157:H7 (F) SDS-PAGE gel showing T3S levels in an OI-51 deletion expressing cut-back 
derivatives of pWZ1835-43 (annotated as shown); where construct pHpaI&Bsu361 (no longer 
harbouring alleles z1840, z1841 and the first half of z1842 (partial)) has lost the capacity to 
activate T3S, indicating that a putative regulator of T3S is located somewhere in this region.  
Protein samples were prepared and analysed as described in Chapter 2. (G) Summary panel 
detailing the restriction sites that were used to digest-out alleles from T3S rescue fragment 




















Restriction sites Orf’s removed
XbaI+SphI (Figure 4.4A) z1835    
z1836
SphI+HpaI (Figure 4.4B) z1838 
z1839
HpaI+BstZ171 (Figure 4.4C) z1840
HpaI+Bsu361 (Figure 4.4D) Z1840
z1841 
z1842 (partial)































Figure 4.4 cont. Z1841 is unable to rescue T3S levels in an OI-51 deletion.  (H) z1841 
was cloned into low copy number plasmid pWSK29 (pZ1841) and analysed for its effects on 
T3S levels in an OI-51 deletion; to ascertain if this protein is capable of rescuing T3S levels.  
Empty vector alone (pWControl) acted as a negative control and the original T3S rescue 
construct pWZ1835-43 acted as a positive control.  Z1841 was unable to complement the 
OI-51 deletion for T3S indicating it is not a T3S regulator.  Protein samples were prepared 
and analysed as described in Chapter 2. (I) Schematic of the genetic organisation of open 
reading frames in the region z1840-z1843 in EHEC O157:H7 strains EDL933 and Sakai; 
where several differences in annotation can be seen between the two strains.  Of pertinence 
is an open reading frame annotated only in the Sakai sequence (ecs1581) but between 












EHEC O157:H7 strain Sakai









4.5 Identification of ecs1581 as a positive regulator of T3S  
To establish ecs1581 as a positive regulator of T3S encoded on OI-51, ecs1581 was 
cloned (pECs1581) and induced in an OI-51 deletion strain and then analysed 
for T3S.  ECs1581 strongly stimulated secretion in this background, bringing 
levels back to beyond wild type and equivalent to the positive control fragment 
pWZ1835-43.  An ecs1581 mutant was then constructed by inserting a 
kanamycin resistance cassette into the open reading frame of this allele in 
TUV93-0.  This strain was then analysed for T3S along with an ecs1581 deletion 
harbouring ECs1581 in trans (pECs1581) (Figure 4.5B).  T3S levels were 
significantly reduced in the ecs1581 mutant.  Further, these reduced levels of T3S 
could be rescued when ecs1581 was introduced in low copy number plasmid 
(pECs1581); in both the defined ecs1581 deletion and OI-51 mutant (Figure 4.5B).  
ecs1581 was therefore identified as a putative new regulator capable of 









































Fig. 4.5 Identification of ecs1581 as a positive regulator of T3S.  (A) SDS-
PAGE gel showing T3S complementation in an OI-51 deletion expressing 
ECs1581 on low copy number vector pWSK29 (pECs1581).  Empty vector alone 
(pWControl) acted as a control.  (B) SDS-PAGE gel showing significantly reduced 
levels of T3S in an ecs1581 deletion strain and then the rescue of this phenotype 
when ECs1581 is provided in trans. Construct pZ1835-43 was included for 
reference and as a positive control for secretion.  The empty vector alone 
(pWControl) acted as a negative control.  Protein samples were prepared and 





Genomic variation in E. coli has been shown to be predominately associated 
with horizontally-acquired genomic islands and phage-related regions that 
often harbour virulence-associated genes.  During this research, a number of 
EHEC prophage deletions (OIs) were examined for their effect on T3S (an 
essential virulence factor for EHEC which is required for successful colonisation 
of the ruminant host) in order to identify horizontally-acquired regions that 
cross-talk with this crucial colonisation system (Chapter 3).  Of the twenty four 
OI mutants studied in TUV93-0 (excluding the LEE1-3 deletion), five had lower 
levels of T3S, including OI-51.  OI-51 is a 14.93 kb region in EDL933/TUV93-0 
and 15.46 kb (Sp7) in the sequenced EHEC O157:H7 strain Sakai (Hayashi et al., 
2001; Perna et al., 2001).  Variations of this island are present in all EHEC 
O157:H7 strains as well as non-O157 EHEC strains, but also in specific UPEC, 
NMEC and commensal E. coli strains that do not contain a LEE-encoded T3S 
system.  Deletion of OI-51 reduced persistence in a competitive ruminant 
colonisation experiment indicating the potential importance of this region.  
Subsequent cloning and complementation in an OI-51 deletion identified a small 
gene on OI-51, ecs1581 that was able to stimulate T3S in EHEC.  OI-51 in the 
sequenced E. coli O157:H7 EDL933 strain contains a predicted 22 open reading 
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frames with most indicating P4 ancestry (including a P4 integrase; a P4-like 
excisionase; a replication gene similar to the P4 α gene; and a putative DNA 
binding protein similar to P4 orf88), although a putative single stranded DNA 
binding protein (ssDNA) and a transcriptional activator (encoded by pchE) 
sharing homology to the PerC locus in EPEC can also be found on this island.  
The genome of EHEC O157:H7 contains five genes homologous to the PerC 
protein which is produced by certain EPEC strains (Abe et al., 2008; Bustamante 
et al., 2011; Iyoda and Watanabe, 2004; Porter et al., 2005).  Two of these perC 
homologue genes, ecs1388 (pchD) and ecs1588 (pchE) encode proteins with 25% 
and 39% sequence identity with respect to EPEC PerC.  Whilst other pch (pchA-
C) genes have been demonstrated to modulate the expression of LEE 
transcription units in EHEC O157:H7, deletion or over-expression of ECs1388 or 
ECs1588 have not; and so their function, if any, in gene regulation remains to be 
determined (Iyoda et al., 2004; Porter et al., 2005; Abe et al., 2008; Yang et al., 
2009).  It is therefore of interest that a new potential regulator of T3S (encoded 
by ecs1581) has now been discovered on OI-51 adjacent to pchE.  ECs1581 was 
able to up-regulate T3S in both a defined ecs1581 and OI-51 deletion, indicating 
that ECs1581 can exert its control over T3S in the absence of pchE and the other 
genes on this island.  Interestingly, suppressive subtractive hybridisation 
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studies have demonstrated that the presence of OI-51 is more closely associated 
with human infection strains of EHEC (Steele et al., 2007).  Again, it is 
noteworthy that a novel positive regulator of T3S has now been indentified on 
OI-51.  In addition, several studies have reported clear differences in expression 
levels of T3S proteins by E. coli O157:H7 (such as stx production and LEE gene 
expression) isolated from humans and from cattle (Roe et al., 2003; Roe et al., 
2004; Steele et al., 2007); and DNA microarray studies (Dowd and Ishizaki, 2006) 
have also demonstrated that lineage specific strains of O157:H7 have evolved 
distinct patterns of gene expression.  As ECs1581 has the capacity to stimulate 
T3S, this regulator may have important implications for the persistence and 
survival of EHEC in vivo in both the ruminant and coincidental human host. 
 
EHEC strain Sakai, a close relative of EDL933, contains 18 prophages (Sp1 to 
Sp18) and 6 prophage like elements (SpLE1 to SpLE6), amounting to 16% of the 
total genome (Hayashi et al., 2001; Ohnishi et al., 2001; Asadulghani et al., 2009).  
Extensive characterisation of these prophage regions by Asadulghani and co-
workers (2009) have indicated that most of these prophage (Sp3– Sp6, Sp8–Sp12, 
Sp14 and Sp15) retain features of lambdoid phages; where one (Sp13) contains 
features similar to P2 phage, one (Sp1) contains P4 features, and one (Sp18) 
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retains Mu features.  The other four prophages, including OI-51/Sp7 (Sp1 Sp7, 
Sp16, and Sp17) are un-assigned to a particular phage family due to their 
chimeric and highly disrupted genomic backbones (Asadulghani et al., 2009).   In 
the case of OI-51/Sp7, this cryptic prophage lacks most morphogenesis genes, 
including repressor and anti-repressor genes, and the replication gene that is 
similar to the α gene of satellite page P4 has also been disrupted in Sakai by 
multiple frame shift mutations (Asadulghani et al., 2009).  However, Sp7 has 
been shown to still be inducible.  Thus, it has hypothesised that the replication 
of Sp7 may be facilitated by the procurement of replication proteins from other 
prophages in the chromosome, for example Sp13 (P2-like phage) or Sp2 (P4-like 
phage); through prophage-prophage interactions.  However, these authors 
concur that some (or all) of the fragmented polypeptides of Sp7 may still contain 
some replication initiation activity (Asadulghani et al., 2009). 
 
In summary, this chapter of work has identified a region in EHEC (OI-51) that is 
important for EHEC colonisation in ruminants; and has identified ECs1581 as a 
new regulator encoded on OI-51 that has the capacity to stimulate T3S.  The 
functional and mechanistic characterisation of this regulatory protein is 





















Cloning and complementation of OI-51 in combination with targeted 
mutagenesis identified ECs1581 as a small and novel protein that is able to 
stimulate T3S in EHEC O157:H7.  This chapter describes the further 
characterisation of ECs1581 together with a selection of sequence related 
variants that are present in other E. coli strains; including strains not harbouring 
a LEE-encoded T3SS. 
 
5.1 Distribution of ECs1581 in E. coli strains  
ECs1581 is predicted to be a small protein of 99 amino acids with a molecular 
mass of 11.704 kDa and a pI of 10.09.  ECs1581 has no significant sequence 
similarity with any known protein although it does have a very short section of 
homology with the spacer region of the LEE encoded regulator (Ler) that 
bridges the known protein-protein interaction domain of Ler with its DNA 
binding domain (Figure 5.1) (Mellies et al., 2008).  However, there is no 
significant homology of ECs1581 with these functional regions of Ler (Figure 
5.1) (Mellies et al., 2008). 
 
Sequence analysis of ECs1581 protein variants in different lineages of EHEC 

























Figure 5.1.  Sequence comparison of ECs1581 with LEE-encoded regulator (Ler).  Alignment 
of ECs1581 and Ler amino acid sequences showing slight homology between the two proteins at 
the N-terminus of ECs1581 and the linker/oligomerisation region of Ler.  Ler’s established DNA 




conserved; with distinct lineage specific amino acid substitutions at the N- and 
C-termini (Figure 5.2A).  Interestingly, this sequence divergence is specific to 
lineage I (LI) EHEC O157:H7 by comparison with lineage II (LII) and lineage I/II 
(LI/II) O157:H7 (Figure 5.2A).  Orthologues of ECs1581 can be found in 
sequenced non-O157 EHEC strains (O103:H2, O26:H11, and O111:H-); in EPEC 
strain O55:H7; newborn meningitis E. coli (NMEC) strain IHE3034; 
enteroaggregative E. coli (EAEC) strain O42; atypical EPEC strain E110019; 
uropathogenic E. coli (UPEC) strains CFT073 (O6:K2:H1) and IAI39 (O7:K1); 
Shigella spp and commensal E. coli strain ED1a (O81); all with >77% homology 
over a region of 99 amino acids (i.e. full length ECs1581) (Table 5.1).  Multiple 
divergent copies of ecs1581 are also present in the chromosomes of some strains 
harbouring this regulator, examples of which are also detailed in Table 5.1.  
Although some variants are truncated (63 amino acids), they do contain a 
putative protein interaction module, PB1, which can be found in a range of 
signalling proteins in eukaryotes and plants (Moscat et al., 2006; Sumimoto et al., 
2007; Terasawa et al., 2001).  Likewise, many of the full length variants share a 
putative N-myristylation motif (GLTD/ASG; amino acids 7-12), which appears 
to have diverged in the EHEC O157:H7 LI variants of ECs1581 with an alanine 
to aspartic acid substitution at amino acid position 10 (A10D) (GLTDSG/LI and 
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Figure 5.2.  Sequence comparison of ECs1581 variants in E. coli. (A) Multiple alignment of the predicted amino acid sequences of 
ECs1581 in different lineages of EHEC O157:H7.  Residue divergence specific to lineage I EHEC O157:H7 isolates is marked by a 
pink shaded box.  (B) Multiple alignment of EHEC variants ECs1581 (EDL933/Sakai) and ECSP_1496 (TW14539) with commensal 
variant ECED1_1787 (ED1a) and UPEC variant C1493 (CFT073).  Stars indicate conserved residues.  Putative domains are marked 
by black boxes (putative RGD motif at amino acid positions 20-22 and a putative N-myristylation site at amino acid positions 7-12).  
Residue divergence between EHEC ECs1581 and commensal ECED1_1787 is outlined with a red box and residue divergence 
between EHEC LI and LI/II&LII variants of ECs1581 is indicated by a black underscore.  
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UPEC C1493















GLTASG/LII and LI/II) (Figure 5.2B).  ECs1581 also contains a tri-peptide 
arginine-glycine-aspartate (RGD) motif (amino acids 20-22, Figure 5.2B) which 
may be important for mediating protein-protein interactions based on 
previously established functions of this motif (D’Souza et al., 1991).  
 
5.2 Analysis of ECs1581 orthologous protein C1493  
Given the diversity of E. coli strains that harbour sequence related variants of 
ECs1581, its prevalence and divergence amongst different EHEC lineages, and 
the fact that not all strains with this regulator harbour a LEE-encoded T3S 
system, the functionality of a subset of these protein variants were investigated 
by testing their effects on T3S and the related but more ubiquitous flagella 
system.  
 
UPEC CFT073 variant C1493 has 83% sequence similarity to ECs1581 (Figure 
5.2B) and is also encoded on a cryptic prophage (CP073-3) that is inserted in an 
identical location on the chromosome as CP-933C (OI-51/Sp7) (Mobley et al., 
1990; Perna et al., 2001; Welch et al., 2002).  c1493 was cloned into the low copy 
number plasmid pWSK29 to create expression plasmid pC1493 and this was 
assessed for its effects on T3S levels following induced expression in an EHEC 
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ecs1581 mutant.  Expression of pC1493 rescued T3S demonstrating that the 
variants are functionally interchangeable, despite UPEC lineages not harbouring 
a LEE encoded T3S system (Figure 5.3A).    
 
To investigate motility, a c1493 mutant was constructed in UPEC strain CFT073 
and examined in soft agar following in trans expression of c1493 and ecs1581; in 
the reciprocal manner motility was examined in a EHEC ecs1581 mutant strain 
with in trans expression of the two variants.  Although only subtle differences in 
motility were observed for wild type and mutant constructs in both EHEC and 
UPEC, the in trans and presumably higher level expression of the two variants 
down regulated motility, a phenotype that was not observed for the strains 
expressing the empty vector (pWControl) (Figure 5.3B). 
 
5.3 Analysis of ECs1581 activity in a grlA mutant  
In EHEC, GrlA is an established regulatory protein encoded by the LEE that 
positively regulates ler transcription and LEE gene expression; and negatively 
regulates motility in a feedback loop with the repressor GrlR (Iyoda et al., 2006).  























Figure 5.3.  ECs1581 and orthologous protein C1493 can activate T3S and 
down-regulate motility in EHEC and UPEC.  (A) SDS-PAGE gel showing 
stimulation of T3S in an EHEC ecs1581 deletion in trans expressing EHEC derived 
ECs1581 (pECs1581) or UPEC derived C1493 (pC1493).  Empty vector 
(pWControl) alone in the ecs1581 mutant acted as a negative control strain.                 
(B) Analysis of motility repression in an EHEC ecs1581 and UPEC c1493 deletion 
background in trans expressing pECs1581, pC1493 or pWControl.  Strains were 
analysed for T3S and motility as described in Chapter 2. 
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motility via grlA, T3S and motility was assessed in a grlA mutant with induced 
expression of ecs1581 from a low copy number plasmid    (pECs1581).  As 
expected, T3S levels were reduced in the grlA mutant compared with the parent 
strain (Figure 5.4A).  Induced expression of ecs1581 in the grlA deletion was then 
able to increase T3S levels in this strain (Figure 5.4A); indicating that ECs1581 
activation of T3S is mediated independently of GrlA.  Moreover, induced 
expression of ECs1581 was enough to repress motility in this strain (Figure 5.4A-
B). 
 
5.4 Analysis of ECs1581 orthologous protein ECED1_1787   
Commensal strain ED1a (a close relative of UPEC strain CFT073; phylogenetic 
group B2) also harbours an orthologue of ECs1581, ECED1_1787, that has 94% 
sequence similarity (Figure 5.2B) (Clermont et al., 2008; Jaureguy et al., 2008; 
Touchon et al., 2009).  Despite having the highest known homology to ECs1581, 
even compared to other EHEC O157:H7 variants, commensal protein 
ECED1_1787 was unable to activate T3S or repress motility following induced 
expression (pECED1_1787) in an EHEC ecs1581 mutant strain (Figure 5.5A).  
This was informative as there are only six amino acid differences between 






















Figure 5.4.  ECs1581 can stimulate T3S independently of GrlA.  (A) SDS-PAGE gel 
showing T3S profile for EHEC strain ZAP193 and isogenic ∆grlA::Tn5 mutant in trans 
expressing ECs1581 (pECs1581) or empty vector control (pWControl).  (B) Motility 
plates showing repression in a grlA mutant expressing pECs1581.  Culture supernatant 
















































































Figure 5.5.  Effects of natural and engineered variants of ECs1581 on T3S and motility.    
(A) SDS-PAGE gel showing T3S levels in an EHEC TUV93-0 ecs1581 mutant in trans expressing 
wild type and engineered variants of commensal protein ECED1_1787 (pECED1_1787, 
pECED1_1787C20R and pECED1_1787N35K).  pWControl in the ecs1581 deletion was used as 
a negative control and wild type variants pECs1581 and pC1493 were included as a reference for 
high T3S levels.  (B) Analysis of motility in an ecs1581 mutant in trans expressing pECED1_1787, 
pECED1_1787C20R, pECED1_1787N35K or pWControl.  Strains were analysed for T3S and 
motility as described in Chapter 2. 
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capacity despite its lower homology to ECs1581 (83% versus 94% respectively).  
The divergence in ECED1_1787 by comparison to ECs1581 maps to the 
following residues: D10A; R20C; Q27K; K35N; H45R and R61D (amino acids 1-
99) (Figure 5.2B).  Interestingly, two of these changes occur within predicted 
domains with a D10A substitution in the putative N-myristylation motif (amino 
acids 7-12), and an R20C substitution in the EHEC conserved RGD motif (amino 
acids 20-22) (Figure 5.2B).  Like ECED1_1787, C1493 has a D10A but harbours an 
RGD motif as in ECs1581 (Figure 5.2B). 
 
5.5 Analysis of natural and engineered variants of ECED1_1787 and ECs1581  
Based on the functional differences demonstrated for the ECs1581 and 
ECED1_1787 proteins, a series of reciprocal substitutions in proteins ECs1581 
and ECED1_1787 were constructed by site-directed mutagenesis and their 
effects on T3S and motility assessed in an EHEC ecs1581 mutant.  A single C20R 
mutation in protein ECED1_1787 (pECED1_1787C20R) was sufficient to enable 
this variant to now activate T3S and repress motility (Figure 5.5A). An 
ECED1_1787 C20R+N35K double mutation (pECED1_1787C20R+N35K) did not 
increase T3S levels over the single C20R change (Figure 5.5A).  Strikingly, 
induced expression of ECED1_1787C20R severely repressed motility (Figure 
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5.5B).  This shift in phenotype between wild type ECED1_1787 and engineered 
variant ECED1_1787C20R was intriguing as induced expression of ECED1_1787 
in the same strain background increased motility (Figure 5.5B).  A K35N 
substitution in ECs1581 (ECED1_1787N35) limited its stimulation of T3S in an 
EHEC ecs1581 mutant when induced (pECs1581K35N) from a low copy number 
plasmid (Figure 5.5C).  Surprisingly, an R20C change in the EHEC conserved 
RGD motif (ECED1_1787C20) slightly increased T3S levels following induced 
expression (pECs1581R20C) in this background, and this engineered variant was 
also more repressive for motility than wild type ECs1581 (Figure 5.5C/D).  A 
further R20C20N mutation in this same RGD motif however did reduce T3S 
levels compared to wild type ECs1581 (Figure 5.5C).  Taken together, these 
results highlight the functional importance of residue 20 and other targeted 
residue combinations for the control exhibited by this novel regulator.  
 
5.5.1 Analysis of EHEC lineage specific variants of ECs1581 
Sequence analyses of ECs1581 in EHEC O157:H7 have shown that two main 
variants of ECs1581 are present.  These variants can be categorised according to 
the O157:H7 lineage from which they derive; where Lineage I variants of 

































































Figure 5.5 continued. (C) SDS-PAGE gel showing T3S levels in an ecs1581 mutant 
expressing wild type and engineered variants of ECs1581 (pC1493, pECs1581, 
pECs1581R20C, pECs1581R20C20N, pECs1581K35N, pECs1581R20C+K35N, 
pECs1581R20C+D10A, pECs1581R20C+H45R, pECs1581R20C+R61D, 
pECs1581R20C+Q27K and pWControl).  (D) Analysis of motility in the same strain set.  The 
motility figures (B and D) are composite images from photographs of motility agar plates 
inoculated with the strain of interest.  The same images are used for the wild types and controls 
in B and D.   Strains were analysed for T3S and motility as described in Chapter 2. 
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identical protein coding sequences.  It was therefore a possibility that these 
lineage II and lineage I/II variants may have differing capacities to stimulate T3S 
and repress motility compared with lineage I derived ECs1581.  To test this, 
representative variants from the three main EHEC lineages were cloned into low 
copy number vector pWSK29 (pECs1581-LI; pTW14539-LI/II and p96788-LII), 
and assessed and for their effects on T3S and motility in an ecs1581 deletion 
background.  All of the variants were able to induce T3S secretion and repress 
motility to similar levels, although the lineage II and lineage I/II variants of 
ECs1581 were slightly more active for these respective phenotypes (Figure 5.6A-
B).  These results may indicate that ECs1581 has the capacity to stimulate T3S 
similarly in all EHEC; although the distinct lineage divergence between these 
proteins may reflect real differences pertaining to the activities of these variants 
in their natural genetic backgrounds. 
 
5.5.2 Congo-red binding 
The ability to bind CR dye has historically been used as a marker to distinguish 
between pathogenic and non-pathogenic strains of bacteria (Payne and 
Finkelstein, 1997).  More specifically, curli fibres are known to bind well to CR 
dye; and the expression of these surface expressed fibres have long been 
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associated with bacterial aggregation, adherence and biofilm formation 
(Barnhart and Chapman, 2006).  Using CR binding as a crude phenotypic 
marker for curli expression, the capacity to bind CR was assessed in an ecs1581 
deletion strain in trans expressing wild type proteins C1493, ECED1_1787 or 
ECs1581; or an engineered derivative.  Poor binding to CR was observed for 
both the ecs1581 deletion and TUV93-0 parent (Figure 5.7).  Enhanced binding 
was observed in those strains expressing pC1493 and pECs1581 in trans; but 
interestingly not ED1a derived ECED1_1787 (pECED1_1787) (Figure 5.7).  This 
same pattern was observed when these strains were analysed for T3S and 
motility (Figures 5.5A-D).  Increased binding was also observed for of all the 
EHEC derived variants (pECs1581R20C, pECs1581K35N and 
pECs1581R20C+K35N) and the commensal ECED1_1787 variant engineered to 
harbour and RGD motif (pECED1_1787C20R) (Figure 5.7 and 5.7); a phenotype 
that was not observed for the empty vector control strain (pWControl).  At this 
stage it is not known how ECs1581 up-regulates CR binding in EHEC, although 
an alteration in charge at the surface of the bacterial cell may help explain this 
phenotype.  More obvious perhaps is the up-regulation of curli fibres; a well 
known ligand for CR and an important colonisation factor associated with 




















Figure 5.6. EHEC O157:H7 lineage specific variants of ECs1581 all 
have the capacity to stimulate T3S and repress motility.  (A-B) 
ECs1581 was PCR amplified from strains representing the three main 
EHEC lineages and cloned into low copy number pWSK29 to create 
expression constructs pECs1581 (LI), pTW14539 (LI/II) and p96788 (LII).  
These variants were then analysed for their effects on T3S levels and 
motility in an ecs1581 deletion background.  Empty vector alone 
(pWControl) acted as negative control.  Strains were assayed as 



















Figure 5.7. ECs1581 enhances binding to Congo-red.  Natural and engineered 
variants of ECs1581 (annotated as shown) were cloned and expressed in an 
ecs1581 deletion background and analysed for their capacity to bind Congo-red.  
Induced expression of ECs1581 enhanced Congo-red binding, a phenotype that 
was not observed for the control strain harbouring only empty vector (pWControl).  
Indeed, all EHEC and UPEC derived variants enhanced binding to the dye, 
although the commensal variant (pECED1_1787) did not appear to have this 
capacity. A targeted C20R mutation in ECED1_1787 (pECED1_1787C20R) was 
enough to then confer an increased Congo-red binding phenotype in the ecs1581 




that ECs1581 is pleiotropic in that it is able to control the expression of multiple 
factors in EHEC including T3S, motility and surface charge.   
 
5.6 Analysis of ECs1581 DNA binding activity 
In order to investigate if ECs1581 regulation of T3S in EHEC is direct or indirect, 
electrophoretic mobility shift assays (EMSA) were carried out using a 291 bp 
LEE1 promoter fragment (-288 to +3 with respect to the ATG translational start 
site of ler) and purified ECs1581.  It was evident that the protein bound to the 
DNA in a concentration-dependent manner (Figure 5.8A).  To examine the 
specificity of this interaction, ECs1581 binding to a control gapA promoter was 
also tested.  Less interaction was evident at this promoter indicating that 
ECs1581 is a promiscuous DNA binding protein but with some degree of 
sequence preference (Figure 5.8B).  As commensal variant ECED1_1787 was 
unable to activate T3S in an EHEC ecs1581 mutant, it was a possibility that this 
variant may be deficient in its capacity to bind the LEE1 promoter fragment.  
Purified ECED1_1787 was unable to bind the LEE1 promoter fragment at the 
same concentrations as ECs1581 (Figure 5.8A).  The commensal derived variant 
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Figure 5.8. ECs1581 interacts with the LEE1 promoter in EHEC.                                  
(A-B) Electrophoresis mobility shift assays examining ECs1581, ECED1_1787 and 
ECED1_1787C20R binding to specific DNA regions.  Purified proteins were added 
to the LEE1 promoter at the concentrations shown. ECs1581 was also incubated 
with a gapA promoter to examine the specificity of this interaction.  ECs1581, and 
to a lesser degree ECED1_1787C20R, but not ECED1_1787 retarded the LEE1 
promoter fragment. No shift was observed with any of the proteins in the presence 
of cold promoter at the highest concentration of each protein.  EMSAs were kindly 
performed by Dr. Jai Tree as described in Chapter 2. 
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(ECED1_1787C20R) and which was partially active for T3S stimulation showed 
some evidence of binding to the same region.  These results suggest that 
ECs1581 may be dependent on both protein-protein and protein-DNA 
interactions for full activity. 
 
5.7 In vitro transcription assay (IVT) 
In vitro transcription assays were used to determine if ECs1581 was able to 
activate RNA transcription from the LEE1 promoter.  However, addition of the 
purified protein repressed transcription in vitro in a concentration dependent 
manner (Figure 5.9A). This supports the EMSA results indicating that ECs1581 
interacts with this promoter region, although the activity of the protein is 
repressive under these in vitro conditions.  This activity was specific as the gapA 
transcript levels were unaffected (Figure 5.9A).  As H-NS is known to be a 
silencer of gene expression, including from the LEE1 promoter, the capacity of 
ECs1581 to activate transcription from the LEE1 promoter was tested in the 


































Figure 5.9 ECs1581 represses LEE1 transcription in an in vitro transcription set 
up (A) Reactions were carried out with two promoter regions, LEE1 and gapA pre-
incubated with the concentrations of ECs1581 as shown.  The main transcript initiated 
from the gapA promoter is estimated to be 39 bp and is indicated.  The LEE1 promoter 
region in EHEC has been shown to contain at least two promoters (Sperandio et al., 
2002); a distal promoter (P1) and proximal promoter (P2) that would give transcripts of 
163 bases and 32 bases respectively in this assay.  Corresponding transcripts 
matching those expected from P1 of (150-160 bases) and also a larger transcript (~250 
bases) are observed and are labelled as LEE1 transcripts.   ECs1581 reduces the 
levels of the LEE1 ascribed transcripts but not that of gapA. (B) H-NS was pre-
incubated with the promoter regions at the concentrations shown and this repressed 
LEE1, but not gapA associated transcripts in a concentration-dependent manner. (C) 
H-NS and ECs1581 were co-incubated with the two promoter regions at the 
concentrations shown.  ECs1581 repressed generation of LEE1 but not gapA 
transcripts in the presence of H-NS.  IVT assays were kindly carried out by Mr Ronen 
Rosenblum and Dr. Thamarai Scheniders at the Queen’s University Belfast. 
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in concentration-dependent manner (Figure 5.9B) and addition of ECs1581 
enhanced this repression (Figure 5.9C).  Again, this ECs1581 activity was 
contrary to that demonstrated for ecs1581 deletion and complementation, but 
supports an interaction of ECs1581 with the LEE1 promoter under the 
conditions used in this assay. 
 
5.8 Analysis of ECs1581 mechanism of action  
To examine how ECs1581 activates T3S, its capacity to stimulate a LEE1::gfp 
transcriptional fusion was studied in different genetic backgrounds.  Population 
fluorescence levels from the LEE1 fusion were reduced significantly in an 
ecs1581 mutant (Figure 5.10A).  The LEE-encoded regulator (Ler) is required for 
normal levels of LEE1 induction leading to T3S and so the ability of ECs1581 to 
stimulate LEE1 expression in the absence of ler was investigated.  Population 
fluorescence levels from the LEE1 reporter were determined in EHEC strains 
ZAP198 (WT) and ZAP1004 (Δler) following induction of ecs1581 (pECs1581) 
(Figure 5.8B-C).  ECs1581 was able to stimulate LEE1 expression in the absence 
of ler (Figure 5.10C).  A strain was also tested (ZAP1327) in which the LEE1 
promoter had been replaced by a cassette that allows constitutive expression of 
ler but without sequences required for the complex transcriptional regulation of 
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this operon, including putative sequences required for ler auto-regulation 
(Mellies et al., 2008; Yerushalmi et al., 2008).  Constitutive ler transcription in this 
replaced promoter strain was confirmed by RT-PCR (Figure 5.10E). ECs1581 
induction of the LEE1 reporter fusion in this strain background was detectable 
but remained at a constant level throughout the growth curve (Figure 5.10D).  
This was in stark contrast to the activation kinetics measured for the LEE1 
fusion in the strain with an unaltered LEE1 promoter on the chromosome.  In 
this wild type background, the stimulation of the LEE1 fusion increased 
exponentially with optical density, where this increase was restricted when the 
LEE1 chromosomal promoter was replaced effectively providing a consistent 
level of ler expression.  Therefore, ECs1581 only completely activates LEE1 in the 
presence of Ler in a background that allows normal Ler auto-regulation.  To 
investigate this further, the impact of induced ECs1581 (pECs1581) and Ler 
(pLer) on T3S levels were examined.  Induced levels of Ler or ECs1581 were able 
to increase T3S in an ecs1581 mutant background while only Ler induction was 
able to induce T3S expression in the strain with the replaced LEE1 promoter 
(Figure 5.10F).  As ECs1581 does not activate T3S in this strain, it indicates as 




























































































































Figure 5.10 ECs1581 stimulates T3S via LEE1 (A) Measurement of LEE1 promoter 
activity in EHEC strain TUV93-0 and isogenic ecs1581 mutant.  (B) Measurement of 
LEE1 promoter activity in EHEC strain ZAP198; with and without induced expression of 
ecs1581 (pECs1581).  (C) Measurement of LEE1 promoter activity in a ler deletion strain 
(ZAP1004); with and without induced expression of pECs1581.  (D) Measurement of 
LEE1 promoter activity in an EHEC strain (ZAP1327) engineered to constitutively 
express ler on the chromosome; with and without induced expression of pECs1581.  
Empty vector controls in each strain background acted as a control for auto-
fluorescence.  All transcriptional fusion experiments were gratefully carried out by Maryia 
Karpiyevich as detailed in Chapter 2. 
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Figure 5.10 continued (E) RT-PCR measurement of ler transcription levels in EHEC strains 
ZAP198 (wild type), ZAP1004 (∆ler) and ZAP1327 (∆LEE1 promoter).  Of note, ler 
transcription is comparable in the wild type and replaced LEE1 promoter strain during 
exponential growth (OD600 0.9), however, a small dip in expression can then be observed in 
the constitutively expressed ler/LEE1 strain as the cells enter into stationary phase (OD600 
2.5).  As ongoing research in the laboratory is identifying multiple sRNAs that can act on LEE 
transcripts, including LEE1, this data may indicate that a change is occurring in the post-
transcriptional control of ler at the transition from exponential phase to stationary phase 
growth; coinciding with the OD at which the dip in expression occurs.  (F) Western blot 
detection of EspD in an EHEC ecs1581 deletion and replaced LEE1 promoter mutant 
(ZAP1327) in trans expressing Ler (pLer) or ECs1581 (pECs1581).  Empty vector alone 
(pWControl) was used as a negative control.  The above RT-PCR experiment was kindly 
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ECs1581/RgdR can further                        
stimulate levels of T3S                                                    
in an already high secreting EHEC                                     
strain (ZAP198); as this has an intact                      
LEE1 promoter and is subject                         
to regulation by other                   
transcriptional regulators acting                                      
on this same DNA region
RgdR can stimulate a LEE1::gfp
promoter construct in the                                  
absence of Ler, however, RgdR
has no impact on effector protein                   
secretion as only Ler has the                         
capacity to activate LEE2-5                                      
and so T3S
RgdR requires a normal LEE1
promoter harbouring inherent                      
regulatory sequences and normal                       
levels of Ler to enable it to exert                              
its effects on T3S through                                       
the Ler regulatory cascade                                        
(Figure 5.10F)
cLEE1 promoter region with normal regulatory activity
pLEE1
(pLEE1/Wild type cLEE1 promoter (428bp) 
































EspD undetectable in culture supernatants                                    
f rom this strain as shown by SDS-PAGE and Western Blot 
(Fig 5.10F)


























Figure 5.11 (A-C) Schematic interpretation of how ECs1581/RgdR acts to positively 
regulate LEE1 and T3S in EHEC.  To examine how ECs1581 activates T3S, its capacity to 
stimulate a 428 bp (-16 to -444 in relation to ler ATG translational start codon) LEE1::gfp 
transcriptional fusion was studied in different genetic backgrounds (Figures 5.10A-D/5.11A-C). 
The LEE-encoded regulator (Ler) is required for normal levels of LEE1 induction leading to 
T3S and so the ability of ECs1581 to stimulate LEE1 expression in the absence of ler was 
investigated (Figure 5.10C/5.11B).  Population fluorescence levels from the LEE1 reporter 
were determined in EHEC strains ZAP198 (WT) and ZAP1004 (∆ler) following induction of 
ecs1581 (pECs1581) (Figure 5.10B-C/5.11A-B).  ECs1581 was able to stimulate LEE1 
expression in the absence of ler (Figure 5.10C/5.11B).  A strain was also tested (ZAP1327) in 
which the LEE1 promoter had been replaced by a cassette that allows constitutive expression 
of ler but without sequences required for the complex transcriptional regulation of this operon, 
including putative sequences required for ler auto-regulation (Figure 5.10D/5.11C) (Mellies et 
al., 2008; Yerushalmi et al., 2008).  Constitutive ler transcription in this replaced promoter 
strain was confirmed by RT-PCR (Figure 5.10E). ECs1581 induction of the LEE1 reporter 
fusion in this strain background was detectable but remained at a constant level throughout 
the growth curve (Figure 5.10D and 5.11C).  This was in stark contrast to the activation 
kinetics measured for the LEE1 fusion in the strain with an unaltered LEE1 promoter on the 
chromosome (Figure 5.10B/5.11A).  In this wild type background, the stimulation of the LEE1 
fusion increased exponentially with optical density, where this increase was restricted when 
the LEE1 chromosomal promoter was replaced effectively providing a consistent level of ler 
expression.  Therefore, ECs1581 only completely activates LEE1 in the presence of Ler in a 
background that allows normal Ler auto-regulation.  To investigate this further, the impact of 
induced ECs1581 (pECs1581) and Ler (pLer) on T3S levels were examined.  Induced levels 
of Ler or ECs1581 were able to increase T3S in an ecs1581 mutant background while only 
Ler induction was able to induce T3S expression in the strain with the replaced LEE1 
promoter (Figure 5.10F).  As ECs1581 does not activate T3S in this strain, it indicates as 
above, that the induction of T3S has to occur through the activation of the LEE1 (Flockhart et 
al., 2012). A blue dotted line indicates probable interactions between Ler and its target DNA.  
A blue dotted line with a black cross indicates that this regulation is in some way 
compromised.  A black dotted line indicates probable interactions between chromosomal (c) 
derived and plasmid (p) derived ECs1581 and its target DNA.  A black dotted line with a black 
cross indicates that this regulation is in some way compromised. Remaining symbols, 
including directional arrows, are annotated as shown. 
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promoter and the Ler auto-stimulatory circuit to promote expression of the 
remaining LEE2-5 operons and T3S effector protein secretion.  A schematic 
model/interpretation of ECs1581’s considered activity is shown in Figure 5.10G 
(Flockhart et al., 2012). 
 
5.9 Discussion 
Through a combination of deletion and complementation analyses, ecs1581 was 
identified as a gene able to up-regulate T3S in EHEC (chapter 4).  ECs1581 
encodes a putative 99 amino acid protein of 11.7 kDa with two main variants 
present in EHEC O157:H7 strains (Figure 5.2A), although multiple minor 
variants are also identified.  This protein has little homology with established 
bacterial regulators although there is a region of homology with Ler over a 
region considered to link the oligomerisation and DNA binding regions of this 
global regulator (Figure 5.1) (Mellies et al., 2008).   
 
Three lineages of EHEC O157:H7 have been proposed based on genome 
sequences (Kim et al., 1999; Zhang et al., 2007).  In the present study, two main 
sequence types of ECs1581 were identified, LI and LII & LI/II, the latter having 
identical protein coding sequences.  EHEC O157:H7 lineage specific variants of 
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ECs1581 (LI) from strains TW14539 (LI/II) and 96788 (LII) were cloned and 
assessed for their effects on T3S and motility.  All the variants were able to 
induce T3S and repress motility although slight variation in induction levels 
was observed (Figure 5.6A-B).  Sequences immediately upstream of these two 
variants also differ (data not shown) but it is not know if expression levels of 
these two variants differ as these were not assessed.  Variation in activity and/or 
expression of ECs1581 could therefore contribute to differences in T3S 
expression demonstrated between EHEC O157:H7 strains (Rashid et al., 2006; 
Roe et al., 2003; Son et al., 2002; Yang et al., 2009).  Of note, the genetic variability 
among the different EHEC O157:H7 lineages is also reported to be associated 
with regions adjacent to pchD and pchE genes on OI-43/48 (the tellurite 
resistance and adhesin-conferring islands) and OI-51 respectively (Zhang et al., 
2007 and Yang et al., 2009).   
 
Other variants of the protein from different E. coli backgrounds exhibited 
markedly different capacities to regulate T3S.  For example the variant from the 
UPEC E. coli strain CFT073 (C1493) induced T3S to higher levels than any other 
variant tested, while a variant (ECED1_1787) from the B2 commensal E. coli 
strain ED1a, a close relative of CFT073, had no discernible effect on T3S; despite 
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varying at only 6 residues compared to ECs1581.  This natural variant therefore 
provided insights into essential residues for ECs1581 function.  One of the 
natural changes in ECED1_1787 was an R20C (CGD) in the EHEC conserved 
RGD motif, and studies have demonstrated that this motif can play an 
important role in mediating cell adhesion and ligand binding (Ruoslahti, 1996).  
Substitution of this residue to generate an RGD motif in ECED1_1787 (C20RGD) 
produced a protein that now had the capacity to activate T3S.  Based on this 
finding, ECs1581 was termed RgdR.  As ECED1_1787 was the only variant with 
an N35, in comparison to K35 in all EHEC ECs1581 variants and CFT073 C1493, 
an ECs1581 K35N variant was constructed and this also had reduced potential 
to activate T3S.  Combining a double R20C+K35N change in ECs1581 resulted in 
a variant that had the lowest capacity of any variant tested to stimulate T3S 
(Figure 5.5C).  While some of these changes will impact directly on activity, it is 
appreciated that the small size of RgdR means that some changes will also affect 
protein conformation and stability.  
 
As bacterial motility was also altered by deletion and complementation of 
ecs1581, the effects of the different variants on motility were examined.  It was 
interesting to note that regardless of the effect on T3S, all variants in RgdR had a 
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marked impact on motility.  In general there was an inverse correlation between 
T3S and motility which was also apparent for several of the engineered variants.  
However, there were clear exceptions to this, for example ECs1581 R20C+K35N 
had a weak capacity to activate T3S yet unusually, showed the strongest 
capacity to inhibit motility.  Additional work confirmed that this regulation of 
T3S and motility was independent of grlA, a LEE-encoded regulator previously 
demonstrated to repress motility on induction of T3S (Iyoda et al., 2006).  RgdR 
is therefore identified as a novel regulator able to coordinate T3 and motility 
expression.  Also of note was the finding that expression of different variants 
could increase bacterial binding to Congo red, indicating that RgdR is likely to 
control the expression of multiple surface components.  Although the 
mechanism of this Congo red binding was not investigated, recent work by Lee 
et al (2011) has demonstrated that EDL933 is able to produce curli fibres.  Taken 
together, the pleiotropic phenotypes displayed by RgdR may explain the 
presence of variants of this regulatory protein in strains without a LEE-encoded 
T3S system.   
 
RgdR was able to stimulate LEE1 expression independently of Ler and required 
a normal LEE1 promoter region for this activation.  A construct that resulted in 
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constitutive expression of LEE1 could be induced to secrete EspD by increased 
expression of Ler in trans but not by induced expression of RgdR in trans.  In this 
background, RgdR was limited in its capacity to induce a LEE1::gfp reporter 
fusion construct.  An explanation for this is that even though RgdR can activate 
the LEE1 promoter in the absence of Ler, Ler expression and the Ler auto-
induction cycle is required for the activation of T3S as Ler, and not RgdR, 
activates transcription of LEE2-5 encoding the T3S system and secreted proteins.   
One explanation for the data is that ECs1581 could inhibit Ler auto-repression at 
the LEE1 promoter.  It has been proposed that high Ler levels allow binding of 
Ler to a low affinity site which may repress transcriptional activation. The 
kinetics of LEE1 activation in the presence of induced ECs1581 would fit this 
model.  Repeated attempts to purify functional Ler to test possible interactions 
were unsuccessful.  Of note, ECs1581 does share homology with Ler over a 
linker region (Figure 5.1) that could be involved in this interaction.  
 
RgdR also bound directly to the LEE1 promoter region and may require this 
function for its activity, supported by the finding that a non-binding variant did 
not stimulate T3S.  Purified RgdR did not activate LEE1 transcription in vitro, in 
fact it repressed transcription.  Moreover, there was no evidence that RgdR 
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could relieve H-NS repression in vitro, as suggested for Ler (Bustamantle et al., 
2001; Stoebel et al., 2008); again ECs1581 enhanced H-NS repression of 
transcription from the LEE1 promoter.  It is important to note that in vitro 
transcriptional assays do not involve the multiple activators and repressors 
demonstrated to act on this promoter (Kendall et al, 2010; Tree et al., 2009) and so 
it is highly plausible that RgdR may act as a co-factor with one or more of these 
to activate transcription.  One regulatory network investigated was the quorum 
sensing two-component system, qseBC, as this controls both T3S and motility 
(Hughes et al., 2009; Kostakioti et al., 2009).  However, RgdR was able to 
significantly increase T3S levels in a TUV93-0 qseC deletion mutant (data not 
shown).  Another possibility that remains to be tested is that RgdR works with 
the Pch family of LEE activators (Iyoda et al., 2004; Abe et al., 2008; Yang et al., 
2009), although there is no significant homology between the two, in particular 
to the region truncated in the smaller Pch variants (PchC-E) (Abe et al., 2008).   
 
With the exception of pchD, all pch alleles are encoded on prophage elements, 
and it is hypothesised that multiple prophages in the chromosome of EHEC 
O157:H7 may be able to recombine to affect the total copy number of pch genes; 
thus potentially impacting on levels of LEE gene expression (Iyoda and 
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Watanabe, 2004; Ohnishi et al., 2001).  As with the Pch activators of LEE, all 
members of the RgdR family of proteins are prophage associated.  For example, 
EHEC strain EDL933 harbours two RgdR truncates (both 63 amino acids), z1197 
and z1636 that are located on OI-43 and OI-48 respectively (Table 5.1).  In EHEC 
strain Sakai only one truncate exists (63 amino acids), ecs5415, that is located on 
Sakai prophage-like element 1 (SpLE1).  In EHEC O26:H11 strain 11368, four 
copies of RgdR can be found (Table 5.1); three full length (99 amino acids) 
variants and one truncate (63 amino acids) which is located on OI-48.  Perhaps, 
as proposed for the Pch proteins, genome integration of CP-933C (OI-51) and 
similar prophages may provide a mechanism whereby RgdR proteins can 
additively influence levels of LEE gene expression in EHEC; however, further 
experimental investigation would be required to address this. 
 
OI-51 was demonstrated to be important for EHEC O157:H7 colonisation and 
persistence in sheep.  This could be a direct result of RgdR acting on T3S 
regulation, but may also reflect coordinated regulation with other genes on this 
island.  Future work should aim to look at the context of RgdR along with the 
function of other genes surrounding this genetic region.  In summary, this 
research has defined an important region (OI-51) necessary for EHEC O157:H7 
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colonisation and persistence in sheep, and has identified a completely new 
family of small bacterial regulators that have the capacity to control surface 
factor expression in E. coli. 
Table 5.1 List of ECs1581 orthologous and paralogous proteins present in E. coli and Shigella spp strains 
ECs1581 variant  































100 over 99 
39 over 41 
39 over 41 
39 over 41 
 
These prototypical EHEC strains were 
isolated during large outbreaks in Japan and 
the US from radish sprouts and 
undercooked hamburger meat respectively.  
Perna et al., 2001; Hayashi et al., 2001 




















94 over 99 
31 over 99 
67 over 97 
42 over 45 
 
 
Commensal E. coli strain isolated from the 





















92 over 99 




Atypical EPEC strain E110010 was isolated 
from an outbreak in a school in Finland.  
This strain lacks the EAF plasmid.  Rasko et 
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Nie et al., 2006 
 










88 over 99 
 
 
S. flexneri 2002017 is an emerging multi drug 
resistant serotype X variant of Shigella, 
isolated in China from an epidemic clone. 
Ye et al., 2010 
 


















85 over 99 




S. dysenteriae 1012 was isolated in 
Bangladesh and is representative of type 4 S. 
dysenteriae that are becoming more prevalent 
in humans infections. Studies have shown 
this to be one of the most virulent S. 
dysenteriae strains identified  
Rasko et al., 2008, J. Craig.Venter Institute 
 

















E. coli sp. 3_2_53FAA was isolated from an 
intestinal biopsy specimen taken from a 52-
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Recently sequenced newborn meningitis     
E. coli strain.  Moriel et al., 2010 










83 over 99 
42 over 41 
 
Prototypical UPEC E. coli strain CFT073.  
Mobley et al., 1990 
     










83 over 99 
44 over 92 
 
Touchon et al., 2009 
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39 over 41 
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A spinach outbreak isolate of EHEC 
O157:H7 that is considered to be hyper-
virulent.  Abu-Ali et al., 2010 
 
Ogura et al., 2009 
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This strain is considered to be the closest 
ancestor of EHEC O157:H7 clones.  Zhou et 
al., 2010 
 













80 over 99 
68 over 99 
 
 
Prototypical enteroaggregative E. coli strain 
O42.  Chaudhuri et al., 2010 
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6.1 General discussion 
6.1.1 E. coli O157:H7: current understandings in relation to this research 
EHEC is an important zoonotic pathogen harbouring prophage-encoding Shiga 
toxins that are associated with severe GI and systemic disease in humans 
(Karmali, 2004; Nataro and Kaper, 1998).  Ruminants are considered to be the 
most important reservoirs for EHEC, particularly cattle and sheep which shed 
the organism in their faeces (La Ragione et al., 2009).  The predominant 
pathogenic serotype in North America, parts of Asia and the United Kingdom is 
O157:H7 (Armstrong et al., 1996; Besser et al.,1999; Caprioli et al., 2005).  The 
horizontally acquired LEE PAI encodes a type III secretion (T3S) system, an 
essential virulence factor for EHEC which allows the direct injection of bacterial 
effector proteins into host cells to subvert host cell signalling pathways and 
promote bacterial attachment (Hemrajani et al., 2010; Kenny et al., 1997; Newton 
et al., 2010).  Whilst T3S has been shown to be critical for EHEC O157:H7 
colonisation in the ruminant host (Naylor et al., 2005), levels of T3S can vary 
significantly amongst different EHEC isolates (Rashid et al., 2006; Roe et al., 
2003; Son et al., 2002; Yang et al., 2009).  Such variation in T3S regulation may 
have important implications for bacterial persistence and shedding in the bovine 
host and for human infection (Chase-Topping et al., 2008).   
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Studies comparing EHEC O157:H7 genome sequences have identified three 
lineages of the organism (Kim et al., 1999; Zhang et al., 2007).  While all lineages 
can be isolated from cattle, lineage I (LI) and lineage I/II (LI/II) strains are more 
frequently associated with human clinical disease than lineage II (LII) strains.  
Further, EHEC O157:H7 strains associated with outbreaks of severe illness in the 
United States of America have been shown to belong to a single subtype of LI/II, 
designated SNP clade 8 (Laing et al., 2009; Manning et al., 2008).  Several studies 
have attempted to understand the genetic basis for the apparent differences in 
the epidemiology and virulence among EHEC O157:H7 genotypes and recent 
studies have shown that LI and LI/II strains produce higher levels of Shiga 
toxins than bovine-associated LII strains (Zhang et al., 2010).  Similarly, hyper-
virulent SNP clade 8 strains have been shown to have higher levels of LEE 
expression than EHEC O157:H7 strain Sakai from SNP clade 2 (Abu-Ali et al., 
2010).   
 
A large number of factors have been shown to influence expression of LEE in 
both EPEC and EHEC (Kendall et al., 2010; Tree et al., 2009).  In both pathotypes, 
the LEE-encoded regulator (Ler) is expressed from the first LEE operon (LEE1) 
and is required to activate expression of all five main LEE operons (LEE1-5) 
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(Elliott et al., 2000; Sharma and Zuerner, 2004).  However, at higher 
concentrations, Ler is considered to be repressive at LEE1 (Berdichevsky et al., 
2005; Yerushalmi et al., 2008).  To date, most of the genetic and environmental 
control of T3S has been shown to occur through LEE1 and Ler activation, 
including an activator and repressor combination within the LEE, GrlA and 
GrlR, that are involved in the reciprocal regulation of LEE and flagella 
expression (Barba et al., 2005; Huang and Syu, 2008; Islam et al., 2011; Iyoda et 
al., 2006; Jimenez et al., 2010).  In EPEC, LEE expression is thought to be 
positively regulated by the plasmid-encoded regulator C (PerC) locus and a 
series of PerC homologue (Pch) proteins; encoded by pchA-E and pchX in EHEC 
O157:H7.  These genes are usually associated with cryptic prophage regions 
encoding effector proteins that are exported by the T3S system and the Pch 
regulators co-ordinate the expression of these horizontally-acquired effectors 
with the LEE-encoded T3S system (Abe et al., 2008; Iyoda and Watanabe, 2004; 
Porter et al., 2005; Yang et al., 2009).  Indeed, the integration and recombination 
of horizontally acquired elements in EHEC O157:H7 have not only facilitated 
phage evolution, but have driven the acquisition of virulence attributes in these 
bacteria and the complex regulatory networks that control their expression.  
These dynamic activities of bacteriophage have sparked new interest in light of 
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the discovery that many sequenced bacterial genomes harbour multiple 
prophages carrying a wide range of genes; in particular genes related to 
bacterial colonisation and host pathogenesis.  However, as many prophages 
often contain various genetic defects, they have previously been regarded as 
mere genetic vestiges (Asadulghani et al., 2009).  Recent studies, including this 
one, have attempted to address the functionality of these prophages in EHEC 
O157:H7; and it has been reported for O157:H7 strain Sakai that many of the 
apparently defective prophages are in fact inducible and can be released from 
O157:H7 cells as particulate DNA, with some even being transferred to other E. 
coli strains (Asadulghani et al., 2009). Moreover, the genotypic diversity amongst 
different strains of EHEC has been attributed, by in large, to phage-related DNA 
fragments (Ohnishi and Hayashi, 2002; Zhang et al., 2007); with these 
horizontally acquired elements being termed ‘O-islands’ (OIs) in the sequenced 
prototypical EHEC O157:H7 strain, EDL933 (Perna et al., 2001).   
 
6.1.1.1 Summary of research findings 
A primary goal of this PhD research was to phenotypically characterise 
prophage associated regions (OIs) in EHEC O157:H7; to try and uncover novel 
horizontally acquired regulators that confer on the bacterium determinants that 
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help it to survive and colonise in its mammalian host.  An OI-51 deletion mutant 
was found to have lower levels of LEE expression in vitro and subsequent 
testing demonstrated that this genomic island contributes to ruminant 
colonisation and persistence.  A novel regulator, termed RgdR, was identified 
on OI-51 and shown to control both LEE expression and motility; independently 
of the global LEE and motility regulator, GrlA, and the major QS regulator, 
QseC that regulates flagella gene expression and pedestal formation in EHEC 
(Barba et al., 2005; Clark and Sperandio, 2005; Iyoda et al., 2006; Kostakioti et al., 
2009; Sperandio et al., 2002; Jobichen et al., 2007).   In vitro transcription assays 
could not substantiate RgdR as a classical transcriptional activator, where 
transcription from the LEE1 promoter was not evident in the presence of RNAP; 
in fact RgdR appeared to slightly repress transcription; although this could have 
been non-specific given how sensitive IVT systems can be to slight changes in 
reaction conditions.  Additionally, RgdR was also unable to stimulate LEE1 
expression in the presence of H-NS, implying that it does not function to 
activate LEE gene expression by de-repressing H-NS as proposed for Ler 
(Bustamantle et al., 2001; Stoebel et al., 2008); or requires the activity of other 
protein(s) to do so.   Again, as IVT systems do not take into account the presence 
of other proteins and transcription factors that act on the LEE regulatory 
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promoter region, RgdR likely activates LEE1 transcription in the presence of 
these other factors.  LEE1::gfp reporter constructs demonstrated that RgdR has 
the capacity to induce LEE1 expression in the absence of the master LEE 
regulator, ler, but requires a normal LEE1 promoter region for this activation.  A 
construct that resulted in constitutive expression of LEE1 could be induced to 
secrete EspD by increased expression of Ler in trans but not by induced 
expression of RgdR in trans.  In this background, RgdR was limited in its 
capacity to induce a LEE1::gfp reporter fusion construct.  One explanation for the 
data is that RgdR could inhibit Ler auto-repression at the LEE1 promoter.  It has 
been proposed that high Ler levels allow binding of Ler to a low affinity site 
which may repress transcriptional activation (Mellies et al., 2008; Yerushalmi et 
al., 2008).  The kinetics of LEE1 activation in the presence of induced RgdR 
would fit this model.  Repeated attempts to purify functional Ler to test possible 
interactions were unsuccessful, although RgdR does share slight homology with 
Ler at a functionally important region spanning Ler’s oligomerisation linker 
domain that could be involved in this interaction (Mellies et al., 2008; 
Yerushalmi et al., 2008).  RgdR did demonstrate a low affinity and non-specific 
interaction with DNA by EMSA, a property that was absent from a commensal 
variant that did not stimulate T3S; and so it is possible that RgdR acts as a co-
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factor with one or more regulators of T3S to control transcription from the LEE1 
promoter. 
 
6.1.1.2 OI-51 encoded RgdR proteins are present in diverse phylogenetic 
groups of E. coli 
RgdR proteins have the capacity to influence pleiotropic phenotypes (including 
T3S, motility and cell surface charge) and so may support a more global role in 
the cell and may explain the presence of these regulatory proteins in strains 
without a LEE-encoded T3S system.  Indeed, a cloned UPEC variant of RgdR 
was able to stimulate T3S in an EHEC background to levels higher than any 
other variant, including other EHEC O157:H7 derived variants; despite UPEC 
lineages not harbouring a classical LEE-encoded T3SS.  This may indicate that in 
specific genetic backgrounds, for example in EHEC strains and Shigella strains, 
RgdR proteins have been adapted to control T3S.  LEE-encoded T3SSs and 
flagella systems are evolutionary and structurally related and so this is 
conceivable (Blocker et al., 2003; Erhardt et al., 2010).  Intriguingly, RgdR 
proteins are also found in commensal E. coli strains, begging the question as to 
the function(s) of these small proteins in these genetic backgrounds.   
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Comparative genome analyses have revealed that bacterial recombination, 
including the acquisition of horizontally-acquired prophage elements, is largely 
responsible for the variation in gene content between different strains of E. coli 
(Kim et al., 1999; Tenaillon et al., 2010; Touchon et al., 2009; Zhang et al., 2007).  
Indeed, the average E. coli genome is estimated to contain over 4000 genes, 
however, only 2000 of these genes are conserved amongst all strains; indicating 
a stark degree of plasticity in these strains at the genome level (Hendrickson, 
2009; Tenaillon et al., 2010).  Further, studies based on MLST and MLEE (multi 
locus enzyme electrophoresis) have demonstrated that E. coli clones have broad 
geographical and host distributions that can be illustrated by the prevalence of 
the four main phylogenetic groups of E. coli in human and animal populations 
(Duriez et al., 2001; Escobar-Paramo et al., 2004; Escobar-Paramo et al., 2006; 
Gordon et al., 2008; Ochman et al., 1984; Tenaillon et al., 2010).  Although this 
variation in the prevalence of phylogenetic groups among different hosts is not 
attributable to the existence of host-specific strains, certain strains are 
considered to have strict host specificity; including and an avirulent B2 clone of 
the O81 type, ED1a, which is reported to be found only in humans (Clermont et 
al., 2008; Tenaillon et al., 2010).  This ED1a clone was of special interest to this 
research as this strain harbours a number of RgdR protein variants in its 
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chromosome, both full length and truncated, that are also present on prophage 
elements in diverse pathogenic E. coli strains; including EHEC, atypical EPEC, 
UPEC, NMEC and Shigella strains.   
 
The presence of OI-51 and RgdR like proteins in these E. coli may illustrate a 
diversity of adaptive paths in the different host species; for which some clusters 
of genes or genomic islands should be found only in a subset of strains that are 
favoured in specific environments; and where several alternative combinations 
of genes could potentially promote similar adaptations to a given environment 
(Hacker and Kaper, 2000; Tenaillon et al., 2010; Touchon et al., 2009).  With this, 
epidemiological data and experimental studies in animal models have identified 
and extensively studied genes that are associated with ‘virulence’, and there is 
now growing evidence that these virulence associated genes have evolved and 
been maintained by selection for other roles that they have in the ecology of the 
bacteria; especially in commensalism (LeGall et al., 2007; Levin, 1996; Tenaillon 
et al., 2010; Touchon et al., 2009).  The presence of RgdR proteins in nearly all of 
the major phylogenetic E. coli groups may indicate that RgdR proteins too have 
important other functions (in addition to their activities on T3S, motility and 
surface charge) in the cell and have been maintained in these species as a result 
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as part of a larger prophage unit; for example on OI-51 and OI-51-like prophage 
elements.  Phenotypic characterisation of a cloned RgdR variant from 
commensal ED1a demonstrated that this protein, somewhat remarkably, was 
unable to stimulate T3S; despite sharing the highest homology (94%) with EHEC 
derived RgdR.  Mutation at position 20 to create an RGD motif (C20RGD) in this 
ED1a wild type variant (as is found in EHEC and UPEC variants of RgdR) was 
enough to now confer on this protein T3S stimulatory activity; and this variant 
was now repressive for motility.  Although purely speculative, perhaps this 
commensal variant has selectively diverged at this critical residue and others 
(whilst retaining extremely high overall sequence homology to ECs1581); to 
‘temper/adapt’ the activity of this protein in response to the specific selective 
pressures that this commensal strain would inevitably encounter in its human 
specific host (Clermont et al., 2008).  Of note, the ED1a wild type protein was the 
only variant observed to enhance motility when induced in an EHEC genetic 
background; all of the other variants that were tested acted to repress motility.  
ED1a has also previously been studied for its use as a potential probiotic 
(Clermont et al., 2008), but rather interestingly, this commensal harbours a 
number of other EHEC prophage OIs in addition to OI-51 (Clermont et al., 2008; 
Perna et al., 2001; Touchon et al., 2009).   
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Future work could look at cytokine responses in eukaryotic cells infected with a 
panel of wild type parent and isogenic rgdR deletions representing the different 
pathotypes of E. coli; and in the same strains expressing intra and inter-
pathotype RgdR variants.  ED1a ECED1_1787 and its engineered variant 
ECED1_1787C20R could prove valuable in this experimental set up; if one of 
these variants were able to up-regulate pro-inflammatory cytokine responses on 
cells and the other not, then one could possibly speculate that this commensal 
variant has adventitiously diverged at residue 20.  Amino acid divergence at 
residue 20 (e.g. R20/C20/N20/T20) is apparent on comparing RgdR sequences 
from EHEC, UPEC, atypical EPEC, commensal ED1a and Shigella spp strains.  
The divergence between EHEC RgdR and ED1a RgdR may therefore reflect real 
differences in the functionality of these proteins with respect to each strains 
particular niche and life style.  In this context, RgdR proteins cloned from 
Shigella spp would be of particular interest to test, as Shigella are invasive on 
cells, non-motile and harbour a T3SS (Ashida et al., 2011; Jin et al., 2002; 






6.1.1.3 Future work to address the functionality of OI-51-like prophage in      
E. coli 
Microarray studies in an extra-intestinal E. coli (e.g UPEC or NMEC) deletion 
strain background would make a good starting point to address the potential 
regulons of OI-51/RgdR in different pathotypes of E. coli.  For UPEC specifically, 
an ascending UTI model is already well established in mice (Hagber et al., 1983; 
Mobley et al., 1990) and so this could be used to compare a UPEC c1493 deletion 
and parent strain for in vivo colonisation.  For EHEC, future work could 
characterise global gene expression patterns in a wild type and isogenic rgdR 
deletion grown under a variety of environmental conditions, for example under 
T3S permissive and T3S repressive growth conditions; as this should provide 
valuable information pertaining to possible other targets for RgdR aside from 
the LEE PAI.  It has been hypothesised that OI-51 interacts with other prophage 
in the chromosome of EHEC to facilitate its own induction and replication 
(Asadulghani et al., 2009).  As RgdR controls multiple phenotypes and is 
encoded on OI-51, it will be interesting to see if this regulator can control the 
expression of other prophage/OIs in the chromosome of EHEC; in this same 
microarray.  On a cautionary note, such analyses would not be able to 
differentiate those regulons target by pleiotropic Ler from those potentially 
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targeted by RgdR; so expression profiling in a ∆rgdR, ∆ler and ∆rgdR-ler double 
mutant would go some way in helping to delineate the activities of these 
regulators also.   
 
Interestingly, OI-51 and OI-51 encoded RgdR proteins do not appear to have 
evolved in typical EPEC strains (although are found in other group B E. coli 
strains), or have perhaps been lost from this pathotype; although RgdR can up-
regulate T3S levels in a wild type EPEC strain (E2348/69).  Regulation of the LEE 
is known to differ between EHEC and EPEC where only one promoter is 
reported to be present in the latter (Elliott et al., 1998; Kendall et al., 2010; Tree et 
al., 2009).  As RgdR was able to stimulate T3S in an EPEC background, this may 
indicate that RgdR stimulates T3S by binding to a common LEE regulatory DNA 
region that is present in both strains; and does not require an EHEC specific 
factor to do this.  Intriguingly, atypical EPEC strains are known to harbour 
variants of RgdR, although these strains do not contain the EAF virulence 
plasmid found in typical EPEC strains.  The significance of this observation if 
any is unclear, although perhaps worth noting is the P4 ancestry of OI-51.  P4 
satellite phage are unusual in that they can follow multiple developmental 
pathways (lysogenic, lytic, or plasmid) and depend on helper P2 phage for these 
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activities; in particular for virion formation (Briani et al., 2001; Christie and 
Calendar, 1990; Halling and Calendar, 1990; Liu et al., 1997).  Although 
unsubstantiated, perhaps OI-51 is in some way incompatible with the EAF 
plasmid of EPEC, or certain EPEC strains do not contain the necessary 
complement of prophages in their chromosome that would be required for OI-
51 to be functional or for it to provide a selective advantage.  RgdR induction of 
T3S in an EPEC background would argue against this, however, this activity 
was in the absence of the rest of the genes on OI-51, i.e. the complete prophage 
unit.  Perhaps OI-51 and the EAF (pMAR2) or smaller plasmid (pE2348-2) found 
in EPEC (Iguchi et al., 2009) require the same replication factors; or are 
incompatible in some other way.  Alternatively, it may be the case that as more 
sequenced EPEC genomes become available, then RgdR proteins will be 
identified in this specific pathotype. 
 
RgdR proteins have acquired the capacity to control gene expression by 
integrating into pre-existing regulatory networks present in the host bacterium.  
However, some very important questions about RgdR still remain un-answered, 
for example; what induces rgdR expression and when; at what concentrations is 
RgdR normally found in the cell; where does RgdR localise to in the cell, if 
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indeed it does; and why does RgdR stimulate T3S.  QseC is an inter-kingdom 
QS regulator that governs multiple colonisation phenotypes in EHEC in 
response to bacterial molecules known as autoinducers (Barba et al., 2005; Clark 
and Sperandio, 2005; Iyoda et al., 2006; Sperandio et al., 2002; Jobichen et al., 
2007).  To investigate the possibility that RgdR may be responding to similar 
signalling molecules, RgdR activity was assessed in a qseC deletion cultured 
under T3S permissive conditions; however, RgdR was able to stimulate T3S 
levels in this strain.  In addition, RgdR was demonstrated to induce T3S in an 
EHEC strain cultured in non-T3S permissive LB broth, indicating that this 
regulator does not strictly require T3S specific signals to exert its control; and 
that RgdR has the capacity to over-ride ‘non-permissive’ signals and act 
alongside other factors that can also be expressed in the cell under these 
conditions to control T3S.  Moreover, RgdR also had the capacity to induce T3S 
levels in low secreting strains of EHEC and increase T3S levels further in high 
secreting strains; possibly by usurping Ler’s own auto-repression at the LEE1 
promoter (Mellies et al., 2008; Yerushalmi et al., 2008).  Use of RT-qPCR to 
determine levels of rgdR transcription under differing environmental conditions 
should give some idea as to how tightly regulated rgdR is in the cell.  
Unfortunately, attempts to localise RgdR were unsuccessful although a variant 
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that had been engineered to contain a frame shift mutation was unable to 
stimulate T3S; indicating that RgdR is a functional protein.  Further, analysis of 
cloned RgdR variants from different E. coli strains demonstrated that these 
variants had pronounced effects on other phenotypes independently of their 
effect on T3S; supporting that they are stably expressed.   
 
As RgdR is a very small protein it was thought that the best chance to look at its 
localisation would be through the construction of RgdR proteins with tags 
recognised by high affinity commercial antibodies; so both His-tag and FLAG-
tag constructs were made.  However, screening of whole cell and supernatant 
preparations failed to give any detectable signal for the protein, despite the fact 
that other fusion proteins were detectable with the same anti-6xHis antibody, 
and by the finding that the His-tag RgdR construct was just as efficient at 
inducing T3S as the wild type variant.  Expression of this His-tagged RgdR 
clone in an E. coli K12 background also failed to give any detectable signal; 
although induction of RgdR in K12 does repress motility in this background; 
indicating that RgdR likely represses motility in both pathogenic and non-
pathogenic E. coli strains via a shared mechanism and does not require EHEC 
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specific factors for this regulation.  Anti-RgdR antibodies were not raised in vivo 
for this research but may provide a valuable tool in future localisation studies.   
Until RgdR can be localised, one cannot rule out the possibility that RgdR is 
somehow making it outside of the cell; either via T3S or via some other secretion 
system (e.g. type IV secretion).  RgdRs ability to alter the charge at the surface of 
the cell could facilitate such an activity and could provide an explanation as to 
why RgdR stimulates T3S.  A more conservative explanation perhaps is that 
RgdR induces T3S to coordinate the expression and translocation of other 
effector proteins that are required for pedestal formation and colonisation in the 
host (Hemrajani et al., 2010; Kenny et al., 1997; Newton et al., 2010).   
 
Horizontally acquired regulators such as the Pch family of regulators are known 
to coordinate T3S with effector protein secretion, and results from recent studies 
have suggested that the pch genes are the target genes for integrating various 
environmental signals that control the expression of the LEE genes (Abe et al., 
2008; Iyoda and Watanabe, 2004; Porter et al., 2005; Tobe et al., 2005; Yang et al., 
2009).  Strain to strain variation in LEE gene expression has also been attributed 
to prophage dense regions of the genome that lie immediately adjacent to the 
late regions of lambdoid prophage carrying highly conserved pchA, pchB, pchC 
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and pchX alleles (Yang et al., 2009).  Moreover, genomic regions adjacent to these 
pch genes are reported to be extraordinarily variable (pch adjacent genomic 
regions/pch AGR) and these regions are reported to have substantial effects on 
patterns of LEE1 transcription (Yang et al., 2009).  This variation in the pch AGR 
has been proposed to serve as a mechanism through which prophage-mediated 
events adjust virulence gene expression at unlinked loci (Yang et al., 2009).  It is 
perhaps noteworthy then that RgdR is located adjacent to a PerC like regulator 
(pchE) on prophage OI-51; although this could just be a coincidence.  RgdR may 
therefore activate T3S in order to facilitate and coordinate effector protein 
secretion into host cells; although this is pure speculation at present.  No major 
differences in A/E lesion formation were observed when an OI-51 and rgdR 
deletion strain were compared in vitro for this phenotype, however, this is not to 
say that other effector functions are not impacted on.  OI-51 was demonstrated 
to be important for EHEC O157:H7 colonisation and persistence in ruminants. 
This could be a direct result of RgdR acting on T3S regulation, or may reflect co-
ordinated regulation with other genes on the island.  While there are no 
identified effector proteins on OI-51, bioinformatics analyses show that z1841 
and ecs1580 harbour a motif consistent with eukaryotic proteins; and RgdR itself 
contains a putative protein interaction domain (RGD) and N-myristylation 
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motif; and truncated variants of RgdR harbour a conserved PB1 domain that can 
be found in proteins associated with intracellular signalling functions in 
eukaryotic yeast cells (Moscat et al., 2006; Sumimoto et al., 2007; Terasawa et al., 
2001).  The context of rgdR expression now needs to be studied along with the 
function of other genes in its operon and locally within this genetic region.   
 
Recent studies have shown that LI and LI/II strains of EHEC produce higher 
levels of Shiga toxins than bovine-associated LII strains (Zhang et al., 2010) and 
hyper-virulent SNP clade 8 strains have been shown to have higher levels of 
LEE expression than EHEC O157:H7 strain Sakai from SNP clade 2 (Abu-Ali et 
al., 2010).  It was a possibility that lineage specific variants of RgdR may control 
T3S to differing degrees and so were examined in this study.  Lineage I/II and 
lineage II variants were slightly more active for T3S stimulation and were more 
repressive on motility; however the effects of these variants on Shiga toxin 
expression were not tested.  This is something that would be worth testing, 






6.1.1.4 Future perspective 
This research has made a significant contribution to the field by identifying a 
genetic region in EHEC that is important for ruminant colonisation and by 
identifying and beginning to characterise a new family of small bacterial 
regulators that control gene expression in E. coli.  Importantly, this work has 
also generated multiple research avenues that can now be pursued.  A grant 
proposal to address the function(s) of OI-51 encoded RgdR proteins in other E. 
coli that present significant economic and public health burdens would surely be 
well received; including in commensal E. coli that may act as a reservoir and 
mixing pot for the evolution of virulence associated factors that may ultimately 
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Summary
This study has identified horizontally acquired
genomic regions of enterohaemorrhagic Escherichia
coli O157:H7 that regulate expression of the type III
secretion (T3S) system encoded by the locus of
enterocyte effacement (LEE). Deletion of O-island 51, a
14.93 kb cryptic prophage (CP-933C), resulted in a
reduction in LEE expression and T3S. The deletion
also had a reduced capacity to attach to epithelial
cells and significantly reduced E. coli O157 excretion
levels from sheep. Further characterization of O-island
51 identified a novel positive regulator of the LEE,
encoded by ecs1581 in the E. coli O157:H7 strain Sakai
genome and present but not annotated in the E. coli
strain EDL933 sequence. Functionally important resi-
dues of ECs1581 were identified based on phenotypic
variants present in sequenced E. coli strains and the
regulator was termed RgdR based on a motif demon-
strated to be important for stimulation of gene expres-
sion. While RgdR activated expression from the LEE1
promoter in the presence or absence of the LEE-
encoded regulator (Ler), RgdR stimulation of T3S
required ler and Ler autoregulation. RgdR also con-
trolled the expression of other phenotypes, including
motility, indicating that this new family of regulators
may have a more global role in E. coli gene expression.
Introduction
Escherichia coli strains are usually present in the flora of
mammalian gastrointestinal (GI) tracts and many are
considered non-pathogenic. However, some strains are
associated with serious intestinal and extra-intestinal
infections. The main differences among strains of these
different pathotypes can be attributed to the acquisition of
genetic information from mobile genetic elements, in par-
ticular bacteriophage (Kaper et al., 2004). Bacteriophage
integration and recombination not only leads to phage
evolution, but is a key driver in the acquisition of virulence
attributes in enteric bacteria, and of the complex regulatory
networks that control their expression. Enterohaemor-
rhagic E. coli (EHEC) contain prophage-encoded Shiga
toxins and are associated with severe GI and systemic
disease in humans (Nataro and Kaper, 1998; Karmali,
2004). Ruminants are considered to be the most important
reservoirs for EHEC, particularly cattle and sheep which
shed the organism in their faeces (La Ragione et al., 2009).
The predominant pathogenic serotype in North America,
parts of Asia and the UK is O157:H7 (Armstrong et al.,
1996; Besser et al., 1999; Caprioli et al., 2005).
Studies on EHEC O157:H7 have shown that the geno-
typic diversity among different strains is largely attributable
to bacteriophage-related DNA fragments (Ohnishi and
Hayashi, 2002; Zhang et al., 2007; Asadulghani et al.,
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2009). In EHEC O157:H7 strain EDL933, these horizon-
tally acquired elements have been termed O-islands (OIs)
and include both fully functional and cryptic prophages
(Perna et al., 2001). The locus of enterocyte effacement
(LEE) encodes a type III secretion (T3S) system, an essen-
tial virulence factor for EHEC that allows the direct injection
of bacterial effector proteins into host cells to subvert host
cell signalling pathways and promote bacterial attachment
(Kenny et al., 1997; Hemrajani et al., 2010; Newton et al.,
2010). While T3S has been shown to be critical for EHEC
O157:H7 colonization in the ruminant host (Naylor et al.,
2005), levels of T3S can vary significantly among different
EHEC isolates (Son et al., 2002; Roe et al., 2003; Rashid
et al., 2006; Yang et al., 2009). Such variation in T3S
regulation may have important implications for bacterial
persistence and shedding in the bovine host and for human
infection (Chase-Topping et al., 2008). Recent studies
comparing EHEC O157:H7 genome sequences have iden-
tified three lineages of the organism (Kim et al., 1999;
Zhang et al., 2007). While all lineages can be isolated from
cattle, lineage I (LI) and lineage I/II (LI/II) strains are more
frequently associated with human clinical disease than
lineage II (LII) strains. Further, EHEC O157:H7 strains
associated with outbreaks of severe illness in the USA
have been shown to belong to a single subtype of LI/II,
designated SNP clade 8 (Manning et al., 2008; Laing et al.,
2009). Several studies have attempted to understand the
genetic basis for the apparent differences in the epidemi-
ology and virulence among EHEC O157:H7 genotypes,
and recent studies have shown that LI and LI/II strains
produce higher levels of Shiga toxins than bovine-
associated LII strains (Zhang et al., 2010). Similarly, hyper-
virulent SNP clade 8 strains have been shown to have
higher levels of LEE expression than EHEC O157:H7
strain Sakai from SNP clade 2 (Abu-Ali et al., 2010).
A large number of factors have been shown to influence
expression of LEE in both enteropathogenic E. coli (EPEC)
and EHEC (Tree et al., 2009; Kendall et al., 2010). In both
pathotypes, the LEE-encoded regulator (Ler) is expressed
from the first LEE operon (LEE1) and is required to activate
expression of all five main LEE operons (LEE1–5) (Elliott
et al., 2000; Sharma and Zuerner, 2004). However, at
higher concentrations, Ler is considered to be repressive
at LEE1 (Berdichevsky et al., 2005; Yerushalmi et al.,
2008). To date, most of the genetic and environmental
control of T3S has been shown to occur through LEE1 and
Ler activation, including an activator and repressor combi-
nation within the LEE, GrlA and GrlR, which are involved in
the reciprocal regulation of LEE and flagella expression
(Barba et al., 2005; Iyoda et al., 2006; Huang and Syu,
2008; Jimenez et al., 2010; Islam et al., 2011;). In EPEC,
LEE expression is thought to be positively regulated by the
plasmid-encoded regulator C (PerC) locus and a series of
PerC homologue (Pch) proteins; encoded by pchA–E and
pchX in EHEC O157:H7. These genes are usually associ-
ated with cryptic prophage regions encoding effector pro-
teins that are exported by the T3S system and the Pch
regulators co-ordinate the expression of these horizontally
acquired effectors with the LEE-encoded T3S system
(Iyoda and Watanabe, 2004; Porter et al., 2005; Abe et al.
2008; Yang et al., 2009).
The aim of the present study was to identify OIs of
EHEC O157:H7 that cross-talk with the T3S system. An
OI-51 deletion mutant was shown to have lower levels of
LEE expression in vitro and subsequent testing demon-
strated that this genomic island contributes to ruminant
colonization and persistence. A novel regulator, termed
RgdR, was identified on OI-51 and shown to control both
LEE expression and motility. The mechanism of RgdR
activation of LEE was investigated.
Results
T3S screening of EHEC O-island mutants
Initial screening identified a subset of OIs with the capac-
ity to either repress or activate T3S in EHEC strains
EDL933 and TUV93-0 (Shiga toxin-negative derivative
strain of EDL933). For example, TUV93-0 derived
mutant’s DOI-47, DOI-76 (Fig. 1A) and DOI-141 (Fig. 1B)
all had levels of T3S above that of the wild-type parent,
suggesting repression by these islands, while DOI-51
(Fig. 1A) and DOI-133 (Fig. 1B) mutants had reduced
levels of T3S, suggesting activation by these islands. In
the present study, we focused on the potential signifi-
cance of OI-51 for colonization and how it controls T3S as
variation in this region has been reported to impact on
LEE regulation (Yang et al., 2009).
Deletion of OI-51 leads to reduced colonization and
shedding levels of E. coli O157 strain TUV93-0 in vivo
In order to assess the importance of OI-51 for colonization
of ruminants, the OI-51 deletion and the parent strain
were co-administered in an established ovine colonization
model (Wales et al., 2001). The OI-51 deletion was
marked with a chloramphenicol resistance cassette and
the parent strain for resistance to nalidixic acid allowing
direct plating and enumeration of the two strains from
faeces. Six animals were orally dosed with the two strains,
with only one animal failing to be properly colonized
(< 20 cfu g-1 faeces from the daily counts) (Fig. 2A). For
the remaining five animals the estimated relative total
levels of the mutant excreted from day 5 onwards, to
remove inoculum effects, were estimated with a statisti-
cally significant reduction demonstrated for the mutant
(P = 0.006, Fig. 2B) indicating that OI-51 is important for
colonization and persistence in the ruminant GI tract.
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OI-51 sequence analysis
Initial phenotypic screening indicated that an EHEC
O157:H7 DOI-51 mutant has reduced levels of T3S. OI-51
is a 14.93 kb cryptic prophage designated as CP-933C in
EHEC strain EDL933 and Sp7 in EHEC strain Sakai
(Hayashi et al., 2001) (Fig. 3). The composition of this
cryptic prophage varies in other referenced E. coli
genomes, including E. coli CFT073 and ED1a (Fig. 3).
Analysis of OI-51/Sp7 genomic structure shows it to be an
unusual and highly degraded prophage comprised mainly
of P4 phage remnants. The majority of the open reading
frames annotated in OI-51/Sp7 are hypothetical although
several share features with known proteins, including a
P4 integrase (similar to CP4-like integrase and integrase
used for 933L and LEE PAI); a P4-like excisionase (Xis);
a replication gene similar to the P4 a gene; a putative
DNA binding protein similar to P4 ORF88 (AlpA); a puta-
tive single-stranded DNA binding protein (ssDNA); a puta-
tive transcriptional activator similar to PerC (PchE); and
phage structural genes.
ECs1581 is a positive regulator of T3S in EHEC
O157:H7
Systematic analysis of cloned OI-51 regions demon-
strated that a 5 kb region (z1835–z1843) was able to
rescue T3S in the TUV93-0 DOI-51 mutant (Fig. 4A) when
expressed from low copy number vector pWSK29
(pZ1835–43) (Table S1). Deletions across this fragment
indicated that a region between z1841 and z1842 was
required for this activation (data not shown). From the
Sakai annotation (Fig. 3), this region does contain an
open reading frame, ecs1581, the identical sequence
being present but not annotated in the EDL933 sequence.
Deletion of ecs1581 by allelic replacement with a resis-
tance cassette significantly reduced T3S levels in a
TUV93-0 background. Further, the reduced levels of T3S
in both the Decs1581 and DOI-51 mutants could be
complemented by in trans expression of ecs1581 from a
low copy number plasmid (pECs1581) (Fig. 4B and C). In
line with the animal colonization data, deletion of OI-51
reduced adherence of E. coli O157 to bovine epithelial
cells and could be complemented by ecs1581 expressed
in trans (Fig. S1). We have therefore been able to identify
ecs1581 as a new regulator in EHEC that is able to
stimulate T3S and adherence.
ECs1581 is predicted to be a small protein of 99 amino
acids with a molecular mass of 11.704 kDa and a pI of
10.09. ECs1581 has no significant sequence similarity
with any known protein although it does have a very short
section of homology with the spacer region of Ler that
bridges the known protein–protein interaction domain of
Ler with its DNA binding domain (Mellies et al., 2008).
However, there is no significant homology of ECs1581
with these functional regions of Ler (Fig. S2).
Fig. 1. Screening of EHEC O157:H7 O-island (OI) mutants for altered levels of T3S. SDS-PAGE gels showing culture supernatant secretion
profiles for EHEC strain TUV93-0 and a selection of 24 isogenic deletion strains. Parent strain TUV93-0 also acted a positive control for T3S
and a T3S system mutant (DLEE1–3) provided a negative control for secretion. OI deletions are as defined with reference to the original
designations in Perna et al. (2001). The translocon protein bands are indicated, EspB/D and EspA as well as BSA which was added as a
loading control to rule out the precipitation process as a source of variation and to act as a co-precipitant. Strains were cultured in
MEM-HEPES to an OD600 of 1.0 and culture supernatants were TCA-precipitated, separated by SDS-PAGE and stained with Colloidal blue as
described in Experimental procedures.
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Distribution of ECs1581 in E. coli strains
Sequence analysis of ECs1581 variants in different line-
ages of EHEC O157:H7 showed the core region of this
protein (amino acids 20–68) to be highly conserved; with
distinct lineage-specific amino acid substitutions at the
N- and C-termini (Fig. 5A). Interestingly, this sequence
divergence was specific to LI EHEC O157 by comparison
with LII and LI/II (Fig. 5A). Similar analyses of sequences
immediately upstream of ecs1581 showed divergence
Fig. 2. OI-51 contributes to ruminant colonization. Six animals were orally dosed with both wild-type (WT) (TUV93-0) and DOI-51 EHEC
O157:H7 strains as described in Experimental procedures.
A. Levels of both strains were determined daily from faecal samples. ‘PosE’ are samples that were positive for the strain following broth
enrichment; ‘NegE’ samples were negative following broth enrichment.
B. The cumulative shedding levels for each animal and strain were estimated for colonized animals from day 5 onwards to avoid inoculum
effects. One animal was excluded from the analysis that was not properly colonized by either strain (< 20 cfu per gram of faeces). The
different symbols represent individual animals and allow direct comparison of the two strains in each animal. The right-hand panel of the graph
shows the percentage mean decrease of the mutant strain by comparison with the WT. The difference in cumulative shedding levels in the five
colonized animals was assessed by a one-sample t-test compared to a null hypothesis of 0 change. The data were log10 transformed data to
normalize the values, and the difference was statistically significant (P = 0.006).
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between these lineages (data not shown) which could
potentially impact ecs1581 expression levels. Ortho-
logues of ECs1581 were also found in sequenced non-
O157 EHEC strains (O103:H2, O26:H11 and O111:H-); in
EPEC strain O55:H7; newborn meningitis E. coli (NMEC)
strain IHE3034; enteroaggregative E. coli (EAEC) strain
O42; atypical EPEC strain E110019; uropathogenic E. coli
(UPEC) strains CFT073 (O6:K2:H1) and IAI39 (O7:K1);
Shigella spp and commensal E. coli strain ED1a (O81); all
with > 77% homology over a region of 99 amino acids (i.e.
full-length ECs1581) (Table S2). Multiple divergent copies
of ecs1581 were also present in the chromosomes of
strains harbouring this regulator and these are also
detailed in Table S2. ECs1581 contains a tri-peptide
arginine-glycine-aspartate (RGD) motif (amino acids
20–22, Fig. 5B) which may be important for mediating
protein–protein interactions based on previously estab-
lished functions of this motif (D’Souza et al., 1991).
ECs1581 and orthologous protein C1493 (UPEC) can
activate T3S and repress motility in EHEC and UPEC
Given the diversity of E. coli strains that harbour
sequence-related variants of ECs1581, its prevalence
and divergence among different EHEC lineages, and the
fact that not all strains with this regulator harbour a LEE-
encoded T3S system, we wanted to investigate the func-
tionality of a subset of these protein variants by testing
their effects on T3S and the related but more ubiquitous
flagella system.
The UPEC CFT073 variant C1493 has 83% sequence
similarity to ECs1581 (Fig. 5B) and is also encoded on a
cryptic prophage (CP073-3) that is inserted in an identical
location on the chromosome as CP-933C (OI-51/Sp7)
(Mobley et al., 1990; Perna et al., 2001; Welch et al.,
2002). c1493 was cloned into the low copy number plasmid
pWSK29 to create expression plasmid pC1493 and this
was assessed for its effects on T3S levels following
induced expression in an EHEC ecs1581 mutant. Expres-
sion of pC1493 rescued T3S demonstrating that the vari-
ants are functionally interchangeable, despite UPEC
lineages not harbouring a LEE-encoded T3S system
(Fig. 5C).
To investigate motility, a c1493 mutant was constructed
in UPEC strain CFT073 and examined in soft agar follow-
ing in trans expression of c1493 and ecs1581; in the
reciprocal manner motility was examined in a EHEC
Fig. 3. Organization of OI-51 from E. coli O157 and nucleotide
sequence homology with related regions from E. coli ED1a and
E. coli CFT073. The E. coli O157 sequence used for the
representation and analysis was from the Sakai strain and the
region shown is between the chromosomal co-ordinates:
1594585–1610169 which lie between ycdF and phoQ of E. coli
K-12 MG1655. The partially homologous region from E. coli
CFT073 (chromosomal co-ordinates: 1377764–1393349) lies in the
same chromosomal location. The related prophage in E. coli ED1a
lies between ydgD and ydgG (chromosomal co-ordinates:
1740689–1756274). The selected regions were compared by
BLASTn; regions and level of homology are indicated by the grey
shading with genes encoding RdgR (ECs1581 in Sakai) and
homologues (ECED1_1787 in ED1a and C1493 in CFT073) shown
in orange. Other characterized genes are annotated as shown with
ssDNA indicating a conserved gene in the three regions that is
predicted to encode a single-stranded DNA binding protein.
Fig. 4. Identification of ecs1581 as a positive regulator of T3S.
A. SDS-PAGE gel showing complementation of T3S in an EHEC DOI-51 strain expressing a cloned OI-51 fragment containing genes
z1835-z1843 (pZ1835-pZ1843). The empty vector alone acted as a control (pWControl).
B. SDS-PAGE gel showing the T3S profiles for the parent strain TUV93-0 and DOI-51 mutant expressing pECs1581 or pWControl.
C. SDS-PAGE gel showing the T3S profiles for parent strain TUV93-0, DOI-51 and a Decs1581 mutant expressing pZ1835–Z1843, pECs1581
or pWControl. Protein samples were prepared and analysed as described in Experimental procedures.
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ecs1581 mutant strain with in trans expression of the two
variants. Although only subtle differences in motility were
observed for wild-type and mutant constructs in both
EHEC and UPEC (Fig. 5D), the in trans and presumably
higher level expression of the two variants downregulated
motility, a phenotype that was not observed for the con-
trol strains expressing the empty vector (pWControl)
(Fig. 5D).
In EHEC, GrlA is an established regulatory protein
encoded by the LEE that positively regulates ler transcrip-
tion and LEE gene expression; and negatively regulates
motility in a feedback loop with the repressor GrlR (Iyoda
et al., 2006). Although unlikely given our observations in
EHEC and UPEC, we wanted to rule out the possibility
that in EHEC, ecs1581 may be acting reciprocally on T3S
and flagella via grlA. We therefore analysed T3S and
motility in a grlA::Tn mutant (Table S1) with and without
induced expression of ecs1581 from a low copy number
plasmid. As expected, T3S levels were reduced in the
grlA::Tn mutant compared with the parent strain (Fig. 5E).
Induced expression of ecs1581, however, was able to
increase T3S levels in the grlA::Tn mutant (Fig. 5E), indi-
cating that ecs1581 activation of T3S is mediated inde-
pendently of grlA. Further, induced expression of ecs1581
in the grlA::Tn mutant downregulated motility in this strain
(data not shown). Other regulators of both T3S and motil-
Fig. 5. Sequence comparison of ECs1581 variants in E. coli.
A. Multiple alignment of the predicted amino acid sequences of ECs1581 in different lineages of O157:H7. Residue divergence specific to
lineage I EHEC O157:H7 isolates is marked by a pink shaded box.
B. Multiple alignment of EHEC variant ECs1581 (EDL933/Sakai) with commensal variant ECED1_1787 (ED1a) and UPEC variant C1493
(CFT073). The RGD motif is at amino acid position 20–22. Residue divergence between the strains is indicated.
C. SDS-PAGE gel showing stimulation of T3S in an EHEC Decs1581 mutant expressing EHEC ECs1581 (pECs1581) or UPEC C1493
(pC1493) from a low copy number plasmid. pWControl alone in the ecs1581 mutant was used as a negative control strain. TCA-precipitated
culture supernatants were analysed as described previously in Experimental procedures.
D. Analysis of motility repression in an EHEC Decs1581 and UPEC Dc1493 deletion background expressing pECs1581, pC1493 or pWControl.
Motility was assessed as described in Experimental procedures.
E. SDS-PAGE gel showing T3S profile for EHEC strain ZAP193 and isogenic DgrlA::Tn mutant expressing pECs1581 or pWControl. Strains
were cultured in DMEM to an OD600 of 1.0 and culture supernatant proteins were analysed exactly as described for strains grown in
MEM-HEPES.
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ity include QseB-C (Hughes et al., 2009; Kostakioti et al.,
2009), although RgdR was able to significantly increase
T3S levels in a TUV93-0 DqseC mutant (data not shown)
indicating it does not act via this pathway.
Commensal orthologue ECED1_1787 is unable to
stimulate T3S or repress motility in EHEC
Commensal strain ED1a (a close relative of UPEC strain
CFT073; phylogenetic group B2) also harbours an
orthologue of ECs1581, ECED1_1787, which has 94%
sequence similarity (Fig. 5B) (Clermont et al., 2008; Jau-
reguy et al., 2008; Touchon et al., 2009). Despite having
the highest known homology to ECs1581, even compared
to other EHEC O157:H7 variants, commensal protein
ECED1_1787 was unable to activate T3S or repress
motility following induced expression (pECED1_1787) in
an EHEC ecs1581 mutant strain (Fig. 6A). This was
informative as there are only six amino acid differences
between ECs1581 and ECED1_1787 (Fig. 5B); and by
the finding that C1493 has this capacity despite its lower
homology to ECs1581 (83% versus 94% respectively).
The residue divergence in ECED1_1787 by comparison
to ECs1581 maps to the following residues: D10A, R20C,
Q27K, K35N, H45R and R61D (amino acids 1–99)
(Fig. 5B). Interestingly, two of these changes occur within
Fig. 6. Effects of natural and engineered variants of ECs1581 on T3S and motility.
A. SDS-PAGE gel showing T3S levels in EHEC strain TUV93-0 and Decs1581 mutant expressing wild-type and engineered variants of
commensal protein ECED1_1787 from a low copy number plasmid (pECED1_1787, pECED1_1787C20R and pECED1_1787N35K).
pWControl in the ecs1581 mutant strain was used as a negative control and wild-type variants pECs1581 and pC1493 were included as a
reference for high T3S levels.
B. Analysis of motility in strain TUV93-0 and Decs1581 mutant expressing pECED1_1787, pECED1_1787C20R, pECED1_1787N35K or
pWControl.
C. SDS-PAGE gel showing T3S levels in strain TUV93-0 and Decs1581 mutant expressing wild-type and engineered variants of ECs1581 from
a low copy number plasmid (pC1493, pECs1581, pECs1581R20C, pECs1581R20C20N, pECs1581K35N, pECs1581R20C + K35N,
pECs1581R20C + D10A, pECs1581R20C + H45R, pECs1581R20C + R61D, pECs1581R20C + Q27K and pWControl).
D. Analysis of motility in the same strain set. Analysis of culture supernatants and motility was carried out as described in Experimental
procedures.
The motility figures (B and D) are composite images from photographs of motility agar plates inoculated with the strain of interest. The same
images are used for the wild types and controls in B and D.
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predicted domains with a D10A substitution in a putative
N-myristylation motif (amino acids 7–12), and an R20C
substitution in the EHEC-conserved RGD motif (amino
acids 20–22) (Fig. 5B). Like ECED1_1787, C1493 has a
D10A but harbours an RGD motif as in ECs1581
(Fig. 5B).
Amino acid substitutions in ECs1581 and ECED1_1787
alter their regulation of T3S and motility
Based on the functional differences demonstrated for the
ECs1581 and ECED1_1787 proteins, a series of recipro-
cal substitutions in proteins ECs1581 and ECED1_1787
were constructed by site-directed mutagenesis and their
effects on T3S and motility assessed in an EHEC ecs1581
mutant. A single C20R mutation in protein ECED1_1787
(pECED1_1787C20R) was sufficient to enable this
variant to now activate T3S and repress motility (Fig. 6A).
An ECED1_1787 C20R + N35K double mutation
(pECED1_1787C20R + N35K) did not increase T3S
levels over the single C20R change (Fig. 6A). Strikingly,
induced expression of ECED1_1787C20R severely
repressed motility (Fig. 6B). This shift in phenotype
between wild-type ECED1_1787 and engineered variant
ECED1_1787C20R was intriguing as induced expression
of ECED1_1787 in the same strain background, if any-
thing, increased motility. A K35N substitution in ECs1581
(ECED1_1787N35) attenuated its stimulation of T3S in an
EHEC ecs1581 mutant when induced (pECs1581K35N)
from a low copy number plasmid (Fig. 6C). Surprisingly,
an R20C change in the EHEC-conserved RGD motif
(ECED1_1787C20) slightly increased T3S levels follow-
ing induced expression (pECs1581R20C) in this back-
ground, and this engineered variant was also more
repressive for motility than wild-type ECs1581 (Fig. 6C
and D). A further R20C20N mutation in this same RGD
motif, however, did reduce T3S levels compared to wild-
type ECs1581 (Fig. 6C). Although the small size of RgdR
means that some changes could affect protein conforma-
tion and stability, these results highlight the functional
importance of residue 20 and other targeted combinations
for the regulatory activities of this novel regulator.
Mechanism of ECs1581 activation of T3S
To examine how ECs1581 activates T3S, its capacity to
stimulate a plasmid-encoded LEE1–GFP transcriptional
fusion was studied in different genetic backgrounds. Popu-
lation fluorescence levels from the LEE1 fusion were
reduced significantly in an ecs1581 mutant (Fig. 7A). Ler,
expressed from LEE1, is required for autoregulation of
LEE1 and activation of the remaining LEE operons leading
to T3S. We determined whether ECs1581 was able to
stimulate LEE1 expression in the absence of ler autoregu-
lation. Population fluorescence levels from the LEE1
reporter were determined in EHEC strains ZAP198 (WT,
Table S1) and ZAP1004 (Dler, Table S1) following induc-
tion of ecs1581 (pECs1581) (Fig. 7B and C). ECs1581 was
able to stimulate LEE1 expression in the absence of ler
(Fig. 7C). To determine if ECs1581 regulation of LEE1
expression in EHEC is direct or indirect, electrophoretic
mobility shift assays (EMSA) were carried out using a
291 bp LEE1 promoter fragment (-288 to +3) and purified
ECs1581. While it was evident that the protein bound to the
DNA in a concentration-dependent manner (Fig. S3),
ECs1581 also bound to the control DNA fragment, indicat-
ing a lack of specificity to this interaction. Of note was the
finding that the commensal variant ECED1_1787, which
was unable to activate T3S, was unable to bind the same
LEE1 promoter fragment indicating that the regulatory
activity of ECs1581 may require DNA binding (Fig. S3).
In order to confirm that ECs1581 stimulates T3S
through activation of the Ler autoregulatory cascade, a
strain (ZAP1327, Table S1) was constructed in which the
LEE1 promoter was replaced by a cassette that allowed
constitutive expression of ler, removing the normal
transcriptional regulation of LEE1 including sequences
required for ler autoregulation (Mellies et al., 2008;
Yerushalmi et al., 2008). Constitutive ler transcription in
this replaced promoter strain was confirmed by RT-PCR
(Fig. 7E). There was, however, no detectable T3S from
this strain (Fig. 7F). Induced Ler expression in this back-
ground was able to stimulate T3S but this was not the
case for induced ECs1581. ECs1581 induction of the
LEE1 reporter fusion in this strain background was detect-
able but remained at a constant level throughout the
growth curve (Fig. 7D). This was in stark contrast to
the activation kinetics measured for the LEE1 fusion in
the strain with an unaltered LEE1 promoter on the
chromosome. In this wild-type background, the stimula-
tion of the LEE1 fusion increased exponentially with
optical density, whereas this increase was restricted in the
strain with a replaced LEE1 chromosomal promoter.
Therefore, stimulation of T3S by ECs1581 occurs through
initial activation of transcription from the LEE1 promoter,
leading to induction of the Ler autoregulatory cascade that
in turn promotes expression of the remaining LEE
operons and T3S.
Discussion
The contribution of bacteriophages to intra- and inter-
species bacterial evolution and adaptation are well docu-
mented. Enterobacteriaceae in particular are exposed to
a plethora of phages in the mammalian GI tract and many
of these phages carry additional genetic information that
allow the host bacteria to adapt to local environments
and occasionally cause disease. EHEC is an important
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attaching and effacing pathogen that can cause serious
complications in at-risk individuals due to the production
of phage-encoded Shiga toxins. T3S is an essential viru-
lence factor for EHEC which is required for successful
colonization of the ruminant host. This virulence secretion
system is encoded by the LEE pathogenicity island and
prophage-encoded effector proteins are able to utilize this
system to be exported directly into host cells to sabotage
host communication pathways and promote bacterial
colonization.
In this study, a number of prophage deletions (OIs)
were examined for their effect on T3S levels in order to
identify horizontally acquired regions that cross-talk with
this essential colonization system. Of the 24 OI mutants
studied in TUV93-0 (excluding the LEE1-3 deletion), five
had lower levels of T3S (Fig. 1A and B), including OI-51.
OI-51 is a 14.93 kb region in EDL933/TUV93-0 and
15.46 kb in the sequenced Sakai strain. Variations of this
island are present in all EHEC O157:H7 strains as well as
non-O157 EHEC strains, but also in specific UPEC,
NMEC and commensal E. coli strains that do not contain
a LEE-encoded T3S system. OI-51 in EDL933 contains a
predicted 22 open reading frames, with a subset indicat-
ing P4 ancestry. Deletion of OI-51 reduced persistence in
competitive ruminant colonization experiments indicating
the potential importance of this region.
Through a combination of deletion and complementa-
tion analyses, ecs1581 was identified as a gene able to
restore T3S levels in both the OI-51 and ecs1581
mutants. Three lineages of EHEC O157:H7 have been
proposed based on genome sequences (Kim et al., 1999;
Zhang et al., 2007). In the present study, two main
sequence types of ECs1581 were identified, LI and LII &
LI/II, the latter having identical protein-coding sequences.
EHEC O157:H7 lineage-specific variants of ECs1581 (LI)
from strains TW14539 (LI/II) and 96788 (LII) were cloned
and assessed for their effects on T3S and motility. All the
variants were able to induce T3S and repress motility,
although slight variation in induction levels was observed
(Fig. S4A and B). Sequences immediately upstream of
these two variants also differ, but it is not known if expres-
sion levels of these two variants differ as these were not
assessed in this study. Variation in activity and/or expres-
sion of ECs1581 could therefore contribute to differ-
ences in T3S expression demonstrated between EHEC
O157:H7 strains (Son et al., 2002; Roe et al., 2003;
Rashid et al., 2006; Yang et al., 2009). We also note that
genetic variability among the different EHEC O157:H7
lineages are associated with regions adjacent to pchD
and pchE genes on OI-43/48 (the tellurite resistance and
adhesin-conferring islands) and OI-51 respectively
(Zhang et al., 2007 and Yang et al., 2009).
Variants of the protein from different E. coli strains
exhibited markedly different capacities to regulate T3S. A
variant present in the commensal strain ED1a did not
activate T3S and contains an R20C (CGD) substitution in
the EHEC-conserved RGD motif. Replacement of this
residue to generate an RGD motif in the commensal
variant produced a protein that now had the capacity to
activate T3S. Based on this we have termed the EHEC
regulator RgdR. It was interesting to note that regardless
of the effect on T3S, all variants in RgdR had a marked
impact on motility. In general, there was an inverse cor-
relation between T3S and motility that was also apparent
for several of the engineered variants. However, there
were clear exceptions to this, for example ECs1581
R20C + K35N had a weak capacity to activate T3S yet
unusually, showed the strongest capacity to inhibit
motility. Additional work confirmed that this regulation of
T3S and motility was independent of grlA, previously
demonstrated to repress motility on induction of T3S
(Iyoda et al., 2006). RgdR is therefore identified as a
novel regulator able to co-ordinate T3 and motility
expression. Also of note was the finding that expression of
different variants could increase bacterial binding to
Congo red (Fig. S4C). Although the mechanism of this
Congo red binding was not investigated in this study,
recent work by Lee et al. (2011) has demonstrated that
EDL933 is able to produce curli fibres. Taken together, the
pleiotropic phenotypes displayed by RgdR including on
Fig. 7. ECs1581 stimulates T3S via LEE1.
A. Measurement of LEE1 promoter activity in EHEC strain TUV93-0 and isogenic Decs1581 mutant. A 428 bp LEE1 promoter fragment (-444
to -16 upstream from the ler ATG start codon) was cloned into the promoter-less green fluorescence protein (GFP) plasmid pKC26 to create
transcriptional fusion plasmid pLEE1–GFP. Strains transformed with this reporter were cultured in DMEM and the fluorescence produced by
each bacterial population measured every 60 min as described in the Experimental procedures. Corresponding OD600 measurements were
taken at each time point and plotted against the mean fluorescence intensity values for each strain. The promoter-less plasmid pKC26 in each
strain background acted as a control.
B. Measurement of the pLEE1–GFP reporter and control plasmids in EHEC strain ZAP198 (Table S1) with and without induced expression of
ecs1581 (pECs1581) from low copy number plasmid pWSK29.
C. Measurement of the pLEE1–GFP reporter and control plasmids in strain ZAP198Dler (ZAP1004, Table S1) with and without induced
expression of pECs1581.
D. Measurement of the pLEE1–GFP reporter and control plasmids in strain ZAP198 with a constitutive LEE1 promoter (ZAP1327, Table S1)
with and without induced expression of pECs1581.
E. RT-PCR measurement of ler expression levels in EHEC strains ZAP198, ZAP1004 and ZAP1327.
F. Western blot of EspD secretion by EHEC Decs1581 and the replaced LEE1 promoter mutant (ZAP1327) trans expressing Ler (pLer) or
ECs1581 (pECs1581) from low copy number plasmids.
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T3S, motility and cell surface charge suggests it may play
a more global role in the cell. This would explain the
presence of variants of this regulatory protein in strains
without a LEE-encoded T3S system. Future work will
address the regulons of RgdR in EHEC O157:H7 and
strains not harbouring a LEE pathogenicity island.
RgdR was able to stimulate LEE1 expression indepen-
dently of Ler and required a normal LEE1 promoter region
for this activation. A construct that resulted in constitutive
expression of LEE1 could be induced to secrete EspD by
increased expression of Ler in trans but not by induced
expression of RgdR in trans. In this background, RgdR
was limited in its capacity to induce a LEE1–GFP reporter
fusion construct. An explanation for this is that even
though RgdR can activate the LEE1 promoter in the
absence of Ler, Ler expression and the Ler auto-induction
cycle is required for the activation of T3S as Ler, and not
RgdR, activates transcription of LEE2-5 encoding the T3S
system and secreted proteins. One explanation for the
data is that ECs1581 could inhibit Ler autorepression at
the LEE1 promoter. It has been proposed that high Ler
levels allow binding of Ler to a low affinity site which may
repress transcriptional activation. The kinetics of LEE1
activation in the presence of induced ECs1581 would fit
this model. Repeated attempts to purify functional Ler to
test possible interactions were unsuccessful. We note that
ECs1581 does share homology with Ler over a linker
region (Fig. 4D) that could be involved in this interaction.
RgdR did demonstrate a low affinity and non-specific
interaction with DNA (Fig. S3), a property that was absent
from the ECED_1787 variant that did not stimulate T3S.
We propose that RgdR may act as a co-factor with one or
more regulators of T3S (Tree et al., 2009; Kendall et al.
2010) to control transcription from the LEE1 promoter.
One regulatory network investigated was the quorum-
sensing two-component system, QseBC, as this controls
both T3S and motility (Hughes et al., 2009; Kostakioti
et al., 2009). However, RgdR was able to significantly
increase T3S levels in a TUV93-0 DqseC mutant (data not
shown). Another possibility is that RgdR works with the
Pch family of LEE activators (Iyoda and Watanabe, 2004;
Porter et al., 2005; Abe et al. 2008; Yang et al., 2009),
although there is no significant homology between the
two, in particular to the region truncated in the smaller Pch
variants (PchC–E) (Abe et al. 2008). With the exception of
pchD, all pch alleles are encoded on prophage elements,
and it is hypothesized that multiple prophages in the chro-
mosome of EHEC O157:H7 may be able to recombine to
affect the total copy number of pch genes; thus potentially
impacting on levels of LEE gene expression (Ohnishi
et al., 2001; Iyoda and Watanabe, 2004; Asadulghani
et al., 2009). As with the Pch activators of LEE, all
members of the RgdR family of proteins are prophage-
associated. For example, EHEC strain EDL933 harbours
two RgdR truncates (both 63 amino acids), z1197 and
z1636 that are located on OI-43 and OI-48 respectively
(Table S2). In EHEC strain Sakai only one truncate exists
(63 amino acids), ecs5415, which is located on Sakai
prophage-like element 1 (SpLE1). In EHEC O26:H11
strain 11368, four copies of RgdR can be found
(Table S2); three full-length (99 amino acids) variants and
one truncate (63 amino acids) which is located on OI-48.
Perhaps, as proposed for the Pch proteins, genome inte-
gration of CP-933C (OI-51) and similar prophages may
additively influence levels of LEE gene expression in
EHEC. It is therefore perhaps not surprising that a number
of deleted prophage regions analysed in this study and
previously (Tree et al., 2011) have a regulatory impact on
T3S. The RgdR, Pch and Psr families of regulators
provide clear examples of how differences in the proph-
age repertoire of EHEC strains can impact on expression
of critical colonization factors and are a major driving force
in the evolution of this pathogen (Asadulghani et al., 2009;
Tree et al., 2009; 2011).
In summary, this research has defined an important
region (OI-51) necessary for EHEC O157:H7 colonization
and persistence in ruminants, and has identified a com-
pletely new family of small bacterial regulators that control
gene expression in E. coli.
Experimental procedures
Bacterial strains, plasmids and primers
All bacterial strains, plasmids and primers used in this study
are detailed in Table S1.
Bacterial culture conditions and media
Bacterial strains were routinely cultured at 37°C with shaking
in Luria–Bertani (LB) broth or agar. In the analysis of T3S
proteins, either DMEM (Sigma-Aldrich) or MEM-HEPES
(Sigma-Aldrich) supplemented with 250 nM Fe(NO3)2 and
0.2% glucose was used for culturing strains. When measuring
promoter activity with GFP transcriptional fusions, strains
were cultured in DMEM. In Congo red binding assays, CFA
agar (LabM) and CFA broth [0.15% tryptone yeast extract
(Becton Dickinson); 1% casamino acids (Oxoid); 0.01%
Congo red (Sigma-Aldrich); 400 mM MgSO4.7H2O and
40 mM MnCl2.4H2O] was used for selecting and culturing
colonies respectively. When required, Isopropyl b-D-1-
thiogalactopyranoside (IPTG), 5-bromo-4-chloro-3-indolyl-
beta-D-galactopyranoside (X-gal) and antibiotics were added
to media at the following final concentrations: 1 mM IPTG,
20 ng ml-1 X-gal, 50 mg ml-1 ampicillin, 50 mg ml-1 chloram-
phenicol, 100 mg ml-1 kanamycin and 15 mg ml-1 nalidixic acid.
OI-51 ruminant colonization study
Crossbred lambs (six 6-week-old) were housed in bio-secure
containment level 2 accommodation and supplied with food
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and water ad libitum. All lambs were confirmed to be free of
EHEC O157 by enrichment and O157 immuno-magnetic
separation prior to commencing the studies. Lambs were
dosed orally with 1 ¥ 1010 cfu of wild-type E. coli O157:H7
and mutant bacteria (5 ¥ 109 cfu of each). Inocula, 10 ml
resuspended in 10 ml of PBS pH 7.4, were delivered using a
worming gun (Novartis Animal Health) ensuring that the
whole inoculum was delivered directly to the pharynx. Rectal
faecal samples from each lamb were collected daily for direct
plating onto sorbitol-MacConkey (Oxoid) plates supple-
mented with appropriate antibiotics. Enrichment was carried
out on samples in buffered peptone water for 6 h at 37°C and
then plated onto sorbitol-MacConkey plates supplemented
with the appropriate antibiotic. Representative colonies were
confirmed to be E. coli O157 by latex agglutination (Oxoid).
Animal experiments were performed in line with the Animals
Scientific Procedures Act (1986) and were approved by the
local ethical review committee.
Construction of mutations in EHEC and UPEC
Defined ecs1581, c1493 and qseC mutants were con-
structed using allelic exchange as described previously by
Blomfield et al. (1991) and Emmerson et al. (2006). Briefly,
chromosomal regions (~ 600–1000 bp) flanking the genes
of interest were PCR-amplified (Table S1) with a high fide-
lity Phusion polymerase (Fiinzyme) and cloned into a
chloramphenicol-resistant temperature-sensitive exchange
plasmid (pIB073) (Table S1). A kanamycin resistance cas-
sette (Gally et al., 1994) was then cloned in between the
homologous flanking regions on the exchange plasmid and
subjected to several rounds of temperature and antibiotic
selection to achieve allelic replacement in the relevant
strain background. All mutants were verified by PCR and
successful complementation was achieved by providing
the related genes in trans on low copy number plasmid
pWSK29 (Table S1).
Construction of plasmids for expression and
complementation
Complementation plasmids were constructed using PCR
products amplified with high fidelity Phusion polymerase
cloned into pWSK29 (Table S1). E. coli strain DH5a was
used as the intermediate host strain for cloning and all con-
structs were verified by sequencing.
Construction of engineered ECs1581 and ECED1_1787
protein variants
Site-directed mutagenesis was carried out using an overlap
PCR approach with the primers listed in Table S1. Briefly, the
5′ and 3′ regions of each gene were PCR-amplified with
engineered mutations in the relevant primers. The two PCR
products were then used as a template for the overlap PCR
using the outside primers. The PCR products were cloned
into vector pWSK29, verified by sequencing (Table S1), and
their effects on motility and T3S in a TUV93-0 Dec1581
mutant background assessed.
Measurement of LEE1 promoter activity
In order to assess LEE1 gene expression in both wild-type
and mutant E. coli O157:H7 backgrounds, a 428 bp PCR-
generated DNA promoter fragment (-444 to -16 bp upstream
from the ler ATG start codon) was amplified from strain
TUV93-0 using high fidelity Phusion polymerase, and cloned
into the promoter-less green fluorescence protein (GFP)
plasmid pKC26 to create transcriptional fusion plasmid
pLEE1–GFP (Table S1). Test strains harbouring this reporter
were cultured in DMEM supplemented with chloramphenicol
and the GFP produced by each bacterial population was
measured every 60 min by transferring 200 ml aliquots of
culture into triplicate wells in a black 96-well plate (Fluoro-
Nunc) and reading the plate in a fluorimeter (FLUOstar
Optima) using 485 nm absorbance and 520 nm emissions.
Promoter-less plasmid pKC26 in each strain background
acted as a control for auto-fluorescence. When LEE1 pro-
moter activity was measured in response to induced expres-
sion of ecs1581 from low copy number plasmid pWSK29
(pECs1581), strains were cultured in DMEM supplemented
with chloramphenicol, ampicillin and IPTG (1 mM). All were
tested in triplicate and on at least three separate occasions.
Congo red binding assay
Strains were initially streaked onto CFA agar plates (LabM)
before individual colonies were taken and inoculated into
CFA broth and grown overnight at 37°C with shaking. Cul-
tures were diluted in PBS to an OD600 of 1.0, centrifuged at
4000 g for 5 min and resuspended in 1 ml of sterile PBS.
Washing was repeated a further two times to remove all
traces of culture broth before finally resuspending the culture
pellets in 2.5 ml of PBS containing a final concentration of
0.01% Congo red. Samples were incubated at 37°C for
30 min before a 1 ml aliquot was taken and centrifuged at
10 000 g for 10 min. Supernatants were discarded and
pellets were air-dried and photographed using a Lumina
digital camera. All strains were tested in triplicate and on
three separate occasions.
Motility assays
Motility plates were prepared by adding 0.3% agar (Sigma) to
1% Bacto-Tryptone (BD; Becton Dickinson) broth containing
0.5% NaCl (Sigma-Aldrich). For plasmid-based complemen-
tation experiments, IPTG and ampicillin was added to plates
when appropriate and all plates were poured the night before
use and allowed to air-dry on the bench. Plates were stab
inoculated and incubated at 37°C for 16 h. All strains were
tested in triplicate and each experiment was carried out on
three separate occasions.
Adherence assays
Bacteria for the assays were cultured in MEM-HEPES and
added at an moi of approximately 100 bacteria to each epi-
thelial cell. Embryonic bovine lung cells (no.21 ACC192,
German Collection of Microorganisms and Cell Cultures)
were cultured in MEM-HEPES in eight-well chamber slides.
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The cells were washed with PBS and incubated in unsupple-
mented MEM-HEPES for 1 h before they were infected with
bacteria. After 180 min, bacteria and EBL cells were fixed by
incubating in 4% paraformaldehyde for 30 min and then
washed three times with PBS. The samples were incubated
for 90 min with anti-O157 LPS antibody (MAST Group) at
1:4000 and following washes incubated with Alexa Fluor 594-
conjugated goat anti-rabbit immunoglobulins antibody
(1/1000, Molecular Probes) for 1 h. The slides were washed
and mounted (Hydromount, National Diagnostic). Imaging
was carried out using a Leica fluorescence microscope and
Open Lab software (PerkinElmer).
Preparation and analysis of T3S culture supernatant
proteins
Bacterial strains were cultured overnight in LB broth at 37°C
with shaking before being diluted to a starting optical density
(OD600) of 0.05 in MEM-HEPES (supplemented with glucose
and iron). Cultures were grown to a final OD600 of 1.0 then
centrifuged at 4000 g for 30 min at 4°C and supernatants
filtered through 0.45 mm low protein-binding filters (Millipore).
A 10% (v/v) final concentration of trichloroacetic acid (TCA;
Sigma-Aldrich) was used to precipitate the proteins and
BSA (NEB) (4 mg ml-1) was added to act as a co-precipitant.
Supernatants were incubated overnight at 4°C and cen-
trifuged at 4000 g for 30 min at 4°C. Protein pellets were
air-dried and resuspended in an appropriate volume of resus-
pension buffer (1.5 M Tris-HCL) in order to standardize
samples and to take into account the slight variation in OD600
at which cultures were harvested. Culture supernatant pro-
teins were subsequently analysed through a 12% SDS-PAGE
and visualized by Colloidal blue staining (Severn Biotech).
Gel images were captured using a Flowgen MultiImage light
cabinet and ChemiImager 4000i v.4.04 software.
Protein detection
SDS-PAGE separated proteins were transferred onto Hybond
ECL nitrocellulose membrane (Amersham Biosciences)
using a Trans-Blot electrophoretic transfer cell (Bio-Rad).
Nitrocellulose membranes were blocked with 8% (w/v) dried
milk powder (Marvel) in PBS at 4°C overnight and incubated
with the relevant antibodies diluted in wash buffer [1% dried
milk (Marvel) and 0.05% (v/v) polyoxyethylenesorbitan mono-
laurate (Tween 20, Sigma-Aldrich) in PBS] at the following
dilutions: mouse monoclonal anti-EspD (kindly provided by
Professor T. Chakraborty, University of Giessen) and rabbit
polyclonal anti-mouse IgG HRP conjugated antibodies
(Dako) were both diluted 1:4000. All antibody-membrane
incubations were carried out for 1 h at RT on a platform
shaker and were washed for 3 ¥ 10 min in wash buffer before
and after each antibody step. For ECL detection, membranes
were incubated in 2.5 ml of ECL Solution 1 (Amersham)
mixed with 2.5 ml of ECL Solution 2 (Amersham) for 5 min at
RT on the bench. Chemiluminescence was detected on
Hyperfilm ECL chemiluminescence film (Amersham) devel-
oped in a Protec automatic film processor (Optimax). Images
were taken using a Flowgen MultiImage light cabinet and
ChemiImager 4000i v.4.04 software.
Native protein purification
Escherichia coli BL21 (DE3) (Invitrogen) cells harbour-
ing plasmid pET28a-ECs1581, pET28a-ECED1_1787 or
pET28a-ECED1_1787C20R were grown in LB broth in the
presence of kanamycin at 37°C with shaking to an OD600 of 0.5.
Cultures were induced with IPTG and grown for a further 4 h
under the same conditions before harvesting by centrifugation
at 4000 g for 30 min. Cell pellets were suspended in lysis
buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole and
1 mg ml-1 lysozyme, pH 8.0) and lysed by sonication (6 ¥ 10 s
pulses with a 10 s cooling period on ice in between each
pulse). Lysates were centrifuged at 10 000 g at 4°C for 30 min,
incubated with Ni2+ NT resin (Qiagen) for 1 h at RT on a
platform shaker and loaded onto a purification column (Bio-
Rad). The column was washed twice with wash buffer (50 mM
NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0) and the
protein was eluted from the column in elution buffer (50 mM
NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0). Crude
preps were transferred into dialysis tubing (8000 kDa molecu-
lar weight cut-off, Medicell international) and dialysed in 2 l of
sterile PBS which was replenished every 24 h for a total of
three changes. Total protein concentration was determined by
BCA according to the manufacturer’s instructions (Novagen)
and purity was verified by SDS-PAGE and antibody detection
of recombinant His-tagged proteins. Purified proteins were
subsequently used in electrophoretic mobility shift and in vitro
transcription assays along with PCR generated DNA promoter
fragments.
Electrophoretic mobility shift assay
To determine if ECs1581 activation of LEE1 is direct or indi-
rect, a 291 bp LEE1 promoter (-288 to +3, with respect to
the ler ATG start codon) and a control gapA fragment (also
291 bp) were PCR-amplified (Table S1) from EHEC strain
TUV93-0 and subjected to EMSA with either purified
ECs1581, ECED1_1787 or ECED1_1787C20R proteins.
EMSA was carried out as described previously (Tree et al.,
2011). Briefly, the purified proteins were co-incubated with
concentrations of ddUTP-11-DIG (Roche) end-labelled DNA
in binding buffer [10 mM Tris (pH 8.0), 50 mM KCl, 5 mM
EDTA, 200 mg ml-1 BSA, 100 ng ml-1 poly d(I-C), 50 mM
glutamate and 5% glycerol] for 30 min at 25°C and loaded
onto 5% non-denaturing polyacrylamide gels in 0.5X TBE.
Fifty nanograms of unlabelled DNA was used for competition
experiments and added to the binding reaction. The DNA and
DNA–protein complexes were electro-transferred onto nylon
membranes and developed with AP-conjugated anti-DIG
antibody (Roche) as per the manufacturer’s instructions.
RT-qPCR
Total RNA was purified from the bacteria using an RNeasy kit
(Qiagen) and random primers used to reverse transcribe the
RNA using Affinityscript (Stratagene). qPCR was carried
out with a PowerSybr mastermix (Applied Biosystems) and
amplified in a MxPro 3000 qPCR machine (Stratagene). The
qPCR primers used are listed in Table S1. Transcript abun-
dance was normalized to 16SrRNA and relative transcription
calculated using MxPro software (Stratagene).
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Bioinformatic analyses
Variants of ECs1581 were identified using BLASTp (http://
www.ncbi.nlm.nih.gov) and sequences were obtained from
GeneBank (http://www.ncbi.nlm.nih.gov/GenBank). Putative
hypothetical domains in ECs1581 were identified using
MyHits (http://myhits.isb-sib.ch/cgi-bin/index) and KEGG
(http://www.genome.jp/kegg). OI-51 prophage alignments
were generated using Easyfig (http://easyfig.sourceforge.




CLC Sequence Viewer (http://www.clcbio.com) was used to
construct and visualize alignments among the protein-coding
regions of ECs1581; the ECs1581 region was identified in
un-annotated draft E. coli sequences through BLASTn
searches.
Sequencing
All DNA sequencing was carried out by GenePool, School of
Biological Sciences, University of Edinburgh, and was per-
formed using an ABI Prism BigDye terminator cycle sequenc-
ing kit version 3.1 (Applied Biosystems). Reactions were
analysed on an ABI 3730 DNA sequencer.
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